<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">106231</article-id><article-id pub-id-type="doi">10.7554/eLife.106231</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.106231.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Functional analysis across model systems implicates ribosomal proteins in growth and proliferation defects associated with hypoplastic left heart syndrome</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Nielsen</surname><given-names>Tanja</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Kervadec</surname><given-names>Anaïs</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Theis</surname><given-names>Jeanne L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4494-8683</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Missinato</surname><given-names>Maria A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Marchant</surname><given-names>James</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Romero</surname><given-names>Michaela</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Marchetti</surname><given-names>Katya</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0000-9635-3246</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Lamba</surname><given-names>Aashna</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Xin-Xin I</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Berenguer</surname><given-names>Marie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3629-9505</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Walls</surname><given-names>Stanley M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Schroeder</surname><given-names>Analyne</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Birker</surname><given-names>Katja</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Duester</surname><given-names>Greg</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Grossfeld</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Nelson</surname><given-names>Timothy J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3862-7023</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Olson</surname><given-names>Timothy M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2716-9423</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ocorr</surname><given-names>Karen</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2593-0119</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Bodmer</surname><given-names>Rolf</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9087-1210</contrib-id><email>rolf@sbpdiscovery.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Vogler</surname><given-names>Georg</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8303-3531</contrib-id><email>gvogler@sbpdiscovery.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Colas</surname><given-names>Alexandre R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8489-0570</contrib-id><email>acolas@sbpdiscovery.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03m1g2s55</institution-id><institution>Center for Cardiovascular and Muscular Diseases, Sanford Burnham Prebys Medical Discovery Institute</institution></institution-wrap><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046ak2485</institution-id><institution>Department of Biochemistry, Chemistry and Pharmacy, Freie Universität Berlin</institution></institution-wrap><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02qp3tb03</institution-id><institution>Cardiovascular Genetics Research Laboratory, Mayo Clinic</institution></institution-wrap><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0168r3w48</institution-id><institution>University of California San Diego, Rady Children’s Hospital</institution></institution-wrap><addr-line><named-content content-type="city">San Diego</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02qp3tb03</institution-id><institution>Center for Regenerative Medicine, Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Division of General Internal Medicine, Department of Molecular and Pharmacology and Experimental Therapeutics, Mayo Clinic</institution></institution-wrap><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02qp3tb03</institution-id><institution>Department of Cardiovascular Medicine, Division of Pediatric Cardiology, Department of Pediatric &amp; Adolescent Medicine, Cardiovascular Genetics Research Laboratory, Mayo Clinic</institution></institution-wrap><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Jagla</surname><given-names>Krzysztof</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052d1cv78</institution-id><institution>GReD Laboratory/Clermont-Auvergne University</institution></institution-wrap><addr-line><named-content content-type="city">Aubière</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0165r2y73</institution-id><institution>Max Planck Institute for Heart and Lung Research</institution></institution-wrap><addr-line><named-content content-type="city">Bad Nauheim</named-content></addr-line><country>Germany</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>11</day><month>12</month><year>2025</year></pub-date><volume>14</volume><elocation-id>RP106231</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2025-03-17"><day>17</day><month>03</month><year>2025</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2025-01-22"><day>22</day><month>01</month><year>2025</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.07.01.22277112"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-05-22"><day>22</day><month>05</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.106231.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-11-28"><day>28</day><month>11</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.106231.2"/></event></pub-history><permissions><copyright-statement>© 2025, Nielsen, Kervadec, Theis et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Nielsen, Kervadec, Theis et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-106231-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-106231-figures-v1.pdf"/><abstract><p>Hypoplastic left heart syndrome (HLHS) is the most lethal congenital heart disease (CHD) whose genetic basis remains elusive, likely due to oligogenic complexity. To identify regulators of cardiomyocyte (CM) proliferation relevant to HLHS, we performed a genome-wide siRNA screen in human iPSC-derived CMs, revealing ribosomal protein (RP) genes as the most prominent effectors of CM proliferation. Whole-genome sequencing of 25 HLHS proband–parent trios similarly showed enrichment of rare RP gene variants, including a damaging RPS15A promoter variant shared in a familial CHD case. Cross-species functional analyses demonstrated that perturbation of RP genes impairs cardiac growth: knockdown of RPS15A, RPS17, RPL26L1, RPL39, or RPS15 reduced CM proliferation, caused cardiac malformations in <italic>Drosophila</italic>, and produced hypoplastic or dysfunctional hearts in zebrafish. Genetic interactions between RP genes and key cardiac transcription factors (TBX5 and NKX2–7) further support their developmental role. Importantly, p53 suppression or Hippo activation partially rescued RP deficiency phenotypes. Together, these findings implicate RP genes as critical regulators of cardiogenesis and candidate contributors to HLHS.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>congenital heart disease</kwd><kwd>HLHS</kwd><kwd>ribosomal poteins</kwd><kwd>hiPSCs</kwd><kwd>zebrafish</kwd><kwd><italic>Drosophila</italic></kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012pb6c26</institution-id><institution>National Heart Lung and Blood Institute</institution></institution-wrap></funding-source><award-id>HL153645</award-id><principal-award-recipient><name><surname>Colas</surname><given-names>Alexandre R</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012pb6c26</institution-id><institution>National Heart Lung and Blood Institute</institution></institution-wrap></funding-source><award-id>HL148827</award-id><principal-award-recipient><name><surname>Colas</surname><given-names>Alexandre R</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012pb6c26</institution-id><institution>National Heart Lung and Blood Institute</institution></institution-wrap></funding-source><award-id>HL054732</award-id><principal-award-recipient><name><surname>Bodmer</surname><given-names>Rolf</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01HL149992</award-id><principal-award-recipient><name><surname>Colas</surname><given-names>Alexandre R</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AG071464</award-id><principal-award-recipient><name><surname>Colas</surname><given-names>Alexandre R</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/033m8b439</institution-id><institution>California Institute for Regenerative Medicine</institution></institution-wrap></funding-source><award-id>DISC2-10110</award-id><principal-award-recipient><name><surname>Colas</surname><given-names>Alexandre R</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013kjyp64</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>AHA Predoctoral Fellowship 18PRE33960593</award-id><principal-award-recipient><name><surname>Birker</surname><given-names>Katja</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Cross-species functional genomics identify ribosomal protein genes as key regulators of cardiomyocyte proliferation and heart development, implicating them as candidate modifiers for HLHS and revealing new avenues for therapeutic discovery.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Hypoplastic left heart syndrome (HLHS) accounts for 2–3% of all cases of congenital heart disease (CHD) <xref ref-type="bibr" rid="bib39">Gordon et al., 2008</xref>; <xref ref-type="bibr" rid="bib79">Reller et al., 2008</xref> and is characterized by underdevelopment of the left ventricle, mitral and aortic valves, and aortic arch (<xref ref-type="bibr" rid="bib19">Crucean et al., 2017</xref>). HLHS has a recognized genetic component based on its familial association with left-sided obstructive CHDs (<xref ref-type="bibr" rid="bib54">Konno et al., 2010</xref>; <xref ref-type="bibr" rid="bib1">Agopian et al., 2017</xref>; <xref ref-type="bibr" rid="bib61">Martin et al., 2018</xref>). However, segregation analyses in multiplex HLHS-CHD families <xref ref-type="bibr" rid="bib61">Martin et al., 2018</xref> and genome-wide association studies of large cohorts <xref ref-type="bibr" rid="bib1">Agopian et al., 2017</xref> have lacked sufficient power to conclusively identify candidate HLHS-susceptibility genes with small to moderate effect sizes. Defects in a small number of genes involved in cardiogenesis, such as <italic>NOTCH1</italic> (<xref ref-type="bibr" rid="bib87">Theis et al., 2015a</xref>), <italic>NKX2–5</italic> (<xref ref-type="bibr" rid="bib29">Elliott et al., 2003</xref>), <italic>MYH6</italic> (<xref ref-type="bibr" rid="bib88">Theis et al., 2015b</xref>), and <italic>GATA4</italic> <xref ref-type="bibr" rid="bib29">Elliott et al., 2003</xref>; <xref ref-type="bibr" rid="bib107">Zanon et al., 2017</xref> have been implicated as contributors to HLHS, as well as multiple other CHDs. However, the variety of phenotypic manifestations of HLHS, together with numerous studies linking it to diverse genetic loci (<xref ref-type="bibr" rid="bib87">Theis et al., 2015a</xref>; <xref ref-type="bibr" rid="bib29">Elliott et al., 2003</xref>; <xref ref-type="bibr" rid="bib88">Theis et al., 2015b</xref>; <xref ref-type="bibr" rid="bib24">Dasgupta et al., 2001</xref>), suggests that HLHS is genetically heterogeneous and has a multigenic etiology (<xref ref-type="bibr" rid="bib100">Yagi et al., 2018</xref>; <xref ref-type="bibr" rid="bib101">Yaich et al., 1998</xref>).</p><p>It has also been hypothesized that the underdevelopment of the left ventricular (LV) myocardium includes restricted blood flow across the mitral valve and its hemodynamic effect during ventricular growth and development (‘no flow – no grow’; <xref ref-type="bibr" rid="bib41">Grossfeld et al., 2009</xref>), as well as endocardial defects (<xref ref-type="bibr" rid="bib65">Miao et al., 2020</xref>). Therefore, HLHS manifestation may be due to a combination of cardiomyocyte (CM) autonomous and non-autonomous genetic as well as mechanical effects, all of which likely affect proliferation and differentiation in the developing heart.</p><p>In a digenic HLHS mouse model, loss of both Sin3A Associated Protein 130 (<italic>Sap130</italic>) and the protocadherin <italic>Pcdha9</italic> causes decreased CM proliferation resulting in LV hypoplasia (<xref ref-type="bibr" rid="bib58">Liu et al., 2017</xref>). In addition, LVs from HLHS patients have cardiac damage associated with CM proliferation defects compared to healthy subjects (<xref ref-type="bibr" rid="bib36">Gaber et al., 2013</xref>). These studies suggest that intrinsically defective cardiac differentiation and impaired CM proliferation are likely contributing to HLHS-associated heart defects. Further strengthening this hypothesis, we found that HLHS-patient-derived hPSC-CMs exhibited reduced proliferation compared to the parents (<xref ref-type="bibr" rid="bib89">Theis et al., 2020</xref>). There is a need to identify the potentially causative genes, which contribute to those processes described above and to elucidate their role in HLHS pathogenesis.</p><p>To advance CHD gene discovery, we have developed a multi-model systems platform enabling both to rigorously prioritize candidate genes from whole-genome sequencing (WGS) based on rare, predicted-damaging variants and their mode of inheritance, and to functionally characterize gene function in complementary and genetically tractable model systems: human-induced pluripotent stem cells (hPSCs), the fruit fly <italic>Drosophila melanogaster</italic>, and zebrafish <italic>Danio rerio</italic>. The genetic basis of cardiac development, originally uncovered in <italic>Drosophila</italic>, is fundamentally conserved across species (<xref ref-type="bibr" rid="bib10">Bodmer, 1993</xref>; <xref ref-type="bibr" rid="bib11">Bodmer, 1995</xref>; <xref ref-type="bibr" rid="bib18">Cripps and Olson, 2002</xref>; <xref ref-type="bibr" rid="bib12">Bodmer and Frasch, 2010</xref>) and ~80% of human disease genes have fly orthologs (<xref ref-type="bibr" rid="bib8">Bier and Bodmer, 2004</xref>). In addition, the non-redundant fly genome, together with the simple structure and function of the fly heart, allows straightforward genotype–phenotype correlations. Zebrafish (<xref ref-type="bibr" rid="bib30">Evans et al., 2010</xref>; <xref ref-type="bibr" rid="bib6">Bakkers, 2011</xref>; <xref ref-type="bibr" rid="bib56">Liu and Stainier, 2012</xref>), which has a two-chambered heart and can be easily manipulated using morpholino (MO) injections and CRISPR technologies to affect heart development and function. In addition, phenotypes can be directly observed in the developing larva for several days post-fertilization (<xref ref-type="bibr" rid="bib32">Fink et al., 2009</xref>). Finally, CMs differentiated from hPSCs (hPSC-CMs) enable the identification and quantification of cellular phenotypes associated with human diseases, including HLHS (<xref ref-type="bibr" rid="bib87">Theis et al., 2015a</xref>; <xref ref-type="bibr" rid="bib47">Huang et al., 2011</xref>; <xref ref-type="bibr" rid="bib105">Yu et al., 2018</xref>; <xref ref-type="bibr" rid="bib72">Paige et al., 2020</xref>) and are amenable to large-scale functional screens (<xref ref-type="bibr" rid="bib28">Diez-Cuñado et al., 2018</xref>; <xref ref-type="bibr" rid="bib68">Murphy et al., 2021</xref>), thereby enabling them to serve both as a discovery and validation platform. This integrated approach allows for rapidly identifying novel HLHS-associated gene candidates and for characterizing their ability to regulate developmental processes associated with disease (e.g., hypoplasia) (<xref ref-type="bibr" rid="bib89">Theis et al., 2020</xref>).</p><p>Defective CM proliferation is likely a hallmark of HLHS (<xref ref-type="bibr" rid="bib58">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib89">Theis et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Gaber et al., 2013</xref>), thus to uncover novel regulators of human CM proliferation with potential links to HLHS, we performed a whole-genome siRNA screen (18,055 genes) using an EdU assay in hPSC-CMs and identified ribosomal proteins (RPs) as the major class of genes controlling CM proliferation. In parallel, WGS of 25 poor-outcome HLHS proband–parent trios followed by unbiased variant filtering revealed an enrichment for rare, predicted-damaging variants in RP genes. Moreover, analysis of a high-value family (75H) comprised of an HLHS proband, his phenotypically normal parents, and a fifth-degree relative born with left-sided CHD led to the identification of a predicted-damaging variant in RP protein gene <italic>RPS15A</italic> that segregated with disease. Consistent with a central role for RPs in the regulation of heart development, heart-specific knockdown (KD) of HLHS-associated RPs in <italic>Drosophila</italic> caused severe phenotypes, including near-complete heart loss and lethality. Similarly, in zebrafish, <italic>rps15a</italic> CRISPR mutants and morphants had greatly reduced heart size and CM number, looping defects, and diminished contractility. In this context, a multi-model system evaluation (hPSC-CMs, flies, and zebrafish) of RP function shows their important role in heart growth and differentiation and CM proliferation by modulating the p53, Myc, and Hippo pathways. Moreover, we find evidence that RPs may regulate heart development and CM proliferation in a cardiac-specific manner by synergistically interacting with core cardiac transcription factors (cTFs) such as T-box, Nkx, and Gata factors. In sum, here we show that RP genes are potent regulators of CM proliferation and cardiac growth and differentiation, consistent with a potentially critical role in the hypoplastic phenotype of HLHS. We suggest that RP genes are an emerging class of novel genetic effectors in HLHS.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Whole-genome siRNA screen identifies RPs as central regulators of CM proliferation</title><p>Based on previous and our recent data (<xref ref-type="bibr" rid="bib58">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Gaber et al., 2013</xref>; <xref ref-type="bibr" rid="bib89">Theis et al., 2020</xref>), impaired CM proliferation is emerging as an important mechanism in HLHS pathogenesis. Thus, to comprehensively map the human genome for novel regulators of CM proliferation, we screened a library of 18,055 siRNAs for their ability to modulate proliferation in human iPSC-derived CMs (hPSC-CMs). To assess CM proliferation, we used a dual read-out and quantified both DNA synthesis using EdU incorporation (<xref ref-type="bibr" rid="bib28">Diez-Cuñado et al., 2018</xref>) and total number of CMs, 3 days after treatment (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). Briefly, siRNAs were transfected into 25-day-old hPSC-CMs (<xref ref-type="bibr" rid="bib105">Yu et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Cunningham et al., 2017</xref>). After 2 days, EdU was added to the wells for 24 hr. On day 3, cells were fixed and co-stained for sarcomeric protein alpha-Actinin (ACTN2), EdU, and DAPI. Next, the number of EdU/alpha-Actinin double-positive cells and the total number of CMs were determined using a commercially available high-throughput image analysis software (MetaXpress, Molecular Devices) (<xref ref-type="bibr" rid="bib28">Diez-Cuñado et al., 2018</xref>). Note that alpha-Actinin-, EdU+ cells which typically express fibroblast markers (i.e POSTN) (<xref ref-type="bibr" rid="bib21">Cunningham et al., 2017</xref>), were excluded from this analysis, to focus on CM biology only. In total, we found 153 siRNAs that decreased proliferation (&lt;0.5-fold EdU incorporation) and number of CMs (&lt;0.8-fold), and 162 siRNAs that increased EdU (&gt;1.2-fold) and CM number (&gt;1.1-fold; <xref ref-type="fig" rid="fig1">Figure 1B, C</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Consistent with previous studies (<xref ref-type="bibr" rid="bib109">Zhang et al., 2003</xref>; <xref ref-type="bibr" rid="bib106">Yuan et al., 2014</xref>), KD of cell cycle checkpoint agonist, CHEK1 and MDM2, the negative regulator of TP53, both were among top hits that reduced CM proliferation. As expected, we identified TP53 and CDKN1A among the genes that significantly increased CM cell number upon KD (<xref ref-type="fig" rid="fig1">Figure 1B, C</xref>). Next, to gain insight into the molecular pathways regulating proliferation in hPSC-CMs, we performed gene ontology (GO) term analysis of hits decreasing EdU incorporation or CM numbers and found an enrichment for genes associated with ‘translation/ribosome’ and p53 signaling as top hits (<xref ref-type="fig" rid="fig1">Figure 1D, E</xref>). Consistent with these observations, we had previously found that the p53 pathway is dysregulated in hPSCs differentiated from an HLHS family trio (<xref ref-type="bibr" rid="bib89">Theis et al., 2020</xref>). Remarkably, the most represented gene family is RPs, KD of which caused consistently the strongest inhibition of cell proliferation (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Next, since the primary screen was performed as a single data point, we next sought to validate these findings by re-testing all 80 RP genes for function (<xref ref-type="bibr" rid="bib111">Zhou et al., 2015</xref>) using a distinct set of siRNAs in biological quadruplicate conditions. Remarkably and consistent with the primary screen, KD of 59/80 RPs significantly reduced proliferation as compared to siControl (p &lt; 0.05; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B</xref>). In this context, further functional testing in fibroblasts revealed that the antiproliferative effect of RP loss of function is cell type independent (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C, D</xref>). Together, these findings establish RP function as essential for cell proliferation, including in hPSC-CMs, and suggest that RPs may represent a previously unrecognized class of regulators of ventricular growth during embryonic development.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Whole-genome siRNA screen identified ribosomal proteins as agonists of cardiomyocyte (CM) proliferation.</title><p>(<bold>A</bold>) High-throughput iPSC-derived CM proliferation screen overview. (<bold>B</bold>) Screen result showing normalized % EdU+ CMs (<italic>X</italic>-axis) and relative total number of CMs (<italic>Y</italic>-axis) upon knockdown of genome-wide siRNAs (18,055 siRNAs). siRNAs for RPL and RPS genes highlighted in red. (<bold>C</bold>) Representative immunofluorescence images of proliferation (EdU incorporation, green, CM marker ACTN2, red) of induced hPSC-CMs upon <italic>TP53</italic> and <italic>RPS14</italic> knockdown. Insets: nuclei (DAPI). (<bold>D</bold>) Gene ontology enrichment analysis for whole-genome sequencing (WGS) hits (BP, biological process; FDR-corrected analysis using gprofiler2). (<bold>E</bold>) Overview of hits corresponding to top 4 non-redundant BP categories.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Functional validation of RP–mediated control of proliferation in hiPSC-CMs and human dermal fibroblasts.</title><p>(<bold>A, B</bold>) Confirmatory siRNA screening for all RP genes confirms critical role for RPs in cardiomyocyte (CM) proliferation. (<bold>C, D</bold>) KD of RPs reduces proliferation in human fibroblasts.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig1-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Enrichment of RP gene variants in an HLHS patient cohort with poor clinical outcome</title><p>To identify candidate genes involved in HLHS pathogenesis, we performed WGS, variant filtering, and enrichment analysis (see also, <xref ref-type="bibr" rid="bib89">Theis et al., 2020</xref>), and Methods: WGS and bioinformatic strategies in a cohort of 25 HLHS patient–parent trios with poor clinical outcome defined as either prenatal – restrictive atrial septal defect (<italic>n</italic> = 2); postnatal – reduced right ventricular ejection fraction following stage II or III surgical palliation (<italic>n</italic> = 19); protein-losing enteropathy (<italic>n</italic> = 2); or cardiac transplantation/failed surgical palliation (<italic>n</italic> = 2). The 25 probands were comprised of 18 males and 7 females, 24 of whom were of white ancestry. The HLHS phenotype with respect to valve morphology (mitral atresia, MA; mitral stenosis, MS; aortic atresia, AA; aortic stenosis, AS) was MA/AA in 10, MS/AS in 9, MA/AA in 4, MA/AS in 1, and unknown in 1. CHD in the parents was excluded by echocardiography in all but two families, in which a bicuspid aortic valve was present in the mother. Genomic sequences were filtered for uncommon (minor allele frequency [MAF] &lt;1%) de novo and recessive variants in coding and regulatory regions of genes expressed in the developing heart and predicted to alter protein structure or expression, yielding 292 unique HLHS candidate genes that primarily fit a recessive mode of inheritance (<xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). To determine whether certain gene networks were over-represented among these variants, we used two online bioinformatics tools (STRING and PANTHER; <xref ref-type="bibr" rid="bib64">Mi et al., 2019</xref>; <xref ref-type="bibr" rid="bib83">Szklarczyk et al., 2019</xref>). After applying Fisher’s exact test and false discovery rate corrections, RPs were the most enriched class of proteins when compared to the reference proteome, which includes data annotated by protein class (5.24-fold, p = 0.0028), and cellular component (7.27-fold, p = 0.011). In total, 14 variants found in 9 RP genes among 6 HLHS probands were identified, most fitting a recessive inheritance disease model (<xref ref-type="table" rid="table1">Table 1</xref>). These RP variants encompass mutations in upstream promoter regions that potentially affect transcription factor-binding sites, as well as non-synonymous substitutions inside the protein coding regions.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Ribosomal gene variants identified in hypoplastic left heart syndrome (HLHS).</title><p>(<bold>A</bold>) Gene prioritization scheme of 25 poor-outcome proband–parent trios. (<bold>B</bold>) Testing 292 HLHS candidate genes from all poor-outcome families in cardiomyocytes (CMs) identified RPs as major regulators of hPSC-CM proliferation (normalized fraction of ACTN2+/EdU+ cells). (<bold>C</bold>) <italic>Drosophila</italic> cardiac phenotypes induced by loss of RP genes affected in HLHS patients with poor outcome. The heart is visualized by RFP expression specifically in CMs (R94C02::tdTom). Knockdown is achieved by sustained Gal4/UAS activity using Hand4.2-Gal4. (<bold>D</bold>) Wild-type zebrafish larva, <italic>rps17</italic> and <italic>rps28</italic> CRISPR mutants, and <italic>rpl39</italic> morphants at 72 hpf. <italic>rpl39</italic> morphants, injected with 1 ng MO in lateral view, show mild edema. (<bold>E</bold>) Systolic surface area (SA) upon <italic>rps17</italic> and <italic>rps28</italic> CRISPR, and diastolic SA after <italic>rpl39</italic> MO in the atrium and ventricle of zebrafish hearts.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig2-v1.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Variants in ribosomal genes in hypoplastic left heart syndrome (HLHS) probands.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Gene</th><th align="left" valign="top">Proband (age, sex)</th><th align="left" valign="top">Mode of inheritance</th><th align="left" valign="top">Variant</th><th align="left" valign="top">Type</th><th align="left" valign="top">MAF%</th><th align="left" valign="top">CADD score</th><th align="left" valign="top">TFBS affected</th><th align="left" valign="top">hPSC-CM proliferation</th><th align="left" valign="top">Fly gene and defects</th><th align="left" valign="top">Zebrafish gene and defects</th><th align="left" valign="top">Patient outcome</th></tr></thead><tbody><tr><td align="left" valign="top">RPL26L1</td><td align="left" valign="top">145H (3y, m)</td><td align="left" valign="top">Compound heterozygous</td><td align="char" char="." valign="top">–1248A&gt;G; V97M</td><td align="left" valign="top">Regulatory; missense</td><td align="char" char="." valign="top">0.029; 0.032</td><td align="char" char="." valign="top">-; 21.3</td><td align="left" valign="top">Pdx1; NFE2L1::MAFG; FOXC1</td><td align="left" valign="top">Reduced</td><td align="left" valign="top">RpL26: lethal, no heart</td><td align="left" valign="top">rpl26: n.t.</td><td align="left" valign="top">Restrictive ASD, PLE</td></tr><tr><td align="left" valign="top">RPL36A</td><td align="left" valign="top"/><td align="left" valign="top">X-linked recessive</td><td align="char" char="." valign="top">–1321C&gt;T</td><td align="left" valign="top">Regulatory</td><td align="char" char="." valign="top">0.055</td><td align="left" valign="top">-</td><td align="left" valign="top">PAX2</td><td align="left" valign="top">No effect</td><td align="left" valign="top">RpL36A: lethal, no heart</td><td align="left" valign="top">rpl36a: n.t.</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">RPS15</td><td align="left" valign="top"/><td align="left" valign="top">Compound heterozygous</td><td align="char" char="." valign="top">–1558C&gt;T; T101S</td><td align="left" valign="top">Regulatory; missense</td><td align="char" char="." valign="top">0; 0.102</td><td align="char" char="." valign="top">-; 23.5</td><td align="left" valign="top">FOXC1</td><td align="left" valign="top">Reduced</td><td align="left" valign="top">RpS15: lethal</td><td align="left" valign="top">rps15: n.t.</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">RPL39</td><td align="left" valign="top">151H (20y, m)</td><td align="left" valign="top">X-linked recessive</td><td align="char" char="." valign="top">–1359T&gt;C</td><td align="left" valign="top">Regulatory</td><td align="char" char="." valign="top">0.653</td><td align="left" valign="top">-</td><td align="left" valign="top">HOXA5</td><td align="left" valign="top">Reduced</td><td align="left" valign="top">RpL39: lethal</td><td align="left" valign="top">rpl39: morphants mild edema, reduced ventricular size</td><td align="left" valign="top">Reduced RV function</td></tr><tr><td align="left" valign="top">RPL3L</td><td align="left" valign="top">96H (22m, m)</td><td align="left" valign="top">Compound heterozygous</td><td align="left" valign="top">R200Q; R242W</td><td align="left" valign="top">Missense; missense</td><td align="char" char="." valign="top">0.966; 0.432</td><td align="char" char="." valign="top">21.2; 14.94</td><td align="left" valign="top">-</td><td align="left" valign="top">Elevated</td><td align="left" valign="top">RpL3: no heart</td><td align="left" valign="top">rpl3: n.t.</td><td align="left" valign="top">Reduced RV function</td></tr><tr><td align="left" valign="top">RPL13A</td><td align="char" char="." valign="top">201H</td><td align="left" valign="top">Compound heterozygous</td><td align="left" valign="top">–92–645C&gt;T; –29–191C&gt;T</td><td align="left" valign="top">Regulatory; regulatory</td><td align="char" char="." valign="top">0.72; 0.046</td><td align="left" valign="top">-</td><td align="left" valign="top">FOXD1; GATA2; ETS1; ELF5; FOXC1</td><td align="left" valign="top">No effect</td><td align="left" valign="top">RpL13A: no phenotype</td><td align="left" valign="top">rpl13a: n.t.</td><td align="left" valign="top">Failing Fontan circulation, transplant at 14y</td></tr><tr><td align="left" valign="top">RPS17</td><td align="char" char="." valign="top">325H</td><td align="left" valign="top">Homozygous recessive</td><td align="left" valign="top">S136N</td><td align="left" valign="top">Missense</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">&lt;10</td><td align="left" valign="top">-</td><td align="left" valign="top">Reduced</td><td align="left" valign="top">RpS17: lethal</td><td align="left" valign="top">rps17: CRISPR mutants show systolic atrial dysfunction, shortened heart period</td><td align="left" valign="top">Reduced RVEF and increased RVEDP at 9m</td></tr><tr><td align="left" valign="top">RPL10</td><td align="char" char="." valign="top">76H</td><td align="left" valign="top">X-linked recessive</td><td align="char" char="ndash" valign="top">24–218G&gt;A</td><td align="left" valign="top">Regulatory</td><td align="char" char="." valign="top">0.583</td><td align="left" valign="top">-</td><td align="left" valign="top">ELK1; ETS1; SPIB; POLR2A; HEY1; Hltf</td><td align="left" valign="top">Reduced</td><td align="left" valign="top">RpL10: constricted</td><td align="left" valign="top">rpl10: n.t.</td><td align="left" valign="top">Reduced RVEF at 9y</td></tr><tr><td align="left" valign="top">RPS28</td><td align="left" valign="top"/><td align="left" valign="top">Compound heterozygous</td><td align="left" valign="top">–589G&gt;A; –505A&gt;T</td><td align="left" valign="top">Regulatory; regulatory</td><td align="char" char="." valign="top">0.061; 0.08</td><td align="left" valign="top">-</td><td align="left" valign="top">CTCF</td><td align="left" valign="top">Reduced</td><td align="left" valign="top">RpS28b: ostia defect</td><td align="left" valign="top">rps28: CRISPR mutants show no heart phenotype</td><td align="left" valign="top"/></tr></tbody></table><table-wrap-foot><fn><p>MAF – minor allele frequency; TFBS – transcription factor-binding site; n.t. – not tested; ASD – atrial septal defect; PLE – protein-losing enteropathy; RV – right ventricle; RVEF – right ventricular ejection fraction; RVEDP – right ventricular end diastolic pressure.</p></fn></table-wrap-foot></table-wrap><p>Next, all 292 prioritized candidate genes were systematically evaluated for effects on the proliferation of hPSC-CMs in vitro and for cardiac differentiation of fly hearts in vivo. Again, loss of RP function (<italic>RPL39</italic>, <italic>RPL26L1</italic>, <italic>RPS15</italic>, <italic>RPS17</italic>, <italic>RSPS28</italic>) caused the most severe phenotypes on proliferation in hPSC-CMs (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>), which was consistent with our genome-wide proliferation screen (see <xref ref-type="fig" rid="fig1">Figure 1B</xref>). In the fly, KD of RPs in the cardiac lineage and throughout embryonic development was achieved using a <italic>Hand<sup>4.2</sup></italic>-Gal4 driver (see <xref ref-type="bibr" rid="bib14">Brand and Perrimon, 1993</xref> and methods) and led to partial or complete heart loss (<italic>RpL26</italic>, <italic>RpL36A</italic>, <italic>RpL3</italic>) or caused lethality (<italic>RpS17</italic>, <italic>RpL39</italic>, <italic>RpS15</italic>, <italic>RpL26</italic>, <italic>RpL36A</italic>) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Also, KD of <italic>RpL10</italic> gave rise to severely constricted hearts, while KD of <italic>RpS28b</italic> caused inflow tract defects (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Finally, functional testing of RPs in zebrafish embryos revealed that KD of <italic>rpl39</italic> leads to reduced ventricle size, whereas <italic>rps17</italic> CRISPR mutants exhibit systolic dysfunction (<xref ref-type="fig" rid="fig2">Figure 2D, E</xref>). In sum, our patient-centric approach (cohort of 25 probands) identifies RPs as the most enriched gene category affected by HLHS-associated variants (STRING, PANTHER analysis). In this context, systematic testing in multi-model systems (fly, zebrafish, hPSC-CMs) identifies RPs as most potent regulators of cardiac differentiation, proliferation, and contractility among HLHS-associated genes. Collectively, these findings highlight that RPs regulate critical steps of cardiogenesis that are also found to be defective in HLHS probands (<xref ref-type="bibr" rid="bib36">Gaber et al., 2013</xref>; <xref ref-type="bibr" rid="bib58">Liu et al., 2017</xref>) and thus suggest a potential link between RP biology and HLHS phenotypic etiology.</p></sec><sec id="s2-3"><title>RPS15A variant associated with HLHS in familial CHD</title><p>To further establish a phenotypic link between RP function and HLHS-associated phenotypes, we selected a rare familial CHD case (75H) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>), that is comprised of a young teenager with HLHS (MS/AS) and normal ventricular function following Fontan operation, his phenotypically normal parents, and a fifth-degree female relative born with left-sided CHD (bicuspid aortic valve and coarctation of the aorta). Based on these observations, we hypothesized the presence of a heterozygous driver variant exhibiting incomplete penetrance and variable expression. To investigate further, we filtered WGS data for rare, predicted-damaging variants in coding and regulatory regions. This analysis identified six prioritized variants (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>), including one located in the <italic>RPS15A</italic> gene locus, shared by the HLHS proband, the unaffected mother, and the proband’s fifth-degree relative with CHD.</p><p>We next investigated whether family members carrying these variants (the mother and proband) exhibit defects in CM proliferation compared to the father. Notably, analysis of EdU incorporation in CMs from the parent–proband trio revealed significantly reduced proliferation in both the proband and mother compared to the father. However, the proband displayed a markedly more severe phenotype than the mother (<xref ref-type="fig" rid="fig3">Figure 3A, B</xref>). Interestingly, this reduction in proliferation appeared to be specific to CMs, as EdU incorporation in the non-CM cell population showed no significant differences among the family members (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Collectively, these findings suggest a phenotypic association between the presence of the variants and impaired CM proliferation.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Characterization of RPS15A from the 75H hypoplastic left heart syndrome (HLHS) index family.</title><p>(<bold>A</bold>–<bold>C</bold>) Prioritized candidate genes from the 75H family and relative hPSC-cardiomyocyte (CM) proliferation capacity upon KD. (<bold>D</bold>) Representative immunofluorescence images of proliferation (EdU incorporation, green; CM marker ACTN2, red) of induced hPSC-CMs upon siRPS15A knockdown. (<bold>E</bold>) Heart-specific KD of <italic>RpS15Aa</italic> in <italic>Drosophila</italic> adult hearts causes loss of heart tissue and is fully penetrant. (<bold>F</bold>) Representative immunofluorescence images of control and <italic>RpS15Aa</italic>-RNAi show partial heart loss (myosin heavy chain, Mhc, red; heart tissue-reporter, green). (<bold>G</bold>) CRISPR-mediated loss of <italic>rps15a</italic> in F<sub>0</sub> larval zebrafish hearts causes decrease in CM number. (<bold>H</bold>) Representative immunofluorescence of hearts and whole-mount images of control and <italic>rps15a</italic>-CRISPR F<sub>0</sub> larval hearts (CM nuclei reporter, red).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Model organism phenotypes caused by loss of RP genes.</title><p>(<bold>A</bold>) Pedigree of the extended 75H family investigated for shared variants between hypoplastic left heart syndrome (HLHS) proband (black square) and distant cousin with congenital heart disease (CHD) (half-filled circle). (<bold>B</bold>, <bold>C</bold>) Diastolic and (<bold>D</bold>) systolic surface area after rps15a CRISPR. Statistics: Mann–Whitney test, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title><italic>rps15a</italic> zebrafish larval morphants show heart dysfunction and reduction in cardiomyocyte (CM) number.</title><p>(<bold>A</bold>) Lateral view (head to the right) of a wild-type control zebrafish larva (top) and a morphant (bottom) following injection of 2 ng/µl <italic>rps15a</italic> morpholino (MO). The morphant exhibits near-normal body/tail but notable pericardial edema (arrowhead). (<bold>B</bold>) Control (left) and morphant hearts (right) stained with Tg(<italic>myl7:EGFP</italic>) and Tg(<italic>myl7:H2A-mCherry</italic>). Note the smaller heart with aberrant looping in morphant heart. (<bold>C</bold>) Total CM counts (mCherry+ cells) in control and <italic>rps15a</italic> morphants shown in (<bold>B</bold>). (<bold>D</bold>) Fractional area change (FAC) in control and <italic>rps15a</italic> morphants. Student’s <italic>t</italic>-test, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Proliferation and heart function depend on RPS15A and are regulated via TP53 in cardiomyocytes (CMs) and zebrafish.</title><p>Cardiac proliferation (by PH3, <bold>A</bold>), total CM number (DAPI, <bold>B</bold>) and ratio of proliferating CMs (<bold>C</bold>) assessed for <italic>rps15a</italic> morphants (KD) and CRISPR (KO) for three timepoints, 24/48/72 hpf (<bold>D, E</bold>) The number of <italic>siRPS15A-</italic>treated CMs is strongly reduced, which can be attenuated by co-KD of <italic>CDKN1A</italic> or <italic>TP53</italic>. (<bold>F, G</bold>) Loss of <italic>rps15a</italic> causes strong reduction in zebrafish heart contractility (measured by fractional area change, <bold>C</bold>) and heart period (<bold>D</bold>), which can be rescued by co-KD of <italic>p53</italic> in both zebrafish heart atrium and ventricle.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig3-figsupp3-v1.tif"/></fig></fig-group><p>Finally, to determine the potential relative contribution of the six genes harboring rare and damaging variants in the regulation of CM proliferation, we performed functional KD experiments in hPSC-CMs in vitro. Remarkably, while KD of 5 of the other prioritized genes from the 75H family also resulted in moderate reduced CM proliferation, RPS15A KD produced the most pronounced effect, with over an 85% reduction in proliferation, emerging as the top candidate (<xref ref-type="fig" rid="fig3">Figure 3C, D</xref>). Together, these findings indicate that RPS15A plays a critical role in regulating CM proliferation in human pluripotent stem cells (hPSCs) and may influence heart developmental processes that are disrupted in HLHS.</p></sec><sec id="s2-4"><title>RPS15A KD in <italic>Drosophila</italic> and zebrafish causes severe cardiac proliferation and differentiation defects</title><p>To characterize the role of <italic>RPS15A</italic> during heart development, we first induced a heart-specific KD of <italic>RpS15Aa</italic> in flies (see methods), which caused a partial or complete loss of the heart (<xref ref-type="fig" rid="fig3">Figure 3E, F</xref>). Note that this phenotype is consistent with our results above and a previous study involving another RP gene (<italic>RPL13</italic>) (<xref ref-type="bibr" rid="bib81">Schroeder et al., 2019</xref>).</p><p>Next, to evaluate the role of <italic>RP</italic> genes during heart development, we knocked out <italic>rps15a</italic> in zebrafish (<italic>D. rerio</italic>) using CRISPR (<xref ref-type="bibr" rid="bib30">Evans et al., 2010</xref>; <xref ref-type="bibr" rid="bib6">Bakkers, 2011</xref>; <xref ref-type="bibr" rid="bib56">Liu and Stainier, 2012</xref>). We examined F<sub>0</sub> larva at 72 hpf (hours post fertilization) using high-speed digital imaging (SOHA; <xref ref-type="bibr" rid="bib32">Fink et al., 2009</xref>, see also methods) and confocal microscopy to monitor heart size and CM numbers, respectively. Remarkably, <italic>rps15a</italic> mutant hearts were smaller in size (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C, D</xref>), with reduced CM numbers (<xref ref-type="fig" rid="fig3">Figure 3G, H</xref>). We observed similar effects in response to injection of a <italic>rps15a</italic> MO compared to uninjected larva (<xref ref-type="bibr" rid="bib92">Uechi et al., 2006</xref>; <xref ref-type="bibr" rid="bib48">Ikeda et al., 2017</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A–D</xref>). In this context, we also noted that the overall body plan and morphology of <italic>rps15a</italic> CRISPR mutants or morphants were largely unaffected, except for a mild pericardial edema, a possible indicator of heart dysfunction (<xref ref-type="fig" rid="fig3">Figure 3H</xref>; <xref ref-type="bibr" rid="bib66">Miura and Yelon, 2011</xref>).</p><p>We quantified CM number using nuclear markers in Tg(<italic>myl7:eGFP</italic>); Tg(<italic>myl7:H2A-mCherry</italic>) embryos 72 hpf. CM numbers were predominantly reduced in the ventricle compared to the atrium (<xref ref-type="fig" rid="fig3">Figure 3G, H</xref>). We also assessed total cardiac cell numbers and cardiac cell proliferation by phospho-histone H3 (PH3) immunostaining and DAPI to quantify total cardiac cells. We again found that the total cell numbers were significantly reduced in both rps15a morphants and crispants (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A–C</xref>). Importantly, the proportion of proliferating (PH3+) cardiac cells was also decreased in rps15a morphants and crispants at both 24 and 48 hpf, but not at 72 hpf when proliferation normally declines (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A–C</xref>). Collectively, these data support the hypothesis that <italic>RPS15A</italic> is required for CM proliferation and heart morphogenesis (hPSC-CMs, fly, and zebrafish), thus suggesting a potential role for RPs as genetic drivers of hypoplasticity observed in HLHS.</p></sec><sec id="s2-5"><title>RPs control CM cell cycle by regulating TP53 pathway activity</title><p>To investigate how RPs regulate cell cycle activity in hPSC-CMs, we performed RNA-seq upon KD of <italic>RPS15A</italic> and <italic>RPL39</italic>, which belong to the small and the large ribosomal subunits that harbor predicted-damaging variants in 75H and 151H probands, respectively. Comparison of differential gene expression between <italic>siRPS15A</italic> and <italic>siRPL39</italic> KD revealed that ~53% of genes were commonly dysregulated (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), indicating the existence of a conserved RP-dependent transcriptional network. Consistent with a central role for RPs in the regulation of proliferation, GO term analysis for differentially expressed genes revealed an enrichment for genes involved in DNA replication, mitosis, and DNA damage response mediated by p53, and included the downregulation of positive regulators of cell cycle such as <italic>CDK1</italic>, <italic>CCNA2</italic>, <italic>AURKA</italic>, <italic>PCNA</italic>, and the upregulation of cell cycle arrest mediators such as <italic>CDKN1A</italic>, <italic>BTG2</italic>, <italic>GADD45A</italic> (<xref ref-type="fig" rid="fig4">Figure 4B</xref> and <xref ref-type="supplementary-material" rid="supp5 supp6">Supplementary file 5 and 6</xref>). To confirm these findings, we performed immunostaining for canonical p53 downstream transcriptional target (<xref ref-type="bibr" rid="bib33">Fischer, 2017</xref>), <italic>CDKN1A</italic>, and observed that the percentage of CDKN1A+ CMs was increased by ~60% in response to <italic>RPS15A</italic> KD (<xref ref-type="fig" rid="fig4">Figure 4C, D</xref>), indicating that RP KD induces cell cycle arrest <italic>via</italic> the activation of the p53 signaling pathway in hPSC-CMs.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Loss of ribosomal gene function in cardiomyocytes (CMs) invokes TP53-stress response.</title><p>(<bold>A</bold>) RNA-sequencing of hPSC-CMs following siRNA treatment for <italic>RPL39</italic> and <italic>RPS15A</italic> shows both convergent and divergent transcriptomic response. (<bold>B</bold>) Gene ontology (GO) term analysis of differentially expressed genes following RP KD shows TP53-mediated response, including upregulation of <italic>CDKN1A</italic>. (<bold>C, D</bold>) CDKN1A is highly upregulated in CMs following <italic>siRPS15A</italic> treatment. (<bold>E, F</bold>) Reduced CM proliferation upon <italic>RPS15A</italic> KD is mediated by <italic>CDKN1A</italic>/<italic>TP53</italic> and can be rescued upon their co-KD. (<bold>G, H</bold>) Larval zebrafish CM number is reduced by morpholino treatment for rps15a and can be attenuated by P53 morpholino co-injection. Control and morphant (MO) hearts of 72 hpf zebrafish larva stained with <italic>Tg(myl7:EGFP)</italic> and <italic>Tg(myl7:H2A-mCherry)</italic>. Note that the smaller heart with aberrant looping by <italic>rps15a</italic> MO is partially reversed by <italic>p53</italic> co-KD. Student’s <italic>t</italic>-test, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig4-v1.tif"/></fig><p>Next, to evaluate if the reduction in proliferation caused by RP KD is mediated by the p53 signaling pathway in CMs, we co-KD <italic>TP53</italic> or <italic>CDKN1A</italic> along with <italic>RPS15A</italic> and observed a significant rescue of CM proliferation by EdU incorporation and CM number in comparison to RPS15A KD (<xref ref-type="fig" rid="fig4">Figure 4E, F</xref> and <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3D, E</xref>).</p><p>Next, we tested if RP-mediated defects in zebrafish can also be rescued by inhibition of p53. To this aim, we used MOs to co-KD <italic>p53</italic> with <italic>rps15a</italic> (<xref ref-type="bibr" rid="bib80">Robu et al., 2007</xref>) and examined larval hearts at 72 hpf. <italic>p53</italic> MO-mediated KD on its own had little effect on heart function but partially reversed the <italic>rps15a</italic> MO-mediated reduction in heart size and CM numbers (<xref ref-type="fig" rid="fig4">Figure 4G, H</xref>). Moreover, bradycardia, heart looping, and reduced contractility phenotypes of <italic>rps15a</italic> morphants were also rescued by co-KD of <italic>p53</italic> (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3F, G</xref>). Collectively, these observations support our hypothesis that RPs control cardiac development, including heart size and function, via a p53 pathway-mediated regulation of CM proliferation.</p></sec><sec id="s2-6"><title>Heart loss in <italic>Drosophila</italic> by RpS15Aa KD is partially rescued by Hippo pathway activation</title><p>The fly heart develops similarly to the vertebrate heart at early stages (<xref ref-type="bibr" rid="bib11">Bodmer, 1995</xref>) and a link between RPs and cell cycle-regulating pathways, such as p53 and Hippo pathways (<xref ref-type="bibr" rid="bib35">Furth et al., 2018</xref>), has been proposed to be conserved between mammals and flies (<xref ref-type="bibr" rid="bib5">Baker et al., 2019</xref>). To test whether p53 has a function in fly heart development similar to hPSC-CMs and zebrafish, we performed cardiac co-KD of <italic>RpS15Aa</italic> and <italic>p53</italic> and examined heart structure and function. Co-KD did not rescue the cardiac defects of <italic>RpS15Aa</italic> KD, suggesting that <italic>p53</italic> has a different role in flies, as compared to vertebrates, as has been reported previously (<xref ref-type="bibr" rid="bib71">Ollmann et al., 2000</xref>).</p><p>In vertebrates, TP53 is known to act through the negative regulation of the Hippo pathway (<xref ref-type="bibr" rid="bib77">Raj and Bam, 2019</xref>). In this context, YAP, a downstream effector of Hippo, has been shown to promote CM proliferation in the mouse heart (<xref ref-type="bibr" rid="bib67">Monroe et al., 2019</xref>). We therefore tested if YAP/yorkie can substitute the function of p53 in the fly heart and found that overexpressing the Hippo pathway gene <italic>yorkie</italic> (<italic>yki</italic>), the fly ortholog of YAP, in the developing heart considerably restored <italic>RpS15Aa</italic> KD-induced heart loss in <italic>Drosophila</italic> (<xref ref-type="fig" rid="fig5">Figure 5A’, B</xref>). We also observe the formation of adult ostial structures, which indicates that the larval heart underwent partial remodeling to an adult heart during metamorphosis. Further, we found that <italic>yki</italic>-mediated rescue depends on the transcriptional co-factor encoded by <italic>scalloped</italic> (<italic>sd</italic>, <italic>Drosophila TEAD1/2/3/4</italic>), since upon <italic>sd</italic> KD, <italic>yki</italic> OE can no longer rescue the <italic>RpS15Aa</italic> KD-induced heart loss (<xref ref-type="fig" rid="fig5">Figure 5A”, B</xref>). Moreover, KD of <italic>sd</italic> in an <italic>RpS15Aa</italic> KD background (without <italic>yki</italic> OE) worsens the <italic>RpS15Aa</italic> KD phenotype (<xref ref-type="fig" rid="fig5">Figure 5A”, B</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Rescue of <italic>RpS15Aa</italic> KD-mediated heart tube loss in <italic>Drosophila</italic> by YAP/yorkie overexpression depending on its co-factor TEAD/scalloped.</title><p>(<bold>A</bold>) Representative images of RFP-expressing fly hearts. RpS15Aa KD-mediated heart tube loss can be partially rescued by overexpression of <italic>yorkie</italic> (<italic>RpS15Aa</italic> RNAi + <italic>yorkie</italic> OE). The rescue by <italic>yki</italic> OE depends on its co-factor <italic>sd</italic>. Flies were raised at 25°C. (<bold>B</bold>) Quantification of events presented as a percentage of flies exhibiting whole heart tube versus partial heart loss (defined as 25–75% heart tube length compared to wildtype) or no heart tube. Statistics: Fisher’s exact test, *p &lt; 0.05. (<bold>C</bold>) Proposed signaling cascade underlying cardiac growth, proliferation, and differentiation impairment following ribosomal stress (adapted from <xref ref-type="bibr" rid="bib5">Baker et al., 2019</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig5-v1.tif"/></fig></sec><sec id="s2-7"><title><italic>RPS15A</italic> genetically interacts with cTFs <italic>nkx2.7</italic>/<italic>tinman</italic>, and TBX5/<italic>tbx5a/Dorsocross</italic>, <italic>nkx2.7</italic>/<italic>tinman</italic>, and <italic>Gata4,5,6/pannier</italic> in model systems</title><p>The profound importance of RPs for cell growth and proliferation in most cell types (<xref ref-type="bibr" rid="bib51">Kang et al., 2021</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) raises the question of how tissue-specific phenotypes such as those observed in HLHS can arise from the defective function of ubiquitously expressed genes. To address this apparent paradox, we hypothesized that RPs might functionally interact with tissue-specific proteins such as cTFs to control CM proliferation. Analysis of the impact of cTFs alone on hPSC-CM proliferation from our whole-genome screen revealed that KD of most cTFs did not cause major proliferation defects (except for, e.g., <italic>HES4</italic> and <italic>HOPX</italic>; <xref ref-type="fig" rid="fig6">Figure 6A</xref>). Among the cTFs, TBX5 is specifically expressed in the left ventricle at stages of intense CM proliferation (<xref ref-type="bibr" rid="bib15">Bruneau et al., 1999</xref>) and thus we next asked if <italic>TBX5</italic> could functionally interact with RPs. Remarkably, while hPSC-CM proliferation was not affected by increasing doses of siTBX5 (0–2 nM), increasing si<italic>TBX5</italic> dosage in siRP backgrounds led to proportional decrease in EdU incorporation (two-way ANOVA; <xref ref-type="fig" rid="fig6">Figure 6B</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A, B</xref>), thereby indicating that <italic>RPs</italic> and <italic>TBX5</italic> genetically interact to regulate proliferation in hPSC-CMs.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><italic>RPS15A</italic> genetically interacts with cardiac transcription factors.</title><p>(<bold>A</bold>) The majority of cardiac transcription factors do not impact cardiomyocyte (CM) proliferation, except for, e.g., HES4 and HOPX. (<bold>B</bold>) <italic>TBX5</italic> genetically interacts with <italic>RPS15A</italic> and <italic>RPL39. siTBX5</italic> does not impact CM proliferation at 0.5, 1, 1.5, or 2 nM si-concentration, and neither do <italic>siRPS15A</italic> and <italic>siRPL39</italic> alone at 0.5 nM. CM proliferation is reduced in siRP backgrounds with increased titration of <italic>siTBX5</italic>. Two-way ANOVA for si<italic>TBX5</italic> dosage, RP-knockdown, and their interaction. (<bold>C</bold>) Representative fly heart segment (A4) from control flies, heterozygous mutants (<italic>tin</italic><sup>346/+</sup>, <italic>pnr</italic><sup>VX6/+</sup>, <italic>Doc</italic><sup>Df/-</sup>, <italic>Df</italic>(<italic>RpS15Aa</italic>)<sup>+/-</sup>) and transheterozygous mutants. <italic>tin</italic><sup>+/-</sup> = <italic>tin<sup>346</sup></italic>/+, pnr<sup>+/-</sup> = <italic>Df(pnr)</italic>/+, Doc<sup>+/-</sup> = <italic>Df(DocA)</italic>/+. Note the deformation and myofibrillar disorganization in the transheterozygous mutants. (<bold>D</bold>) Quantification of adult <italic>Drosophila</italic> heart defects and genetic interaction. Statistics: Fisher’s exact test on absolute numbers testing <italic>normal</italic> versus <italic>severely deformed</italic> hearts. *p &lt; 0.05, **p &lt; 0.005, ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Genetic interaction between <italic>RpS15Aa/RPS15A</italic> and <italic>cabeza/EWSR1</italic>.</title><p>(<bold>A, B</bold>) Dose-dependent inhibition of hPSC-cardiomyocytes (CMs) proliferation by RPS15A KD. (<bold>C</bold>) Diastolic diameter (DD), and heart period (HP) of 3-week-old female control and heterozygous RpS15Aa deficient flies with or without additional heterozygous mutation in tinman, pannier, or Dorsocross. Statistics: Kruskal–Wallis, *p &lt; 0.05, **p &lt; 0.005, ***p &lt; 0.001, ****p &lt; 0.0001. Note the prolonged HP in transheterozygous mutants for Df(RpS15Aa) and tinman. (<bold>D, E</bold>) FAC and HP of the atria and ventricles at 72 hpf in zebrafish embryos injected with 0.5 ng rps15a and/or 1 ng nkx2.7 MOs (<bold>E</bold>) or 0.5 ng rps15a and/or 0.5 ng tbx5 MOs (<bold>F</bold>). Note that FAC and heart periods show synergistic genetic interaction between rps15a and nkx2.7 and tbx5a. Statistics: Two-way ANOVA, *p &lt; 0.05, **p &lt; 0.01, ****p &lt; 0.0001. (<bold>F</bold>) Systolic intervals (SI) of 1-week-old adult flies upon heart-specific knockdown of <italic>cabeza</italic> (<italic>caz<sup>32990</sup></italic> or <italic>caz<sup>34839</sup></italic> RNAi) using Hand<sup>4.2</sup>-Gal4 driver with or without additional RpS15Aa heterozygosity (RpS15Aa<sup>Df/+</sup>) and age-matched controls. Automated analysis of SI depicted as median with interquartile range obtained from 5 s high-frame-rate videos. Statistics: Kruskal–Wallis test, *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig6-figsupp1-v1.tif"/></fig></fig-group><p>Conservation of genetic interactions between human and fly cTFs and constitutive genes has been identified before (<xref ref-type="bibr" rid="bib75">Qian et al., 2011</xref>). We therefore specifically tested for genetic interaction between <italic>RpS15Aa</italic> and the cardiac TFs <italic>tinman/NKX2–5</italic>, <italic>pannier/GATA4/5/6</italic>, and <italic>Dorsocross/TBX5</italic> in adult <italic>Drosophila</italic> hearts<italic>.</italic> A heterozygous deficiency covering <italic>RpS15Aa</italic> causes moderate dilation of hearts compared to controls (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>). However, when <italic>RpS15Aa</italic> was placed in trans to loss of function alleles of cardiac TFs <italic>tinman</italic>, <italic>pannier</italic>, or <italic>Dorsocross1/2/3</italic>, these hearts exhibited significantly deformed hearts, which is only rarely observed in the single heterozygotes (<xref ref-type="fig" rid="fig5">Figure 5C, D</xref>). In addition, <italic>RpS15Aa</italic> heterozygous flies showed a prolonged heart period when combined with a <italic>tinman</italic> or <italic>pannier</italic> heterozygous mutations (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>).</p><p>Next, we tested whether similar genetic interactions are conserved in zebrafish. Zebrafish express the NKX2–5 ortholog <italic>nkx2.7</italic> in the heart, and functional studies have shown that both <italic>nkx2.5</italic> and <italic>nkx2.7</italic> play critical roles in cardiac development (<xref ref-type="bibr" rid="bib55">Lee et al., 1996</xref>). To determine whether <italic>rps15a</italic> and <italic>nkx2.7 or tbx5a</italic> genetically interact in zebrafish, we injected low doses of <italic>rps15a</italic> (<xref ref-type="bibr" rid="bib92">Uechi et al., 2006</xref>) MO, in combination with <italic>nkx2.7</italic> (<xref ref-type="bibr" rid="bib86">Targoff et al., 2008</xref>) or <italic>tbx5a</italic> MO. <italic>nkx2.7</italic> MO alone had little effect on heart size, cross-sectional area, or contractility, whereas double morphants exhibited cardiac dysfunction, with contraction virtually abolished in some animals (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>). Furthermore, we observed a significant prolongation of the heart period in double morphants (<italic>rps15a + nkx2.7</italic> or <italic>rps15a + tbx5</italic>a) in comparison to each MO alone (two-way ANOVA; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D, E</xref>) consistent with the effects observed in <italic>Drosophila</italic>. Together, these results highlight the existence of evolutionarily conserved (fly, zebrafish, and hPSC-CMs) genetic interactions between RPs and cardiac TF genes in the regulation of cardiogenesis. These data also illustrate how the activity of ubiquitously expressed genes such as RPs can be modulated by cell type-specific genes, like cardiac TFs, to achieve tissue-specific outcomes.</p></sec><sec id="s2-8"><title>RP-regulated HLHS-associated genes control proliferation in a CM-specific manner</title><p>Previous studies and this work show that reduced RP function can lead to tissue-specific developmental defects, that in turn can be rescued by loss of p53 (<xref ref-type="bibr" rid="bib90">Tiu et al., 2021</xref>; <xref ref-type="bibr" rid="bib62">McGowan et al., 2011</xref>). While these findings highlight a downstream role for p53 in the development of RP-dependent phenotypes, they also imply that RPs can regulate cell cycle and/or p53 activity in a tissue-specific manner. Thus, to delineate how RPs might control proliferation in a CM-specific manner, we compared differential gene expression profiles upon the two RP KDs in hPSC-CMs and undifferentiated hPSCs (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Consistent with our hypothesis, this analysis revealed that RPs regulate the expression of 493 genes in a CM-specific manner (<xref ref-type="supplementary-material" rid="supp5 supp6 supp7 supp8">Supplementary files 5–8</xref>), thereby suggesting the existence of a cell type-specific (cardiac) transcriptional response to RP loss of function.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>RP-dependent cardiac-specific regulation of cell proliferation.</title><p>(<bold>A</bold>) Schematic illustrating approach to identify novel RP-dependent and cardiac-specific hypoplastic left heart syndrome (HLHS)-associated gene network controlling cardiomyocyte (CM) proliferation. (<bold>B</bold>) Heatmap showing differential expression (hiPSC-CMs vs hiPSCs) of genes regulating CM proliferation. (<bold>C</bold>) Histogram showing effect of cardiac-specific and HLHS-associated genes on CM proliferation. (<bold>D</bold>) Visualization of RP-dependent and cardiac-specific HLHS-associated gene network (GeneMania). HLHS families. (<bold>E</bold>) Table of HLHS families harboring rare and damaging variant in RP-dependent and cardiac-specific genes. (<bold>F</bold>) Histogram showing lack of effect of siEWSR1 on OCT4+ hiPSCs. (<bold>G</bold>) Representative images of OCT4+ cells in siControl and siEWSR1. (<bold>H</bold>) Histogram showing that siEWSR1 increases the % of CDKN1A+ CMs as compared to siControl. (<bold>I</bold>) Histogram showing that siEWSR1 concomitantly decreases the % of EDU+ CMs as compared to siControl. (<bold>J</bold>) Representative images showing immunostaining for CDKN1A (white), EDU (green), and ACTN2 (red) in siEWSR1 and siControl conditions. (<bold>K</bold>) Pathway reconstruction of cardiac and RP-dependent regulation of CM proliferation by HLHS-associated genes. Chi-square test, <italic>*</italic>p &lt; 0.05, **p &lt; 0.005, ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig7-v1.tif"/></fig><p>Next, to evaluate whether HLHS-associated genes were part of this lineage-specific transcriptional response, we selected those differentially expressed genes harboring rare and predicted-damaging variants in probands from the poor-outcome cohort and 75H family (<xref ref-type="supplementary-material" rid="supp2 supp4">Supplementary files 2 and 4</xref>). Remarkably, this prioritization strategy identified 12 genes potentially associated with HLHS (<xref ref-type="supplementary-material" rid="supp9">Supplementary file 9</xref>), 6 of which were found to also regulate cell cycle activity in hPSC-CMs (<xref ref-type="fig" rid="fig7">Figure 7B, C</xref>). Thus, collectively, this approach led us to identify an RP-dependent and cardiac-specific HLHS-associated gene network that supports CM proliferation <italic>via</italic> the upregulation of <italic>EWSR1</italic>, <italic>MDC1</italic>, <italic>PKMYT1</italic>, and <italic>KIF1C</italic>, and downregulation of <italic>FAT4</italic> and <italic>EPHA4</italic> (<xref ref-type="fig" rid="fig7">Figure 7D, E</xref>).</p><p>To further explore if RP-regulated HLHS-associated genes control proliferation in a cell type-specific manner, we asked if <italic>EWSR1</italic> KD<italic>,</italic> which elicited the strongest proliferation phenotype in hPSC-CMs, could regulate proliferation in non-cardiac cell types such as hPSCs. In contrast to hPSC-CMs, siEWSR1 did not affect the number of OCT4+ cells (<xref ref-type="fig" rid="fig7">Figure 7F, G</xref>), which suggests that EWSR1 is able to regulate proliferation CM-specifically. EWSR1 is an RNA/DNA-binding protein that regulates transcription and RNA splicing and plays a major role as oncogenic driver when fused to ETS transcription factors (<xref ref-type="bibr" rid="bib34">Flucke et al., 2021</xref>). In the next step, we tested if EWSR1 regulates CM proliferation by modulating the p53 pathway. Consistent with this hypothesis, immunostaining for p53 downstream target, CDKN1A, revealed that EWSR1 KD both increased the percentage of CDKN1A-positive CMs and decreased EdU incorporation as compared to siControl (<xref ref-type="fig" rid="fig7">Figure 7H–J</xref>). Consistent with these observations, <italic>RpS15Aa</italic> deficiency fly line placed in trans to loss of function allele for <italic>cabeza</italic> (<italic>caz</italic>), the ortholog of <italic>EWSR1</italic>, caused prolongation of systolic interval lengths (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1F</xref>) as compared to controls, suggesting a genetic interaction between these two genes. Collectively, these results support the conclusion that RPs can modulate proliferation in a cell type-specific manner, by controlling the expression of downstream effectors (i.e. <italic>EWSR1</italic>), with a cell type-specific ability to modulate the p53 pathway activity (<xref ref-type="fig" rid="fig7">Figures 7k</xref> and <xref ref-type="fig" rid="fig8">8</xref>).</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Model for RP-dependent involvement in hypoplastic left heart syndrome (HLHS)-associated phenotypes.</title><p>Schematic showing that combined prioritization and unbiased screening led to the identification of a novel HLHS-associated gene network regulating cardiomyocyte (CM) proliferation as potential disease-causing mechanism.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig8-v1.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>RpS15Aa KD induces nucleolar stress in third instar larval hearts.</title><p>(<bold>A</bold>) Nucleolar stress induction in third instar larval hearts upon <italic>RpS15Aa</italic> KD as indicated by enlarged nucleoli. Hearts from control and <italic>RpS15Aa</italic> KD. Third instar larva stained for F-actin (red), DAPI (blue), and nucleolus marker Fibrillarin (green) and cardiomyocyte (CM) nuclei in magnifications. Note, heart constriction upon <italic>RpS15Aa</italic> KD in the larval heart. (<bold>B</bold>) Quantification of nucleolus area and area ratio (nucleolus/nucleus) indicates significantly enlarged nucleoli upon <italic>RpS15Aa</italic> KD. Statistics: Mann–Whitney test, ****p &lt; 0001. (<bold>C</bold>) Schematic representation of different nucleolar phenotypes upon RNAi-mediated loss of function. (<bold>D</bold>) As a positive control, KD of another nucleolar key player <italic>Nopp140</italic> specifically in the heart using Hand<sup>4.2</sup>-Gal4 combined with Fibrillarin<sup>EGFP</sup> (kind gift of the Wieschaus lab) leads to loss of nucleolar maintenance. Third instar larva stained for F-actin (red) and DAPI (blue). Fibrillarin in green. CM nuclei in magnifications. PC = pericardial cell.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-fig8-figsupp1-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><sec id="s3-1"><title>Implication of RPs as genetic modulators in HLHS pathogenesis</title><p>Recent work, including our own, strongly suggests that defective cardiac differentiation and impaired CM proliferation contribute to HLHS-associated heart defects (<xref ref-type="bibr" rid="bib58">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Gaber et al., 2013</xref>; <xref ref-type="bibr" rid="bib89">Theis et al., 2020</xref>). In this study, we find that RPs are critical for maintaining CM proliferation, as well as cardiac structure and function in fish and fly heart models. We show a potential role for RP function in cardiac development and HLHS pathogenesis as: (1) RPs are central regulators of CM proliferation; (2) RP variants are enriched in a cohort of poor-outcome HLHS patients; (3) a rare predicted-damaging promoter variant in <italic>RPS15A</italic> was associated with HLHS in familial CHD (75H); (4) KD of RPs in vivo results in cardiac deficiencies in hPSC-CMs, <italic>Drosophila</italic>, and zebrafish; and (5) induces TP53 signaling and blocks proliferation that can be alleviated by inhibition of TP53 in the vertebrate models. Interestingly, the transcriptomic response of a previously reported HLHS proband (<xref ref-type="bibr" rid="bib89">Theis et al., 2020</xref>) paralleled these findings and raised the possibility of an underlying ribosomopathy condition in that HLHS family. While universally important for cellular growth, an increasing number of variants in RP genes have been linked to CHD in humans, indicating tissue-specific differences in the penetrance of RP gene mutations. Most notably, ~30% of patients with Diamond-Blackfan anemia (<xref ref-type="bibr" rid="bib93">Vlachos et al., 2018</xref>), a ribosomopathy characterized by hypo-proliferative, proapoptotic erythropoiesis, also have CHD. In agreement with another study (<xref ref-type="bibr" rid="bib48">Ikeda et al., 2017</xref>), <italic>rps15a</italic> KD in fish caused a noticeable reduction in circulating red blood cells.</p><p>In addition to RPS15A, <italic>RpL13</italic> was recently identified as a potential candidate gene involved in CHD from a screen for de novo copy number variations in 167 patients with CHD (<xref ref-type="bibr" rid="bib81">Schroeder et al., 2019</xref>). Furthermore, the Pediatric Cardiac Genomics Consortium (PCGC) exome dataset of 2871 patients with CHD identified several rare, predicted-damaging de novo variants in RP genes, 2 of which were found in patients with HLHS (<xref ref-type="bibr" rid="bib50">Jin et al., 2017</xref>). Our finding that RPs genetically interact with core cTFs provides a potential mechanism for the cardiac specificity of RP phenotypes. In this context, we hypothesize that RP gene variants might play a role as genetic modifiers (or sensitizers) in the oligogenic pathogenesis of HLHS.</p></sec><sec id="s3-2"><title>Cardiac-specific and RP-dependent regulation of proliferation in the context of HLHS</title><p>Defective proliferation in LV CMs is a phenotypic hallmark of HLHS (<xref ref-type="bibr" rid="bib58">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Gaber et al., 2013</xref>), thereby implying the existence of HLHS-associated mechanisms that regulate proliferation in a CM-specific manner. In this study, we identified RPs as novel candidate genetic regulators of hypoplastic phenotypes observed in HLHS, as (1) rare, predicted-damaging variants affecting RP genes are enriched in HLHS probands as compared to healthy controls, (2) KD of most RPs impairs proliferation in hiPSC-CMs (59/80 tested) and heart development in flies (6/6 tested), and (3) systemic loss of <italic>rps15A</italic> function causes heart-specific hypoplastic phenotypes in zebrafish. However, in this context, the evaluation of RPs function in multiple cell types revealed that they are generally required for proliferation (hPSCs, hPSC-CMs, and dermal fibroblasts), thus indicating that RP loss of function triggers a non-cell type-specific cell cycle block.</p><p>Thus, an appealing mechanism by which RP function could be invoked in a spatially restricted manner would involve the regulation of RP expression by cell type-specific TFs. Consistent with this model, all probands harboring RP variants contain mutations affecting their promoter regions (<xref ref-type="table" rid="table1">Table 1</xref>). Also, several of these mutations are predicted to disrupt the binding site of previously identified HLHS-associated TF, ETS1 (<xref ref-type="bibr" rid="bib65">Miao et al., 2020</xref>; <xref ref-type="bibr" rid="bib103">Ye et al., 2010</xref>). Consistent with these observations, a recent study from the Bruneau lab (<xref ref-type="bibr" rid="bib53">Kathiriya et al., 2021</xref>) shows that 38 RP genes are downregulated in TBX5-null hiPSC-CMs and ChIP analysis (<xref ref-type="bibr" rid="bib4">Ang et al., 2016</xref>) reveals that a third of these dysregulated RPs (14/38 genes) are bound by TBX5 at their core promoter regions. Thus, we speculate that cell type-specific TFs controlling RP expression represent a promising gene class enabling the modulation of RP-dependent proliferation in a tissue-specific manner.</p><p>A second mechanism by which RPs might control proliferation and differentiation in a CM-specific manner is based on the hypothesis that CMs may be molecularly more sensitive to RP loss of function than other cell types. Consistent with this model, RP deficiency predisposes flies, fish, and hPSC-CM for interactions with core cardiogenic TFs, including TBX5/<italic>Doc</italic>, GATA4/<italic>pnr</italic>, and NKX2–5/<italic>tin</italic>, the latter being the most cardiac restricted. (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Moreover, our comparative transcriptomics analysis (<xref ref-type="fig" rid="fig4">Figure 4</xref>) revealed that RPs regulate gene expression in a CM-specific manner. Among these RP-regulated genes, <italic>EWSR1</italic>, <italic>MDC1</italic>, <italic>PKMYT1</italic>, <italic>KIF1C</italic>, <italic>FAT4</italic>, and <italic>EPHA4</italic>, were found to be mutated in HLHS families and regulate CM proliferation (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Remarkably, EWSR1 KD did not affect proliferation in hPSCs, while it strongly reduced EdU incorporation in hPSC-CMs, thus suggesting that EWSR1 regulates proliferation in a CM-specific manner. Interestingly, in flies, <italic>RpS15Aa</italic> genetically interacts with <italic>cabeza</italic> (<italic>caz</italic>, the fly ortholog of <italic>EWSR1</italic>). Consistent with our observations, a recent study has found that overexpression of a fusion Ewsr1-Fli1 protein in mice specifically induces dilated cardiomyopathy by promoting apoptosis in cardiac myocytes (<xref ref-type="bibr" rid="bib85">Tanaka et al., 2015</xref>). Similarly, Fat4, a negative regulator of the Hippo pathway, which is upregulated upon RP KD, was found to specifically regulate heart size via the regulation of CM size and proliferation (<xref ref-type="bibr" rid="bib76">Ragni et al., 2017</xref>). Thus, collectively, we propose that RPs represent a central regulatory hub for cell proliferation and differentiation during embryonic development, which can be modulated in a cell type-specific manner by tissue-restricted modulators of RP expression and/or activity.</p></sec><sec id="s3-3"><title>An RP–MDM2–p53/YAP surveillance network in heart development</title><p>Defects in ribosome biogenesis caused, for example, by reduction in RP gene copy numbers induce a stress response program that activates TP53 (p53) and a cascade of cellular events resulting in apoptosis, inhibition of the cell cycle, or DNA damage response (reviewed in e.g. <xref ref-type="bibr" rid="bib23">Danilova and Gazda, 2015</xref>), commonly referred to as nucleolar stress response (<xref ref-type="bibr" rid="bib13">Boulon et al., 2010</xref>) with activation of TP53 being a key hallmark (<xref ref-type="bibr" rid="bib102">Yang et al., 2018</xref>). A key mechanism involves the release of RPs to the nucleoplasm, where several RPs bind and inhibit MDM2, which again results in p53 stabilization and pathway activation (<xref ref-type="bibr" rid="bib22">Dai et al., 2004</xref>; <xref ref-type="bibr" rid="bib110">Zhang and Lu, 2009</xref>). A recent study showed that RP haploinsufficiency in the developing mouse limb bud also activates a common TP53 cascade but results in TP53-dependent tissue-specific changes of the translatome, which might confer the specificity often observed in ribosomopathy (<xref ref-type="bibr" rid="bib90">Tiu et al., 2021</xref>). The TP53-MDM2 feedback loop is the central molecular node in response to a wide variety of stress signals, including in the human diseased adult heart (<xref ref-type="bibr" rid="bib63">Men et al., 2021</xref>; <xref ref-type="bibr" rid="bib60">Mak et al., 2017</xref>). As mentioned above, the transcriptomic response of the HLHS family 5H (<xref ref-type="bibr" rid="bib89">Theis et al., 2020</xref>) also showed activation of the TP53 pathway potentially due to an underlying ribosomopathy. Since low RP levels induce a proliferation blockade that can be overridden by p53-p21/CDKN1A KD, we hypothesize that RP levels may act as signaling components sensing cellular fitness and with a functional outcome either being p53 activation or non-activation. Such an RP–MDM2–p53 surveillance network was previously proposed to be important in response to nutrient availability changes and inhibition of oncogenic activity (<xref ref-type="bibr" rid="bib25">Deisenroth and Zhang, 2011</xref>; <xref ref-type="bibr" rid="bib57">Liu et al., 2016</xref>). Thus, the inhibition of the RP–MDM2–p53 axis might be a therapeutic avenue to consider for functional intervention, although further studies are needed to identify the upstream mechanisms leading to the <italic>p53</italic> pathway activation observed in HLHS proband cells.</p><p>Heart-specific KD of the <italic>RpS15Aa</italic> in <italic>Drosophila</italic> causes constriction of larval hearts and atrophy in adult hearts, due to heart loss during metamorphosis, which could not be rescued by p53 reduction, unlike in hPSC-CMs and zebrafish. This might be due to a different, context-dependent role of <italic>p53</italic> in flies previously reported to cause a dwarfing, <italic>Minute</italic>-like phenotype (<xref ref-type="bibr" rid="bib20">Cui and DiMario, 2007</xref>). We hypothesized that the loss of RPs in flies, in conjunction with reduced protein synthesis, might cause nucleolar stress, triggering a cell-intrinsic signaling cascade that prevents the heart from further differentiating and growing. To determine whether cardiac KD of <italic>RpS15Aa</italic> causes nucleolar stress in the <italic>Drosophila</italic> heart, we stained larval hearts for Fibrillarin, a marker for nucleoli and nucleolar integrity. We found that <italic>RpS15Aa</italic> KD causes expansion of nucleolar Fibrillarin staining in CM, which is a hallmark of nucleolar stress (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1A–C</xref>). As a control, we also performed cardiac KD of <italic>Nopp140</italic>, which is known to cause nucleolar stress upon loss of-function. We found a similar expansion of Fibrillarin staining in larval CM nuclei (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1C, D</xref>). This suggests that <italic>RpS15Aa</italic> KD indeed causes nucleolar stress in the <italic>Drosophila</italic> heart, which likely contributes to the dramatic heart loss in adults.</p><p>The role of the Hippo pathway to regulate cell growth/organ size, proliferation, and survival, and its importance in cardiac biology is conserved between humans and fly (<xref ref-type="bibr" rid="bib7">Barron and Kagey, 2014</xref>; <xref ref-type="bibr" rid="bib27">Del Re, 2014</xref>; <xref ref-type="bibr" rid="bib104">Yu et al., 2015</xref>; <xref ref-type="bibr" rid="bib97">Wang et al., 2018</xref>). The Hippo–YAP pathway is a cell-intrinsic pathway that regulates CM proliferation and thus heart size during development, as demonstrated by the ability of activated Yap to induce postnatal CM regeneration (<xref ref-type="bibr" rid="bib98">Xiao et al., 2016</xref>). Interestingly, we find here that overexpression of the <italic>Drosophila</italic> ortholog of YAP/TAZ, Yorkie, rescues <italic>RpS15Aa</italic> KD-induced heart loss, dependent on its downstream factor <italic>scalloped</italic> (the <italic>Drosophila</italic> ortholog of <italic>TEAD1/2/3/4</italic>) (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Of note, YAP1 is not only an important regulator of CM proliferation in the embryo but also promotes CM survival and growth in the postnatal heart (<xref ref-type="bibr" rid="bib96">von Gise et al., 2012</xref>; <xref ref-type="bibr" rid="bib26">Del Re et al., 2013</xref>), which is in line with our findings. Interestingly, a proband among the PCGC HLHS patients was transheterozygous for mutations in <italic>RPL15</italic> and <italic>TEAD4</italic> (<xref ref-type="bibr" rid="bib50">Jin et al., 2017</xref>), making this an interesting disease candidate pair.</p></sec><sec id="s3-4"><title>Rapid gene discovery and prioritization approach for complex genetic diseases</title><p>Uncovering the genetic basis of polygenic and heterogeneous diseases, such as HLHS, remains a significant challenge. This difficulty arises from the lack of experimental approaches capable of rapidly determining the role and contribution of genetic variants, as well as their epistatic relationships, in generating disease-associated phenotypes. The current state-of-the-art approach involves using CRISPR-mediated editing or correction of gene variants (<xref ref-type="bibr" rid="bib38">Gifford et al., 2019</xref>), which is effective for analyzing single-family pedigrees. However, this method is impractical for prioritizing the large number of candidate genes identified through cohort-wide analyses. Consequently, progress in gene discovery for HLHS has been limited in recent years (<xref ref-type="bibr" rid="bib100">Yagi et al., 2018</xref>; <xref ref-type="bibr" rid="bib9">Birla et al., 2022</xref>). In this study, we aimed to address these limitations by employing a HT and unbiased exploration of genes regulating a conserved HLHS-relevant phenotype (<xref ref-type="bibr" rid="bib36">Gaber et al., 2013</xref>; <xref ref-type="bibr" rid="bib65">Miao et al., 2020</xref>; <xref ref-type="bibr" rid="bib89">Theis et al., 2020</xref>; <xref ref-type="bibr" rid="bib99">Xu et al., 2022</xref>), such as reduced CM proliferation, in hiPSCs. Notably, results integration from a whole-genome functional screen in hiPSC-derived CMs (<xref ref-type="fig" rid="fig1">Figure 1</xref>, RPs are top hits from the screen), genomic data from an HLHS parent–proband cohort (<xref ref-type="fig" rid="fig2">Figure 2</xref>, RPs represent the most enriched gene class containing rare damaging variants), hiPSC-CM phenotyping from a high-value HLHS family (75H), and functional validation in two independent in vivo model systems (<xref ref-type="fig" rid="fig3">Figure 3</xref>), identified RPs as a novel class of HLHS-associated genes. While our study highlights the potential of this approach for gene prioritization, additional research is needed to directly demonstrate the functional consequence of the identified genetic variants, to verify an association between RP encoding genes and HLHS in other patient cohorts with and without poor outcome, and determine if RP variants have a broader role in CHD susceptibility. In conclusion, we propose that the approach outlined in this study provides a novel framework for rapidly prioritizing candidate genes and systematically testing them, individually or in combination, using a CRISPR/Cas9 genome-editing strategy in mouse embryos (<xref ref-type="bibr" rid="bib21">Cunningham et al., 2017</xref>). Applied in the context of complex genetic diseases, this framework has the potential to yield deeper insights into their underlying mechanisms.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Reagent type (species) or resource</th><th align="left" valign="top">Designation</th><th align="left" valign="top">Source or reference</th><th align="left" valign="top">Identifiers</th><th align="left" valign="top">Additional information</th></tr></thead><tbody><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top"><italic>Hand<sup>4.2</sup></italic>-Gal4</td><td align="left" valign="top">Bodmer lab</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16467358/">16467358</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">R94C02::tdTomato</td><td align="left" valign="top">N. Jan lab</td><td align="left" valign="top">FBtp0137272</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-RpS15Aa<sup>RNAi</sup></td><td align="left" valign="top">Vienna <italic>Drosophila</italic> Resource Center (VDRC)</td><td align="left" valign="top">FBgn0010198</td><td align="left" valign="top">v19198</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">Df(RpS15Aa)</td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center (BDSC)</td><td align="left" valign="top">FBab0047266</td><td align="left" valign="top">39614</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-RpL26<sup>RNAi</sup></td><td align="left" valign="top">Vienna <italic>Drosophila</italic> Resource Center (VDRC)</td><td align="left" valign="top">FBgn0036825</td><td align="left" valign="top">v40402<break/>v100280</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-RpL36A<sup>RNAi</sup></td><td align="left" valign="top">Vienna <italic>Drosophila</italic> Resource Center (VDRC)</td><td align="left" valign="top">FBgn0031980</td><td align="left" valign="top">v108391</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-RpS15<sup>RNAi</sup></td><td align="left" valign="top">Vienna <italic>Drosophila</italic> Resource Center (VDRC)</td><td align="left" valign="top">FBgn0034138</td><td align="left" valign="top">v35415<break/>v104439</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-RpL39<sup>RNAi</sup></td><td align="left" valign="top">Vienna <italic>Drosophila</italic> Resource Center (VDRC)</td><td align="left" valign="top">FBgn0023170</td><td align="left" valign="top">v23578<break/>v108821</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-RpL3<sup>RNAi</sup></td><td align="left" valign="top">Vienna <italic>Drosophila</italic> Resource Center (VDRC)</td><td align="left" valign="top">FBgn0020910</td><td align="left" valign="top">v109820</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-yorkie</td><td align="left" valign="top">Pan</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-Myc<sup>RNAi</sup></td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center (BDSC)</td><td align="left" valign="top">FBgn0262656</td><td align="left" valign="top">25784</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-sd<sup>RNAi</sup></td><td align="left" valign="top">Vienna <italic>Drosophila</italic> Resource Center (VDRC)</td><td align="left" valign="top">FBgn0003345</td><td align="left" valign="top">v101497</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top"><italic>Df(3L)DocA</italic></td><td align="left" valign="top">Reim</td><td align="left" valign="top">Fbab0037663</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">tin<sup>EC40</sup></td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center (BDSC)</td><td align="left" valign="top">Fbal0032861</td><td align="left" valign="top">78560</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">tin<sup>346</sup></td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center (BDSC)</td><td align="left" valign="top">Fbal0035787</td><td align="left" valign="top">92964</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">pnr<sup>VX6</sup></td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center (BDSC)</td><td align="left" valign="top">Fbal0032468</td><td align="left" valign="top">6334</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">Df(pnr)</td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center (BDSC)</td><td align="left" valign="top">Fbab0038315</td><td align="left" valign="top">7982</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top">Oregon AB wild-type</td><td align="left" valign="top">Ocorr lab, SBP</td><td align="left" valign="top"/><td align="left" valign="top">A commonly used wild-type strain</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>Tg(myl7:EGFP)<sup>twu277</sup></italic></td><td align="left" valign="top">Tsai Lab, National Taiwan University</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/12950077/">12950077</ext-link></td><td align="left" valign="top">A transgenic line of zebrafish labeled with heart-specific EGFP fluorescence</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>Tg(myl7:H2A-mCherry)<sup>sd12</sup></italic></td><td align="left" valign="top">Yelon Lab, University of California, San Diego</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/24075907/">24075907</ext-link></td><td align="left" valign="top">A transgenic line of zebrafish specifically expressing mCherry in cardiomyocyte nuclei</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Mouse monoclonal anti-ACTN1</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">A7811</td><td align="left" valign="top">1:800</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Mouse monoclonal anti-POU5F1 (OCT4)</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">P0082</td><td align="left" valign="top">1:500</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Donkey polyclonal anti-mouse Alexa Fluor 568</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">A10037</td><td align="left" valign="top">1:500</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Chicken polyclonal anti-GFP</td><td align="left" valign="top">Aves Labs</td><td align="left" valign="top">GFP-1020</td><td align="left" valign="top">1:300</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Rabbit polyclonal anti-mCherry</td><td align="left" valign="top">Rockland</td><td align="left" valign="top">600-401P16S</td><td align="left" valign="top">1:200</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Donkey polyclonal anti-chicken AlexaFluor 488</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">703-545-155</td><td align="left" valign="top">1:200</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Donkey polyclonal anti-rabbit AlexaFluor 568</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">A10042</td><td align="left" valign="top">1:200</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">DAPI (iPSC) 500 mg/ml</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">D9542</td><td align="left" valign="top">Nuclear stain<break/>1:1000</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Mouse anti-Mhc (<italic>Drosophila</italic>)</td><td align="left" valign="top">DSHB</td><td align="left" valign="top">3E8-3D3</td><td align="left" valign="top">1:50</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-mouse-Alexa Fluor 488</td><td align="left" valign="top">Jackson Labs</td><td align="left" valign="top">115-545-003</td><td align="left" valign="top">1:500</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Alexa Fluor 647 phalloidin</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">A22287</td><td align="left" valign="top">1:500</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">DAPI (Zebrafish) 500 mg/ml</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">D1306</td><td align="left" valign="top">Nuclear stain<break/>1:200</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">RPS15A siRNA</td><td align="left" valign="top">Entrez Gene ID: 6210</td><td align="left" valign="top">Dharmacon</td><td align="left" valign="top">On-Target plus, individual sequence</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">TP53 siRNA</td><td align="left" valign="top">Entrez Gene ID: 7157</td><td align="left" valign="top">Dharmacon</td><td align="left" valign="top">On-Target plus, Individual Sequence</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">CDKN1A siRNA</td><td align="left" valign="top">Entrez Gene ID: 1026</td><td align="left" valign="top">Dharmacon</td><td align="left" valign="top">On-Target plus, SmartPool</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">TP53</td><td align="left" valign="top">371502118c1</td><td align="left" valign="top">IDT Integrated DNA Technologies, Coralville, IA</td><td align="left" valign="top">Expression level</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">CDKN1A</td><td align="left" valign="top">310832423c1</td><td align="left" valign="top">IDT Integrated DNA Technologies, Coralville, IA</td><td align="left" valign="top">Expression level</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">CCNB1</td><td align="left" valign="top">356582356c1</td><td align="left" valign="top">IDT Integrated DNA technologies, Coralville, IA</td><td align="left" valign="top">Expression level</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">CCNB2</td><td align="left" valign="top">332205979c1</td><td align="left" valign="top">IDT Integrated DNA technologies, Coralville, IA</td><td align="left" valign="top">Expression level</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">CDK1</td><td align="left" valign="top">281427275c1</td><td align="left" valign="top">IDT Integrated DNA technologies, Coralville, IA</td><td align="left" valign="top">Expression level</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">MCM2</td><td align="left" valign="top">33356546c1</td><td align="left" valign="top">IDT Integrated DNA technologies, Coralville, IA</td><td align="left" valign="top">Expression level</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">RPS15A</td><td align="left" valign="top">71772358c2</td><td align="left" valign="top">IDT Integrated DNA Technologies, Coralville, IA</td><td align="left" valign="top">Expression level</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">GAPDH</td><td align="left" valign="top">Hs.PT.45.8326</td><td align="left" valign="top">IDT Integrated DNA Technologies, Coralville, IA</td><td align="left" valign="top">Expression level</td></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">EdU</td><td align="left" valign="top">Click-it Plus EdU Imaging Kit</td><td align="left" valign="top">Life Technologies</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Prism v7 and v8</td><td align="left" valign="top">SBP license</td><td align="left" valign="top">GraphPad Software</td><td align="left" valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Study subjects</title><p>Written informed consent was obtained for HLHS probands and family members under a research protocol approved by the Mayo Clinic Institutional Review Board. The studies described in this manuscript were conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of the Mayo Clinic (HLHS protocol 11-000114 approved 10 March 2011).</p><p>Cardiac anatomy was assessed by echocardiography. Candidate genes were identified and prioritized by WGS of genomic DNA and RNA-sequencing of patient-specific iPSC and CMs. Methods for genomic analyses, RNA-sequencing, iPSC technology, bioinformatics, and statistics are described in the Online Appendix.</p></sec><sec id="s4-2"><title>WGS and bioinformatic strategies</title><p>Our methods for family phenotyping, WGS, variant filtering, and candidate gene prioritization in the rare HLHS-CHD family and 25 HLHS proband–parent trios have been previously described (<xref ref-type="bibr" rid="bib87">Theis et al., 2015a</xref>; <xref ref-type="bibr" rid="bib88">Theis et al., 2015b</xref>; <xref ref-type="bibr" rid="bib10">Bodmer, 1993</xref>). In brief, WGS of DNA isolated from blood or cheek swabs was performed on a HiSeq 4000 platform at the Mayo Clinic Medical Genome Facility. BAM files underwent primary and secondary analyses using an established workflow with standard data quality metrics, and reads were aligned to the human hg38 reference genome. Variant call format files with single nucleotide variants and small insertion–deletion (indel) calls were analyzed using Ingenuity Variant Analysis software and knowledge database (QIAGEN). To retain only high-confidence data, variants were required to have a base call quality of at least 20 and to pass Variant Quality Score Recalibration. Functionally annotated coding and regulatory variants underwent primary filtering and prioritization by an iterative approach with variants required to have an MAF &lt;0.01 across all races in gnomAD v2.1 (<xref ref-type="bibr" rid="bib52">Karczewski et al., 2020</xref>). Variants predicted to impact protein structure were retained and included missense, frameshift, stop-gain, stop-loss, canonical splice, and non-canonical variants predicted to disrupt splicing based upon MaxEntScan (<xref ref-type="bibr" rid="bib40">Grodecká et al., 2014</xref>). Regulatory variants were defined as those that (a) impact a microRNA or microRNA-binding site, (b) reside in an enhancer binding site annotated in the VISTA database (<ext-link ext-link-type="uri" xlink:href="http://enhancer.lbl.gov/">http://enhancer.lbl.gov/</ext-link>), or (c) disrupt a predicted promoter or transcription factor-binding site informed by the position-weighted matrices available in JASPAR (<ext-link ext-link-type="uri" xlink:href="http://jaspar.cgb.ki.se/">http://jaspar.cgb.ki.se/</ext-link>). Genes harboring a rare functional variant were further required to have upper quartile cardiac expression during mouse embryonic (e14.5) or human fetal heart development ranked percentiles from RNA-seq experiments available in ENCODE: ENCSR047LLJ (120-day male); ENCSR863BUL (91-day female); ENCSR000AEZ (28- and 19-week female).</p><p>For the HLHS-CHD family, a secondary segregation filter was applied to model autosomal dominant inheritance with incomplete penetrance, which required sharing of prioritized rare variants between affected family members. For the poor-outcome HLHS proband–parent trios, a secondary Mendelian filter was applied to identify major-effect driver variants that arose de novo or fit recessive modes of inheritance (i.e., homozygosity, hemizygosity, compound heterozygosity).</p><p>To determine whether certain gene networks were over-represented, two online bioinformatics tools were used. First, STRING (<xref ref-type="bibr" rid="bib83">Szklarczyk et al., 2019</xref>) was used to investigate experimental and predicted protein–protein and genetic interactions, and clustering of RP genes was demonstrated when the highest stringency filter was applied. In addition, PANTHER (<xref ref-type="bibr" rid="bib64">Mi et al., 2019</xref>) was employed to identify potential enrichment of genes by ontology classification.</p></sec><sec id="s4-3"><title>Generation of hPSC-VCMs</title><p>Id1 overexpressing hPSCs (derived from <xref ref-type="bibr" rid="bib16">Burridge et al., 2015</xref>) were dissociated with 0.5 mM EDTA (Thermo Fisher Scientific) in PBS without CaCl<sub>2</sub> and MgCl<sub>2</sub> (Corning) for 7 min at room temperature (RT). hPSCs were resuspended in mTeSR-1 media (StemCell Technologies) supplemented with 2 µM Thiazovivin (StemCell Technologies) and plated in a Matrigel-coated 12-well plate at a density of 3 × 10<sup>5</sup> cells per well. After 24 hr after passage, cells were fed daily with mTeSR-1 media (without Thiazovivin) for 3–5 days until they reached ≥90% confluence to begin differentiation. hPSC-VCMs were differentiated as previously described (<xref ref-type="bibr" rid="bib16">Burridge et al., 2015</xref>). At day 0, cells were treated with 6 µM CHIR99021 (Selleck Chemicals) in S12 media (<xref ref-type="bibr" rid="bib73">Pei et al., 2017</xref>) for 48 hr. At day 2, cells were treated with 2 µM Wnt-C59 (Selleck Chemicals), an inhibitor of WNT pathway, in S12 media. Forty-eight hours later (at day 4), S12 media is fully changed. At day 5, cells were dissociated with TrypLE Express (Gibco) for 2 min and blocked with RPMI (Gibco) supplemented with 10% FBS (Omega Scientific). Cells were resuspended in S12 media supplemented with 4 mg/l Recombinant Human Insulin (Gibco) (S12+ media) and 2 µM Thiazovivin and plated onto a Matrigel-coated 12-well plate at a density of 9 × 10<sup>5</sup> cells per well. S12+ media was changed at day 8 and replaced at day 10 with RPMI (Gibco) media supplemented with 213 µg/µl <sc>l</sc>-ascorbic acid (Sigma), 500 mg/l BSA-FV (Gibco), 0.5 mM L-carnitine (Sigma), and 8 g/l AlbuMAX Lipid-Rich BSA (Gibco; CM media). Typically, hPSC-ACMs start to beat around day 10. At day 15, cells were purified with lactate media RPMI without glucose, 213 µg/µl L-ascorbic acid, 500 mg/l BSA-FV, and 8 mM sodium-DL-<sc>l</sc>actate (Sigma), for 4 days. At day 19, media was replaced with CM media.</p></sec><sec id="s4-4"><title>siRNA transfection, proliferation assay, and immunostaining in hPSC-VCMs</title><p>At day 25 of differentiation, hPSC-VCMs were dissociated with TrypLE Select 10X (Gibco), 10 min and neutralized with RPMI supplemented with 10% FBS. Cells were resuspended in RPMI with 2% KOSR (Gibco) and 2% B27 50X with vitamin A (Life Technologies) supplemented with 2 μM Thiazovivin and plated at a density of 5000 cells/well in a Matrigel-coated 384-well plate. hPSC-VCMs were transfected with siRNA (Dharmacon: ON-TARGETplus, custom RNAi cherry-pick libraries 0.1 nmol). For the whole-genome screening, siRNAs directed to 18,000 human genes were purchased from the Genomic Center Facility at SBP at a final concentration of 25 nM using lipofectamine RNAiMax (Thermo Fisher) and opti-MEM (Gibco). Forty-eight hours post-transfection, cells were labeled with 10 μM EdU (Thermo Fisher). After 24 hr of EdU incubation, cells were fixed with 4% paraformaldehyde for 30 min and blocked in blocking buffer (10% Horse Serum, 10% Gelatin, and 0.5% Triton X-100) for 20 min. EdU was detected according to protocol and cells were stained with cardiac-specific marker ACTN2 (A7811, Sigma, dilution 1/800), secondary antibody Alexa Fluor 568 (Invitrogen, 1/500) and DAPI (1/1000) in Blocking Buffer. Cells were imaged with ImageXpress Micro XLS microscope (Molecular Devices) and custom algorithms were used to quantify % of EdU+ ACTN1+ hPSC-VCMs and the number of ACTN1+ cells. To quantify TP53 levels in hPSC-VCMs, cells were stained with Phospho-p53 (700439, Thermo Fisher, 1/500), counterstained with ACTN1 (anti-mouse A7811, Sigma, or anti-rat ab50599, Abcam), and imaged and quantified with ImageXpress microscope. Whole-genome screening was performed in one replicate. All the other siRNA experiments were performed in quadruplicates.</p></sec><sec id="s4-5"><title>RNA-seq and data analysis</title><p>hPSCs and hPSC-derived CMs were transfected with 25 nM final concentrations of siRNA against RPS15A, RPL39, and with scrambled control siRNAs as above. Two days after siRNA transfection, RPs KD were verified and confirmed by proliferation assay (see above), and cells were pelleted and resuspended in 500 µl TRIzol reagent followed by total RNA extraction. Library preparation and sequencing of the samples was done at La Jolla Institute of Immunology (La Jolla, CA). FASTQ files were processed using nf-core/rnaseq (version 21.03.0.edge; <xref ref-type="bibr" rid="bib31">Ewels et al., 2020</xref>). Differential gene expression was determined using R/DESeq2 (<xref ref-type="bibr" rid="bib59">Love et al., 2014</xref>) and GO term enrichment was done using gprofiler2 (<xref ref-type="bibr" rid="bib78">Raudvere et al., 2019</xref>). Analysis scripts can be downloaded at <ext-link ext-link-type="uri" xlink:href="https://github.com/gvogler/elife-2025-nielsen-et-al">https://github.com/gvogler/elife-2025-nielsen-et-al</ext-link> (copy archived at <xref ref-type="bibr" rid="bib95">Vogler, 2025</xref>). Raw reads and counts tables are available at GEO accession number GSE207658.</p></sec><sec id="s4-6"><title>Proliferation assay in parent/proband iPSCs</title><p>hPSCs were dissociated as described previously and plated in a Matrigel-coated 384-well plate at a density of 3000 cells per well. Cells were transfected with siRNA at a final concentration of 25 nM using lipofectamine RNAiMax and opti-MEM. After 3 days, cells were labeled with 10 μM EdU for 1 hr. Cells were fixed with 4% paraformaldehyde for 30 min and blocked in blocking buffer for 20 min. EdU was detected according to the protocol and stained with stem cell-specific marker OCT4 (P0082, Sigma, 1/500), secondary antibody Alexa Fluor 568 and DAPI in Blocking Buffer. Cells were imaged with ImageXpress microscope, and % of EdU+ cells and number of OCT4+ cells were quantified.</p></sec><sec id="s4-7"><title>Quantitative real-time PCR (RT-qPCR) in parent/proband iPSCs and hPSC-CMs</title><p>Total RNA was extracted using TRIzol and chloroform. 1 µg of RNA was converted to cDNA using QuantiTect Reverse Transcription kit (QIAGEN). qRT-PCR was performed using SYBR green (Bio-Rad). Human primer sequences for qRT-PCR were obtained from Harvard Primer Bank: TP53 (Primer Bank ID: 371502118c1), CDKN1A (Primer Bank ID: 310832423c1), CCNB1 (Primer Bank ID: 356582356c1), CCNB2 (Primer Bank ID: 332205979c1), CDK1 (Primer Bank ID: 281427275c1), MCM2 (Primer Bank ID: 33356546c1), RPS15A (Primer Bank ID: 71772358c2). All values were normalized to <italic>GAPDH</italic> (<italic>Primer Bank ID: 378404907c1)</italic>. At least three independent biological replicates were performed for each experiment.</p></sec><sec id="s4-8"><title>Statistical analysis</title><p>To determine any statistical significance between experimental and control groups in hPSC-VCMs and iPSCs from parent/proband trio, we calculated two-sided p values with Student’s <italic>t</italic>-test using GraphPad Prism 8.1.2 software.</p></sec><sec id="s4-9"><title><italic>Drosophila</italic> heart function studies</title><p><italic>Drosophila</italic> orthologs were determined using the DIOPT database (<xref ref-type="bibr" rid="bib45">Hu et al., 2011</xref>), and fly stocks were obtained from the Vienna <italic>Drosophila</italic> Resource Center (VDRC) stock center or Bloomington <italic>Drosophila</italic> Stock Center (BDSC) as indicated in the key source table. For in vivo functional heart analysis, we developed a high-throughput method based on genetically modified flies with CM-specific RFP fluorescence. The reporter line by itself or combined with the heart-specific <italic>Hand<sup>4.2</sup></italic>-Gal4 driver including all cardioblasts/CMs, pericardial cells, and wing hearts throughout development starting at post-mitotic, mid-embryonic stages through adulthood (<xref ref-type="bibr" rid="bib43">Han et al., 2006</xref>; <xref ref-type="bibr" rid="bib91">Tögel et al., 2013</xref>; <xref ref-type="bibr" rid="bib42">Hallier et al., 2015</xref>) was crossed to UAS-lines or mutant flies. For interaction studies, a fly line harboring the fluorescent reporter, <italic>Hand<sup>4.2</sup></italic>-Gal4 driver, and a deficiency for RpS15Aa was generated. Adult progeny flies were immobilized and exposed to fluorescence light to record 5 s high-frame-rate movies of the beating heart. Movies were analyzed by fully automated quantification of contractility and rhythmicity parameters of the heart (<xref ref-type="bibr" rid="bib94">Vogler, 2021</xref>). Semi-intact adult fly hearts were filmed and analyzed according to standard protocol (<xref ref-type="bibr" rid="bib32">Fink et al., 2009</xref>; <xref ref-type="bibr" rid="bib17">Cammarato et al., 2015</xref>).</p></sec><sec id="s4-10"><title>Immunostainings of the fly heart</title><p>The immunostaining of fly adult hearts was performed as described previously (<xref ref-type="bibr" rid="bib2">Alayari et al., 2009</xref>). In short, adult flies were dissected in a semi-intact fashion to expose the heart according to protocol (<xref ref-type="bibr" rid="bib32">Fink et al., 2009</xref>; <xref ref-type="bibr" rid="bib70">Ocorr et al., 2014</xref>). Myofibrils were relaxed using 10 mM EGTA followed by fixation in 4% formaldehyde for 15 min. Hearts were washed with PBS + Triton (PBT; 0.03% Triton X-100) and stained using Alexa 647 phalloidin (Life Technologies) 2 hr at RT. For Mhc labeling, hearts were stained using anti-Mhc antibody (1:50, incubation overnight at 4°C) and after three washes with PBT, secondary antibody was applied for 2 hr at RT. Hearts were washed with PBT three times and PBS one time and mounted using ProLong Gold mountant with DAPI (Life Technologies). Heart preparations were imaged with the Imager.Z1 with an Apotome (Carl Zeiss), Hamamatsu Orca Flash 4.0, and ZEN imaging software (Carl Zeiss).</p></sec><sec id="s4-11"><title>Zebrafish husbandry</title><p>All zebrafish experiments were performed in accordance with protocols approved by IACUC, AUF 22-073. Zebrafish were maintained under standard laboratory conditions at 28.5°C. In addition to Oregon AB wild-type, the following transgenic lines were used: <italic>Tg(myl7:EGFP)<sup>twu277</sup></italic> (<xref ref-type="bibr" rid="bib46">Huang et al., 2003</xref>) and <italic>Tg(myl7:H2A-mCherry)<sup>sd12</sup></italic> (<xref ref-type="bibr" rid="bib82">Schumacher et al., 2013</xref>).</p><p>In zebrafish, gene expression was manipulated using standard microinjection of MO antisense oligonucleotides (<xref ref-type="bibr" rid="bib97">Wang et al., 2018</xref>). In addition, we performed targeted mutagenesis using CRISPR/Cas9 genome editing (<xref ref-type="bibr" rid="bib84">Talbot and Amacher, 2014</xref>; <xref ref-type="bibr" rid="bib37">Gagnon et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">Irion et al., 2014</xref>), to create insertion/deletion (INDEL) mutations in relevant ribosomal genes (F<sub>0</sub>). Subsequently, zebrafish were raised to 72 hr post-fertilization (hpf), immobilized in low melt agarose, and the hearts were filmed and analyzed according to standard protocol (<xref ref-type="bibr" rid="bib32">Fink et al., 2009</xref>).</p></sec><sec id="s4-12"><title>MO sequence information</title><p>All MOs were purchased from Gene Tools, LLC, synthesized at 300 nmol, except zebrafish p53 oligos at 100 nmol.</p><list list-type="simple" id="list1"><list-item><p>Zebrafish <italic>rpl13</italic> 5′-UTR MO: <named-content content-type="sequence">TTGTTCACTCCGTCCTTAGCGGAAA</named-content></p></list-item><list-item><p>Zebrafish <italic>rps15a</italic> 5′-UTR MO: <named-content content-type="sequence">CGCACCATGATGCCAGTTCTGCAAT</named-content></p></list-item><list-item><p>Zebrafish <italic>rpl39</italic> 5′-UTR MO: <named-content content-type="sequence">GGATCGCAATCCGTTCACCACTATG</named-content></p></list-item><list-item><p>Zebrafish p53 MO: <named-content content-type="sequence">GCGCCATTGCTTTGCAAGAATTG</named-content></p></list-item><list-item><p>Zebrafish Control MO: 5′-<named-content content-type="sequence">CCT CTT ACC TCA GTT ACA ATT TAT</named-content> A-3′.</p></list-item></list></sec><sec id="s4-13"><title>Zebrafish SOHA (semi-automated optical heartbeat analysis)</title><p>Larval zebrafish (72 hpf) were immobilized in a small amount of low melt agarose (1.5%) and submerged in conditioned water. Beating hearts were imaged with direct immersion optics and a digital high-speed camera (up to 200 frame/s, Hamamatsu Orca Flash) to record 30 s movies; images were captured using HC Image (Hamamatsu Corp). Cardiac function was analyzed from these high-speed movies using semi-automatic optical heartbeat analysis software (<xref ref-type="bibr" rid="bib32">Fink et al., 2009</xref>; <xref ref-type="bibr" rid="bib69">Ocorr et al., 2009</xref>), which for zebrafish quantifies heart period (R–R interval), cardiac rhythmicity, as well as chamber size and fractional area change. All hearts were imaged at RT (20–21°C). Statistical analyses were performed using Prism software (GraphPad). Significance was determined using two-tailed, unpaired Student <italic>t</italic>-test or one-way ANOVA and Dunnett’s multiple comparisons post hoc test as appropriate.</p></sec><sec id="s4-14"><title>Zebrafish CM cell counts and cardiac immunofluorescent imaging</title><p>To count CMs, we used the expression of H2AmCherry in the nuclei (<italic>Tg(myl7:H2A-mCherry)</italic>) (<xref ref-type="bibr" rid="bib82">Schumacher et al., 2013</xref>) to qualify as an individual cell, performed the ‘Spot’ function in Imaris to distinguish individual cells in reconstructions of confocal z-stacks. (<xref ref-type="bibr" rid="bib108">Zeng and Yelon, 2014</xref>; <xref ref-type="bibr" rid="bib74">Pradhan et al., 2017</xref>). To compare datasets, we used Prism software (GraphPad) to perform Student’s <italic>t</italic>-test with two-tail distribution. Graphs display mean and standard deviation for each dataset.</p><p>Whole-mount immunofluorescence was performed as previously described (<xref ref-type="bibr" rid="bib89">Theis et al., 2020</xref>; <xref ref-type="bibr" rid="bib108">Zeng and Yelon, 2014</xref>; <xref ref-type="bibr" rid="bib74">Pradhan et al., 2017</xref>; <xref ref-type="bibr" rid="bib3">Alexander et al., 1998</xref>) (see also key resources table). Confocal imaging was performed on an LSM 710 confocal microscope (Zeiss, Germany) with a 40x water objective. Exported z-stacks were processed with Imaris software (Bitplane), Zeiss Zen, and Adobe Creative Suite software (Photoshop and Illustrator 2020). All confocal images shown are projection views of partial reconstructions from multiple z-stack slices, except where noted that images are views of a single slice.</p><p>For proliferation assays, embryos at 24, 48, and 72 hpf were fixed in 4% paraformaldehyde overnight at 4°C, washed in PBS with 0.1% Tween-20 (PBST). Samples were blocked in 5% normal goat serum in PBST prior to incubation with primary antibodies. Proliferating cells were labeled with anti-phospho-histone H3 (Sigma-Aldrich-H0412 PH3; 1:500) and total nuclei were counterstained with DAPI. Embryos were mounted in ProLong Gold for imaging. Whole-mount hearts were imaged on a Zeiss Apotome microscope at ×10 magnification. Z-stacks were acquired and reconstructed using Fiji/ImageJ. Regions corresponding to atrium, ventricle, atrioventricular canal, and outflow tract were manually segmented. For some experiments, CM nuclei were identified based on Tg(myl7:H2A-mCherry) expression, with DAPI used to quantify total cell counts. For proliferation experiments, DAPI was used to identify cardiac cells, and proliferating cells were identified by PH3 staining. Proliferative indices were calculated as PH3+/DAPI+ ratios from z-stacks analyzed in Fiji/ImageJ using the Cell Counter plugin. Cell counts were performed on at least 10 embryos per condition per timepoint.</p></sec><sec id="s4-15"><title>Zebrafish CRISPR/Cas9 experiments</title><p>Detailed steps were previously described (<xref ref-type="bibr" rid="bib44">Hoshijima et al., 2019</xref>) and we followed IDT manufacture instruction for complexes preparation. crRNA:tracrRNA Duplex Preparation:Target-specific Alt-R crRNA (sequence information see below) and common Alt-R tracrRNA were synthesized by IDT and each RNA was dissolved in duplex buffer (IDT) as 100 μM stock solution. Stock solutions were stored at –20°C. To prepare the crRNA:tracrRNA duplex, equal volumes of 100 μM Alt-R crRNA and 100 μM Alt-R tracrRNA stock solutions were mixed together and annealed by heating followed by gradual cooling to RT by manufacture instruction: 95°C, 5 min on PCR machine; cool to 25°C; cool to 4°C rapidly on ice. The 50 μM crRNA:tracrRNA duplex stock solution was stored at –20°C. Preparation of crRNA:tracrRNA:Cas9 RNP complexes: Cas9 protein (Alt-R S.p. Cas9 nuclease, v.3, IDT) was adjusted to 25 μM stock solution in 20 mM HEPES-NaOH (pH 7.5), 350 mM KCl, 20% glycerol, dispensed as 8 µl aliquots, and stored at –80°C. 25 μM crRNA:tracrRNA duplex was produced by mixing equal volumes of 50 μM crRNA:tracrRNA duplex stock and duplex buffer (IDT). We used 5 μM RNP complex. To generate 5 μM crRNA:tracrRNA:Cas9 RNP complexes: 1 μl 25 μM crRNA:tracrRNA duplex was mixed with 1 μl 25 μM Cas9 stock, 2 μl H<sub>2</sub>O, and 1 μl 0.25% phenol red solution. Prior to microinjection, the RNP complex solution was incubated at 37°C for 5 min and then placed at RT. Approximately one nanoliter of 5 μM RNP complex was injected into the cytoplasm of one-cell stage embryos to generate F<sub>0</sub> larva.</p></sec><sec id="s4-16"><title>IDT crRNA sequence information</title><p>All crRNAs were purchased from Integrated DNA Technologies, Inc, synthesized at 2 nmol with standard desalting condition.</p><list list-type="simple" id="list2"><list-item><p><named-content content-type="sequence">Dr.Cas9.RPS15A.1.AC: /AltR1/rUrU rGrUrU rGrUrC rArArU rCrUrC rArCrA rGrGrG rGrUrU rUrUrA rGrArG rCrUrA rUrGrC rU/AltR2/</named-content></p></list-item><list-item><p><named-content content-type="sequence">Dr.Cas9.RPS15A.1.AB: /AltR1/rGrC rGrUrA rCrUrA rUrGrA rCrUrU rUrArG rArGrC rGrUrU rUrUrA rGrArG rCrUrA rUrGrC rU/AltR2/</named-content></p></list-item><list-item><p><named-content content-type="sequence">Dr.Cas9.RPS17.1.AC: /AlTR1/rUrGrArCrUrUrCrCrArCrArUrUrArArCrArArGrCrGrUrUrUrUrArGrArGrCrUrArUrGrCrU/AlTR2/</named-content></p></list-item><list-item><p><named-content content-type="sequence">Dr.Cas9.RPS28.1.AA: /AlTR1/rCrUrGrGrGrArArGrArArCrUrGrGrCrUrCrCrCrArGrUrUrUrUrArGrArGrCrUrArUrGrCrU/AlTR2/</named-content></p></list-item></list></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Investigation</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Formal analysis</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Investigation</p></fn><fn fn-type="con" id="con11"><p>Investigation</p></fn><fn fn-type="con" id="con12"><p>Investigation</p></fn><fn fn-type="con" id="con13"><p>Investigation</p></fn><fn fn-type="con" id="con14"><p>Methodology</p></fn><fn fn-type="con" id="con15"><p>Methodology</p></fn><fn fn-type="con" id="con16"><p>Conceptualization</p></fn><fn fn-type="con" id="con17"><p>Conceptualization, Supervision, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con18"><p>Conceptualization, Supervision, Investigation, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con19"><p>Conceptualization, Supervision, Funding acquisition, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con20"><p>Conceptualization, Supervision, Investigation, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con21"><p>Conceptualization, Supervision, Funding acquisition, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human studies described in this manuscript were conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of the Mayo Clinic (HLHS protocol 11-000114 approved 10 March 2011). Informed consent was obtained from all participants, and all work complied with the Declaration of Helsinki and relevant privacy regulations, including HIPAA. De-identified samples were used whenever possible to ensure confidentiality.</p></fn><fn fn-type="other"><p>All experiments were conducted in accordance with institutional, national, and international ethical guidelines. Zebrafish studies were approved by the Institutional Animal Care and Use Committee (IACUC) of SBP under AUF 22-073 and were performed in accordance with the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals and the NIH Guide for the Care and Use of Laboratory Animals. Animals were housed in accredited facilities and all procedures, including anesthesia and euthanasia, were carried out to minimize pain, distress, and the number of animals used.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Whole-genome siRNA screen results table.</title></caption><media xlink:href="elife-106231-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>292 filtered variants from poor-outcome HLHS probands.</title><p>MOI – mode of inheritance.</p></caption><media xlink:href="elife-106231-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Subset from all 292 genes that cause CM proliferation defects and/or fly heart defects.</title></caption><media xlink:href="elife-106231-supp3-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Segregating variants of 75H proband.</title></caption><media xlink:href="elife-106231-supp4-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Differential gene expression lists for siRPL39 and siRPS15A in hPSCs and CMs.</title></caption><media xlink:href="elife-106231-supp5-v1.txt" mimetype="text" mime-subtype="plain"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Differential gene expression lists for siRPL39 and siRPS15A in hPSCs and CMs.</title></caption><media xlink:href="elife-106231-supp6-v1.txt" mimetype="text" mime-subtype="plain"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Differential gene expression lists for siRPL39 and siRPS15A in hPSCs and CMs.</title></caption><media xlink:href="elife-106231-supp7-v1.txt" mimetype="text" mime-subtype="plain"/></supplementary-material><supplementary-material id="supp8"><label>Supplementary file 8.</label><caption><title>Differential gene expression lists for siRPL39 and siRPS15A in hPSCs and CMs.</title></caption><media xlink:href="elife-106231-supp8-v1.txt" mimetype="text" mime-subtype="plain"/></supplementary-material><supplementary-material id="supp9"><label>Supplementary file 9.</label><caption><title>Twelve genes prioritized after RNA-seq and whole-genome sequencing (WGS) analysis.</title></caption><media xlink:href="elife-106231-supp9-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-106231-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>For RNA-sequencing, raw reads and counts tables are available at GEO accession number GSE207658.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Vogler</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>siRPS15A-3</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM6304454">GSM6304454</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by a grant from the Wanek Foundation at Mayo Clinic in Rochester, MN, to JLT, TJN, TMO, RB, and ARC. We gratefully acknowledge the patients and families who participated in this study. We thank Marco Tamayo for excellent technical assistance. This work was supported by National Institutes of Health (R01 HL054732 to RB.; R01 HL153645, R01 HL148827, R01 HL149992, R01 AG071464 to ARC); by California Institute for Regenerative Medicine (DISC2-10110 to ARC); by the American Heart Association (AHA Predoctoral Fellowship 18PRE33960593 to KB).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agopian</surname><given-names>AJ</given-names></name><name><surname>Goldmuntz</surname><given-names>E</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Sewda</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>D</given-names></name><name><surname>Mitchell</surname><given-names>LE</given-names></name><collab>Pediatric Cardiac Genomics Consortium*</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Genome-wide association studies and meta-analyses for congenital heart defects</article-title><source>Circulation. Cardiovascular Genetics</source><volume>10</volume><elocation-id>e001449</elocation-id><pub-id pub-id-type="doi">10.1161/CIRCGENETICS.116.001449</pub-id><pub-id pub-id-type="pmid">28468790</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alayari</surname><given-names>NN</given-names></name><name><surname>Vogler</surname><given-names>G</given-names></name><name><surname>Taghli-Lamallem</surname><given-names>O</given-names></name><name><surname>Ocorr</surname><given-names>K</given-names></name><name><surname>Bodmer</surname><given-names>R</given-names></name><name><surname>Cammarato</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Fluorescent labeling of Drosophila heart structures</article-title><source>Journal of Visualized Experiments</source><volume>32</volume><elocation-id>1423</elocation-id><pub-id pub-id-type="doi">10.3791/1423</pub-id><pub-id pub-id-type="pmid">19826399</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>J</given-names></name><name><surname>Stainier</surname><given-names>DY</given-names></name><name><surname>Yelon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Screening mosaic F1 females for mutations affecting zebrafish heart induction and patterning</article-title><source>Developmental Genetics</source><volume>22</volume><fpage>288</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1520-6408(1998)22:33.0.CO;2-2</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ang</surname><given-names>YS</given-names></name><name><surname>Rivas</surname><given-names>RN</given-names></name><name><surname>Ribeiro</surname><given-names>AJS</given-names></name><name><surname>Srivas</surname><given-names>R</given-names></name><name><surname>Rivera</surname><given-names>J</given-names></name><name><surname>Stone</surname><given-names>NR</given-names></name><name><surname>Pratt</surname><given-names>K</given-names></name><name><surname>Mohamed</surname><given-names>TMA</given-names></name><name><surname>Fu</surname><given-names>JD</given-names></name><name><surname>Spencer</surname><given-names>CI</given-names></name><name><surname>Tippens</surname><given-names>ND</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Narasimha</surname><given-names>A</given-names></name><name><surname>Radzinsky</surname><given-names>E</given-names></name><name><surname>Moon-Grady</surname><given-names>AJ</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Pruitt</surname><given-names>BL</given-names></name><name><surname>Snyder</surname><given-names>MP</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Disease model of GATA4 mutation reveals transcription factor cooperativity in human cardiogenesis</article-title><source>Cell</source><volume>167</volume><fpage>1734</fpage><lpage>1749</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.11.033</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>NE</given-names></name><name><surname>Kiparaki</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A potential link between p53, cell competition and ribosomopathy in mammals and in Drosophila</article-title><source>Developmental Biology</source><volume>446</volume><fpage>17</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2018.11.018</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkers</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Zebrafish as a model to study cardiac development and human cardiac disease</article-title><source>Cardiovascular Research</source><volume>91</volume><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvr098</pub-id><pub-id pub-id-type="pmid">21602174</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barron</surname><given-names>DA</given-names></name><name><surname>Kagey</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The role of the Hippo pathway in human disease and tumorigenesis</article-title><source>Clinical and Translational Medicine</source><volume>3</volume><elocation-id>25</elocation-id><pub-id pub-id-type="doi">10.1186/2001-1326-3-25</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bier</surname><given-names>E</given-names></name><name><surname>Bodmer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title><italic>Drosophila</italic>, an emerging model for cardiac disease</article-title><source>Gene</source><volume>342</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2004.07.018</pub-id><pub-id pub-id-type="pmid">15527959</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birla</surname><given-names>AK</given-names></name><name><surname>Brimmer</surname><given-names>S</given-names></name><name><surname>Short</surname><given-names>WD</given-names></name><name><surname>Olutoye</surname><given-names>OO</given-names><suffix>II</suffix></name><name><surname>Shar</surname><given-names>JA</given-names></name><name><surname>Lalwani</surname><given-names>S</given-names></name><name><surname>Sucosky</surname><given-names>P</given-names></name><name><surname>Parthiban</surname><given-names>A</given-names></name><name><surname>Keswani</surname><given-names>SG</given-names></name><name><surname>Caldarone</surname><given-names>CA</given-names></name><name><surname>Birla</surname><given-names>RK</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Current state of the art in hypoplastic left heart syndrome</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>9</volume><elocation-id>878266</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2022.878266</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodmer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>The gene tinman is required for specification of the heart and visceral muscles in Drosophila</article-title><source>Development</source><volume>118</volume><fpage>719</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1242/dev.118.3.719</pub-id><pub-id pub-id-type="pmid">7915669</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodmer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Heart development in Drosophila and its relationship to vertebrates</article-title><source>Trends in Cardiovascular Medicine</source><volume>5</volume><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/1050-1738(94)00032-Q</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bodmer</surname><given-names>R</given-names></name><name><surname>Frasch</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><chapter-title>Chapter 1.2 - development and aging of the drosophila heart</chapter-title><person-group person-group-type="editor"><name><surname>Rosenthal</surname><given-names>N</given-names></name><name><surname>Harvey</surname><given-names>RP</given-names></name></person-group><source>Heart Development and Regeneration</source><publisher-loc>Boston</publisher-loc><publisher-name>Academic Press</publisher-name><fpage>47</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-381332-9.00002-5</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulon</surname><given-names>S</given-names></name><name><surname>Westman</surname><given-names>BJ</given-names></name><name><surname>Hutten</surname><given-names>S</given-names></name><name><surname>Boisvert</surname><given-names>FM</given-names></name><name><surname>Lamond</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The nucleolus under stress</article-title><source>Molecular Cell</source><volume>40</volume><fpage>216</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.09.024</pub-id><pub-id pub-id-type="pmid">20965417</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>AH</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Targeted gene expression as a means of altering cell fates and generating dominant phenotypes</article-title><source>Development</source><volume>118</volume><fpage>401</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1242/dev.118.2.401</pub-id><pub-id pub-id-type="pmid">8223268</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruneau</surname><given-names>BG</given-names></name><name><surname>Logan</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>N</given-names></name><name><surname>Levi</surname><given-names>T</given-names></name><name><surname>Tabin</surname><given-names>CJ</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome</article-title><source>Developmental Biology</source><volume>211</volume><fpage>100</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1006/dbio.1999.9298</pub-id><pub-id pub-id-type="pmid">10373308</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burridge</surname><given-names>PW</given-names></name><name><surname>Holmström</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Chemically defined culture and cardiomyocyte differentiation of human pluripotent stem cells</article-title><source>Current Protocols in Human Genetics</source><volume>87</volume><elocation-id>2103</elocation-id><pub-id pub-id-type="doi">10.1002/0471142905.hg2103s87</pub-id><pub-id pub-id-type="pmid">26439715</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cammarato</surname><given-names>A</given-names></name><name><surname>Ocorr</surname><given-names>S</given-names></name><name><surname>Ocorr</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Enhanced assessment of contractile dynamics in Drosophila hearts</article-title><source>BioTechniques</source><volume>58</volume><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.2144/000114255</pub-id><pub-id pub-id-type="pmid">25652030</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cripps</surname><given-names>RM</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Control of cardiac development by an evolutionarily conserved transcriptional network</article-title><source>Developmental Biology</source><volume>246</volume><fpage>14</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1006/dbio.2002.0666</pub-id><pub-id pub-id-type="pmid">12027431</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crucean</surname><given-names>A</given-names></name><name><surname>Alqahtani</surname><given-names>A</given-names></name><name><surname>Barron</surname><given-names>DJ</given-names></name><name><surname>Brawn</surname><given-names>WJ</given-names></name><name><surname>Richardson</surname><given-names>RV</given-names></name><name><surname>O’Sullivan</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>RH</given-names></name><name><surname>Henderson</surname><given-names>DJ</given-names></name><name><surname>Chaudhry</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Re-evaluation of hypoplastic left heart syndrome from a developmental and morphological perspective</article-title><source>Orphanet Journal of Rare Diseases</source><volume>12</volume><elocation-id>138</elocation-id><pub-id pub-id-type="doi">10.1186/s13023-017-0683-4</pub-id><pub-id pub-id-type="pmid">28793912</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Z</given-names></name><name><surname>DiMario</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>RNAi knockdown of Nopp140 induces Minute-like phenotypes in <italic>Drosophila</italic></article-title><source>Molecular Biology of the Cell</source><volume>18</volume><fpage>2179</fpage><lpage>2191</lpage><pub-id pub-id-type="doi">10.1091/mbc.e07-01-0074</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>TJ</given-names></name><name><surname>Yu</surname><given-names>MS</given-names></name><name><surname>McKeithan</surname><given-names>WL</given-names></name><name><surname>Spiering</surname><given-names>S</given-names></name><name><surname>Carrette</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>CT</given-names></name><name><surname>Bushway</surname><given-names>PJ</given-names></name><name><surname>Tierney</surname><given-names>M</given-names></name><name><surname>Albini</surname><given-names>S</given-names></name><name><surname>Giacca</surname><given-names>M</given-names></name><name><surname>Mano</surname><given-names>M</given-names></name><name><surname>Puri</surname><given-names>PL</given-names></name><name><surname>Sacco</surname><given-names>A</given-names></name><name><surname>Ruiz-Lozano</surname><given-names>P</given-names></name><name><surname>Riou</surname><given-names>JF</given-names></name><name><surname>Umbhauer</surname><given-names>M</given-names></name><name><surname>Duester</surname><given-names>G</given-names></name><name><surname>Mercola</surname><given-names>M</given-names></name><name><surname>Colas</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Id genes are essential for early heart formation</article-title><source>Genes &amp; Development</source><volume>31</volume><fpage>1325</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1101/gad.300400.117</pub-id><pub-id pub-id-type="pmid">28794185</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>MS</given-names></name><name><surname>Zeng</surname><given-names>SX</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>XX</given-names></name><name><surname>David</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition</article-title><source>Molecular and Cellular Biology</source><volume>24</volume><fpage>7654</fpage><lpage>7668</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.17.7654-7668.2004</pub-id><pub-id pub-id-type="pmid">15314173</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danilova</surname><given-names>N</given-names></name><name><surname>Gazda</surname><given-names>HT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ribosomopathies: how a common root can cause a tree of pathologies</article-title><source>Disease Models &amp; Mechanisms</source><volume>8</volume><fpage>1013</fpage><lpage>1026</lpage><pub-id pub-id-type="doi">10.1242/dmm.020529</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasgupta</surname><given-names>C</given-names></name><name><surname>Martinez</surname><given-names>AM</given-names></name><name><surname>Zuppan</surname><given-names>CW</given-names></name><name><surname>Shah</surname><given-names>MM</given-names></name><name><surname>Bailey</surname><given-names>LL</given-names></name><name><surname>Fletcher</surname><given-names>WH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Identification of connexin43 (alpha1) gap junction gene mutations in patients with hypoplastic left heart syndrome by denaturing gradient gel electrophoresis (DGGE)</article-title><source>Mutation Research</source><volume>479</volume><fpage>173</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/s0027-5107(01)00160-9</pub-id><pub-id pub-id-type="pmid">11470490</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deisenroth</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The ribosomal protein-Mdm2-p53 pathway and energy metabolism</article-title><source>Genes &amp; Cancer</source><volume>2</volume><fpage>392</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1177/1947601911409737</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Re</surname><given-names>DP</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Nakano</surname><given-names>N</given-names></name><name><surname>Cho</surname><given-names>J</given-names></name><name><surname>Zhai</surname><given-names>P</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Yabuta</surname><given-names>N</given-names></name><name><surname>Nojima</surname><given-names>H</given-names></name><name><surname>Pan</surname><given-names>D</given-names></name><name><surname>Sadoshima</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury</article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>3977</fpage><lpage>3988</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.436311</pub-id><pub-id pub-id-type="pmid">23275380</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Re</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The hippo signaling pathway: implications for heart regeneration and disease</article-title><source>Clinical and Translational Medicine</source><volume>3</volume><elocation-id>27</elocation-id><pub-id pub-id-type="doi">10.1186/s40169-014-0027-0</pub-id><pub-id pub-id-type="pmid">26932373</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diez-Cuñado</surname><given-names>M</given-names></name><name><surname>Wei</surname><given-names>K</given-names></name><name><surname>Bushway</surname><given-names>PJ</given-names></name><name><surname>Maurya</surname><given-names>MR</given-names></name><name><surname>Perera</surname><given-names>R</given-names></name><name><surname>Subramaniam</surname><given-names>S</given-names></name><name><surname>Ruiz-Lozano</surname><given-names>P</given-names></name><name><surname>Mercola</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>miRNAs that induce human cardiomyocyte proliferation converge on the hippo pathway</article-title><source>Cell Reports</source><volume>23</volume><fpage>2168</fpage><lpage>2174</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.04.049</pub-id><pub-id pub-id-type="pmid">29768213</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>DA</given-names></name><name><surname>Kirk</surname><given-names>EP</given-names></name><name><surname>Yeoh</surname><given-names>T</given-names></name><name><surname>Chandar</surname><given-names>S</given-names></name><name><surname>McKenzie</surname><given-names>F</given-names></name><name><surname>Taylor</surname><given-names>P</given-names></name><name><surname>Grossfeld</surname><given-names>P</given-names></name><name><surname>Fatkin</surname><given-names>D</given-names></name><name><surname>Jones</surname><given-names>O</given-names></name><name><surname>Hayes</surname><given-names>P</given-names></name><name><surname>Feneley</surname><given-names>M</given-names></name><name><surname>Harvey</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome</article-title><source>Journal of the American College of Cardiology</source><volume>41</volume><fpage>2072</fpage><lpage>2076</lpage><pub-id pub-id-type="doi">10.1016/s0735-1097(03)00420-0</pub-id><pub-id pub-id-type="pmid">12798584</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>SM</given-names></name><name><surname>Yelon</surname><given-names>D</given-names></name><name><surname>Conlon</surname><given-names>FL</given-names></name><name><surname>Kirby</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Myocardial lineage development</article-title><source>Circulation Research</source><volume>107</volume><fpage>1428</fpage><lpage>1444</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.227405</pub-id><pub-id pub-id-type="pmid">21148449</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewels</surname><given-names>PA</given-names></name><name><surname>Peltzer</surname><given-names>A</given-names></name><name><surname>Fillinger</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>H</given-names></name><name><surname>Alneberg</surname><given-names>J</given-names></name><name><surname>Wilm</surname><given-names>A</given-names></name><name><surname>Garcia</surname><given-names>MU</given-names></name><name><surname>Di Tommaso</surname><given-names>P</given-names></name><name><surname>Nahnsen</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The nf-core framework for community-curated bioinformatics pipelines</article-title><source>Nature Biotechnology</source><volume>38</volume><fpage>276</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0439-x</pub-id><pub-id pub-id-type="pmid">32055031</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>M</given-names></name><name><surname>Callol-Massot</surname><given-names>C</given-names></name><name><surname>Chu</surname><given-names>A</given-names></name><name><surname>Ruiz-Lozano</surname><given-names>P</given-names></name><name><surname>Izpisua Belmonte</surname><given-names>JC</given-names></name><name><surname>Giles</surname><given-names>W</given-names></name><name><surname>Bodmer</surname><given-names>R</given-names></name><name><surname>Ocorr</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A new method for detection and quantification of heartbeat parameters in <italic>Drosophila</italic>, zebrafish, and embryonic mouse hearts</article-title><source>BioTechniques</source><volume>46</volume><fpage>101</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.2144/000113078</pub-id><pub-id pub-id-type="pmid">19317655</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Census and evaluation of p53 target genes</article-title><source>Oncogene</source><volume>36</volume><fpage>3943</fpage><lpage>3956</lpage><pub-id pub-id-type="doi">10.1038/onc.2016.502</pub-id><pub-id pub-id-type="pmid">28288132</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flucke</surname><given-names>U</given-names></name><name><surname>van Noesel</surname><given-names>MM</given-names></name><name><surname>Siozopoulou</surname><given-names>V</given-names></name><name><surname>Creytens</surname><given-names>D</given-names></name><name><surname>Tops</surname><given-names>BBJ</given-names></name><name><surname>van Gorp</surname><given-names>JM</given-names></name><name><surname>Hiemcke-Jiwa</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title><italic>EWSR1</italic>-The most common rearranged gene in soft tissue lesions, which also occurs in different bone lesions: an updated review</article-title><source>Diagnostics</source><volume>11</volume><elocation-id>1093</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics11061093</pub-id><pub-id pub-id-type="pmid">34203801</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furth</surname><given-names>N</given-names></name><name><surname>Aylon</surname><given-names>Y</given-names></name><name><surname>Oren</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>p53 shades of Hippo</article-title><source>Cell Death and Differentiation</source><volume>25</volume><fpage>81</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.163</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaber</surname><given-names>N</given-names></name><name><surname>Gagliardi</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Kinnear</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Chitayat</surname><given-names>D</given-names></name><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Jaeggi</surname><given-names>E</given-names></name><name><surname>Tabori</surname><given-names>U</given-names></name><name><surname>Keller</surname><given-names>G</given-names></name><name><surname>Mital</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Fetal reprogramming and senescence in hypoplastic left heart syndrome and in human pluripotent stem cells during cardiac differentiation</article-title><source>The American Journal of Pathology</source><volume>183</volume><fpage>720</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2013.05.022</pub-id><pub-id pub-id-type="pmid">23871585</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagnon</surname><given-names>JA</given-names></name><name><surname>Valen</surname><given-names>E</given-names></name><name><surname>Thyme</surname><given-names>SB</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Akhmetova</surname><given-names>L</given-names></name><name><surname>Pauli</surname><given-names>A</given-names></name><name><surname>Montague</surname><given-names>TG</given-names></name><name><surname>Zimmerman</surname><given-names>S</given-names></name><name><surname>Richter</surname><given-names>C</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e98186</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0098186</pub-id><pub-id pub-id-type="pmid">24873830</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gifford</surname><given-names>CA</given-names></name><name><surname>Ranade</surname><given-names>SS</given-names></name><name><surname>Samarakoon</surname><given-names>R</given-names></name><name><surname>Salunga</surname><given-names>HT</given-names></name><name><surname>de Soysa</surname><given-names>TY</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Elfenbein</surname><given-names>A</given-names></name><name><surname>Wyman</surname><given-names>SK</given-names></name><name><surname>Bui</surname><given-names>YK</given-names></name><name><surname>Cordes Metzler</surname><given-names>KR</given-names></name><name><surname>Ursell</surname><given-names>P</given-names></name><name><surname>Ivey</surname><given-names>KN</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Oligogenic inheritance of a human heart disease involving a genetic modifier</article-title><source>Science</source><volume>364</volume><fpage>865</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1126/science.aat5056</pub-id><pub-id pub-id-type="pmid">31147515</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>BM</given-names></name><name><surname>Rodriguez</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>RK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Decreasing number of deaths of infants with hypoplastic left heart syndrome</article-title><source>The Journal of Pediatrics</source><volume>153</volume><fpage>354</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2008.03.009</pub-id><pub-id pub-id-type="pmid">18534240</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grodecká</surname><given-names>L</given-names></name><name><surname>Kramárek</surname><given-names>M</given-names></name><name><surname>Lockerová</surname><given-names>P</given-names></name><name><surname>Kováčová</surname><given-names>T</given-names></name><name><surname>Ravčuková</surname><given-names>B</given-names></name><name><surname>Richterová</surname><given-names>R</given-names></name><name><surname>Kyselová</surname><given-names>K</given-names></name><name><surname>Augste</surname><given-names>E</given-names></name><name><surname>Freiberger</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>No major effect of the CDH1 c.2440‐6C&gt;G mutation on splicing detected in last exon‐specific splicing minigene assay</article-title><source>Genes, Chromosomes &amp; Cancer</source><volume>53</volume><fpage>798</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1002/gcc.22186</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grossfeld</surname><given-names>P</given-names></name><name><surname>Ye</surname><given-names>M</given-names></name><name><surname>Harvey</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hypoplastic left heart syndrome: new genetic insights</article-title><source>Journal of the American College of Cardiology</source><volume>53</volume><fpage>1072</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2008.12.024</pub-id><pub-id pub-id-type="pmid">19298922</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallier</surname><given-names>B</given-names></name><name><surname>Hoffmann</surname><given-names>J</given-names></name><name><surname>Roeder</surname><given-names>T</given-names></name><name><surname>Tögel</surname><given-names>M</given-names></name><name><surname>Meyer</surname><given-names>H</given-names></name><name><surname>Paululat</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The bHLH transcription factor hand regulates the expression of genes critical to heart and muscle function in <italic>Drosophila melanogaster</italic></article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0134204</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0134204</pub-id><pub-id pub-id-type="pmid">26252215</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Z</given-names></name><name><surname>Yi</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Hand, an evolutionarily conserved bHLH transcription factor required for <italic>Drosophila</italic> cardiogenesis and hematopoiesis</article-title><source>Development</source><volume>133</volume><fpage>1175</fpage><lpage>1182</lpage><pub-id pub-id-type="doi">10.1242/dev.02285</pub-id><pub-id pub-id-type="pmid">16467358</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshijima</surname><given-names>K</given-names></name><name><surname>Jurynec</surname><given-names>MJ</given-names></name><name><surname>Klatt Shaw</surname><given-names>D</given-names></name><name><surname>Jacobi</surname><given-names>AM</given-names></name><name><surname>Behlke</surname><given-names>MA</given-names></name><name><surname>Grunwald</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Highly efficient CRISPR-Cas9-based methods for generating deletion mutations and F0 embryos that lack gene function in zebrafish</article-title><source>Developmental Cell</source><volume>51</volume><fpage>645</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.10.004</pub-id><pub-id pub-id-type="pmid">31708433</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Flockhart</surname><given-names>I</given-names></name><name><surname>Vinayagam</surname><given-names>A</given-names></name><name><surname>Bergwitz</surname><given-names>C</given-names></name><name><surname>Berger</surname><given-names>B</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>An integrative approach to ortholog prediction for disease-focused and other functional studies</article-title><source>BMC Bioinformatics</source><volume>12</volume><elocation-id>357</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-12-357</pub-id><pub-id pub-id-type="pmid">21880147</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>CJ</given-names></name><name><surname>Tu</surname><given-names>CT</given-names></name><name><surname>Hsiao</surname><given-names>CD</given-names></name><name><surname>Hsieh</surname><given-names>FJ</given-names></name><name><surname>Tsai</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Germ-line transmission of a myocardium-specific GFP transgene reveals critical regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish</article-title><source>Developmental Dynamics</source><volume>228</volume><fpage>30</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1002/dvdy.10356</pub-id><pub-id pub-id-type="pmid">12950077</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>G-Y</given-names></name><name><surname>Xie</surname><given-names>L-J</given-names></name><name><surname>Linask</surname><given-names>KL</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>X-Q</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>G-M</given-names></name><name><surname>Wu</surname><given-names>Y-J</given-names></name><name><surname>Marquez-Rosado</surname><given-names>L</given-names></name><name><surname>McElhinney</surname><given-names>DB</given-names></name><name><surname>Goldmuntz</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Lampe</surname><given-names>PD</given-names></name><name><surname>Chatterjee</surname><given-names>B</given-names></name><name><surname>Lo</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Evaluating the role of connexin43 in congenital heart disease: Screening for mutations in patients with outflow tract anomalies and the analysis of knock-in mouse models</article-title><source>Journal of Cardiovascular Disease Research</source><volume>2</volume><fpage>206</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.4103/0975-3583.89804</pub-id><pub-id pub-id-type="pmid">22135478</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>F</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Toki</surname><given-names>T</given-names></name><name><surname>Uechi</surname><given-names>T</given-names></name><name><surname>Ishida</surname><given-names>S</given-names></name><name><surname>Nakajima</surname><given-names>Y</given-names></name><name><surname>Sasahara</surname><given-names>Y</given-names></name><name><surname>Okuno</surname><given-names>Y</given-names></name><name><surname>Kanezaki</surname><given-names>R</given-names></name><name><surname>Terui</surname><given-names>K</given-names></name><name><surname>Kamio</surname><given-names>T</given-names></name><name><surname>Kobayashi</surname><given-names>A</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Sato-Otsubo</surname><given-names>A</given-names></name><name><surname>Shiraishi</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Chiba</surname><given-names>K</given-names></name><name><surname>Muramatsu</surname><given-names>H</given-names></name><name><surname>Kanno</surname><given-names>H</given-names></name><name><surname>Ohga</surname><given-names>S</given-names></name><name><surname>Ohara</surname><given-names>A</given-names></name><name><surname>Kojima</surname><given-names>S</given-names></name><name><surname>Kenmochi</surname><given-names>N</given-names></name><name><surname>Miyano</surname><given-names>S</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Ito</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Exome sequencing identified <italic>RPS15A</italic> as a novel causative gene for Diamond-Blackfan anemia</article-title><source>Haematologica</source><volume>102</volume><fpage>e93</fpage><lpage>e96</lpage><pub-id pub-id-type="doi">10.3324/haematol.2016.153932</pub-id><pub-id pub-id-type="pmid">27909223</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irion</surname><given-names>U</given-names></name><name><surname>Krauss</surname><given-names>J</given-names></name><name><surname>Nüsslein-Volhard</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Precise and efficient genome editing in zebrafish using the CRISPR/Cas9 system</article-title><source>Development</source><volume>141</volume><fpage>4827</fpage><lpage>4830</lpage><pub-id pub-id-type="doi">10.1242/dev.115584</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>SC</given-names></name><name><surname>Homsy</surname><given-names>J</given-names></name><name><surname>Zaidi</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Morton</surname><given-names>S</given-names></name><name><surname>DePalma</surname><given-names>SR</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>Chang</surname><given-names>W</given-names></name><name><surname>Sierant</surname><given-names>MC</given-names></name><name><surname>Hung</surname><given-names>WC</given-names></name><name><surname>Haider</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Knight</surname><given-names>J</given-names></name><name><surname>Bjornson</surname><given-names>RD</given-names></name><name><surname>Castaldi</surname><given-names>C</given-names></name><name><surname>Tikhonoa</surname><given-names>IR</given-names></name><name><surname>Bilguvar</surname><given-names>K</given-names></name><name><surname>Mane</surname><given-names>SM</given-names></name><name><surname>Sanders</surname><given-names>SJ</given-names></name><name><surname>Mital</surname><given-names>S</given-names></name><name><surname>Russell</surname><given-names>MW</given-names></name><name><surname>Gaynor</surname><given-names>JW</given-names></name><name><surname>Deanfield</surname><given-names>J</given-names></name><name><surname>Giardini</surname><given-names>A</given-names></name><name><surname>Porter</surname><given-names>GA</given-names><suffix>Jr</suffix></name><name><surname>Srivastava</surname><given-names>D</given-names></name><name><surname>Lo</surname><given-names>CW</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Watkins</surname><given-names>WS</given-names></name><name><surname>Yandell</surname><given-names>M</given-names></name><name><surname>Yost</surname><given-names>HJ</given-names></name><name><surname>Tristani-Firouzi</surname><given-names>M</given-names></name><name><surname>Newburger</surname><given-names>JW</given-names></name><name><surname>Roberts</surname><given-names>AE</given-names></name><name><surname>Kim</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Kaltman</surname><given-names>JR</given-names></name><name><surname>Goldmuntz</surname><given-names>E</given-names></name><name><surname>Chung</surname><given-names>WK</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Gelb</surname><given-names>BD</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Lifton</surname><given-names>RP</given-names></name><name><surname>Brueckner</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands</article-title><source>Nature Genetics</source><volume>49</volume><fpage>1593</fpage><lpage>1601</lpage><pub-id pub-id-type="doi">10.1038/ng.3970</pub-id><pub-id pub-id-type="pmid">28991257</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Brajanovski</surname><given-names>N</given-names></name><name><surname>Chan</surname><given-names>KT</given-names></name><name><surname>Xuan</surname><given-names>J</given-names></name><name><surname>Pearson</surname><given-names>RB</given-names></name><name><surname>Sanij</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy</article-title><source>Signal Transduction and Targeted Therapy</source><volume>6</volume><elocation-id>323</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-021-00728-8</pub-id><pub-id pub-id-type="pmid">34462428</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karczewski</surname><given-names>KJ</given-names></name><name><surname>Francioli</surname><given-names>LC</given-names></name><name><surname>Tiao</surname><given-names>G</given-names></name><name><surname>Cummings</surname><given-names>BB</given-names></name><name><surname>Alföldi</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Collins</surname><given-names>RL</given-names></name><name><surname>Laricchia</surname><given-names>KM</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Birnbaum</surname><given-names>DP</given-names></name><name><surname>Gauthier</surname><given-names>LD</given-names></name><name><surname>Brand</surname><given-names>H</given-names></name><name><surname>Solomonson</surname><given-names>M</given-names></name><name><surname>Watts</surname><given-names>NA</given-names></name><name><surname>Rhodes</surname><given-names>D</given-names></name><name><surname>Singer-Berk</surname><given-names>M</given-names></name><name><surname>England</surname><given-names>EM</given-names></name><name><surname>Seaby</surname><given-names>EG</given-names></name><name><surname>Kosmicki</surname><given-names>JA</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name><name><surname>Tashman</surname><given-names>K</given-names></name><name><surname>Farjoun</surname><given-names>Y</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Poterba</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Seed</surname><given-names>C</given-names></name><name><surname>Whiffin</surname><given-names>N</given-names></name><name><surname>Chong</surname><given-names>JX</given-names></name><name><surname>Samocha</surname><given-names>KE</given-names></name><name><surname>Pierce-Hoffman</surname><given-names>E</given-names></name><name><surname>Zappala</surname><given-names>Z</given-names></name><name><surname>O’Donnell-Luria</surname><given-names>AH</given-names></name><name><surname>Minikel</surname><given-names>EV</given-names></name><name><surname>Weisburd</surname><given-names>B</given-names></name><name><surname>Lek</surname><given-names>M</given-names></name><name><surname>Ware</surname><given-names>JS</given-names></name><name><surname>Vittal</surname><given-names>C</given-names></name><name><surname>Armean</surname><given-names>IM</given-names></name><name><surname>Bergelson</surname><given-names>L</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Connolly</surname><given-names>KM</given-names></name><name><surname>Covarrubias</surname><given-names>M</given-names></name><name><surname>Donnelly</surname><given-names>S</given-names></name><name><surname>Ferriera</surname><given-names>S</given-names></name><name><surname>Gabriel</surname><given-names>S</given-names></name><name><surname>Gentry</surname><given-names>J</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Jeandet</surname><given-names>T</given-names></name><name><surname>Kaplan</surname><given-names>D</given-names></name><name><surname>Llanwarne</surname><given-names>C</given-names></name><name><surname>Munshi</surname><given-names>R</given-names></name><name><surname>Novod</surname><given-names>S</given-names></name><name><surname>Petrillo</surname><given-names>N</given-names></name><name><surname>Roazen</surname><given-names>D</given-names></name><name><surname>Ruano-Rubio</surname><given-names>V</given-names></name><name><surname>Saltzman</surname><given-names>A</given-names></name><name><surname>Schleicher</surname><given-names>M</given-names></name><name><surname>Soto</surname><given-names>J</given-names></name><name><surname>Tibbetts</surname><given-names>K</given-names></name><name><surname>Tolonen</surname><given-names>C</given-names></name><name><surname>Wade</surname><given-names>G</given-names></name><name><surname>Talkowski</surname><given-names>ME</given-names></name><name><surname>Aguilar Salinas</surname><given-names>CA</given-names></name><name><surname>Ahmad</surname><given-names>T</given-names></name><name><surname>Albert</surname><given-names>CM</given-names></name><name><surname>Ardissino</surname><given-names>D</given-names></name><name><surname>Atzmon</surname><given-names>G</given-names></name><name><surname>Barnard</surname><given-names>J</given-names></name><name><surname>Beaugerie</surname><given-names>L</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Bottinger</surname><given-names>EP</given-names></name><name><surname>Bowden</surname><given-names>DW</given-names></name><name><surname>Bown</surname><given-names>MJ</given-names></name><name><surname>Chambers</surname><given-names>JC</given-names></name><name><surname>Chan</surname><given-names>JC</given-names></name><name><surname>Chasman</surname><given-names>D</given-names></name><name><surname>Cho</surname><given-names>J</given-names></name><name><surname>Chung</surname><given-names>MK</given-names></name><name><surname>Cohen</surname><given-names>B</given-names></name><name><surname>Correa</surname><given-names>A</given-names></name><name><surname>Dabelea</surname><given-names>D</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Darbar</surname><given-names>D</given-names></name><name><surname>Duggirala</surname><given-names>R</given-names></name><name><surname>Dupuis</surname><given-names>J</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Elosua</surname><given-names>R</given-names></name><name><surname>Erdmann</surname><given-names>J</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Färkkilä</surname><given-names>M</given-names></name><name><surname>Florez</surname><given-names>J</given-names></name><name><surname>Franke</surname><given-names>A</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Glaser</surname><given-names>B</given-names></name><name><surname>Glatt</surname><given-names>SJ</given-names></name><name><surname>Goldstein</surname><given-names>D</given-names></name><name><surname>Gonzalez</surname><given-names>C</given-names></name><name><surname>Groop</surname><given-names>L</given-names></name><name><surname>Haiman</surname><given-names>C</given-names></name><name><surname>Hanis</surname><given-names>C</given-names></name><name><surname>Harms</surname><given-names>M</given-names></name><name><surname>Hiltunen</surname><given-names>M</given-names></name><name><surname>Holi</surname><given-names>MM</given-names></name><name><surname>Hultman</surname><given-names>CM</given-names></name><name><surname>Kallela</surname><given-names>M</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>BJ</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Kirov</surname><given-names>G</given-names></name><name><surname>Kooner</surname><given-names>J</given-names></name><name><surname>Koskinen</surname><given-names>S</given-names></name><name><surname>Krumholz</surname><given-names>HM</given-names></name><name><surname>Kugathasan</surname><given-names>S</given-names></name><name><surname>Kwak</surname><given-names>SH</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Lubitz</surname><given-names>SA</given-names></name><name><surname>Ma</surname><given-names>RCW</given-names></name><name><surname>MacArthur</surname><given-names>DG</given-names></name><name><surname>Marrugat</surname><given-names>J</given-names></name><name><surname>Mattila</surname><given-names>KM</given-names></name><name><surname>McCarroll</surname><given-names>S</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>McGovern</surname><given-names>D</given-names></name><name><surname>McPherson</surname><given-names>R</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Nilsson</surname><given-names>PM</given-names></name><name><surname>O’Donovan</surname><given-names>MC</given-names></name><name><surname>Ongur</surname><given-names>D</given-names></name><name><surname>Orozco</surname><given-names>L</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>Palmer</surname><given-names>CNA</given-names></name><name><surname>Palotie</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name><name><surname>Pato</surname><given-names>C</given-names></name><name><surname>Pulver</surname><given-names>AE</given-names></name><name><surname>Rahman</surname><given-names>N</given-names></name><name><surname>Remes</surname><given-names>AM</given-names></name><name><surname>Rioux</surname><given-names>JD</given-names></name><name><surname>Ripatti</surname><given-names>S</given-names></name><name><surname>Roden</surname><given-names>DM</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Samani</surname><given-names>NJ</given-names></name><name><surname>Scharf</surname><given-names>J</given-names></name><name><surname>Schunkert</surname><given-names>H</given-names></name><name><surname>Shoemaker</surname><given-names>MB</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Sokol</surname><given-names>H</given-names></name><name><surname>Spector</surname><given-names>T</given-names></name><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Suvisaari</surname><given-names>J</given-names></name><name><surname>Tai</surname><given-names>ES</given-names></name><name><surname>Teo</surname><given-names>YY</given-names></name><name><surname>Tiinamaija</surname><given-names>T</given-names></name><name><surname>Tsuang</surname><given-names>M</given-names></name><name><surname>Turner</surname><given-names>D</given-names></name><name><surname>Tusie-Luna</surname><given-names>T</given-names></name><name><surname>Vartiainen</surname><given-names>E</given-names></name><name><surname>Vawter</surname><given-names>MP</given-names></name><name><surname>Ware</surname><given-names>JS</given-names></name><name><surname>Watkins</surname><given-names>H</given-names></name><name><surname>Weersma</surname><given-names>RK</given-names></name><name><surname>Wessman</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>JG</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>MacArthur</surname><given-names>DG</given-names></name><collab>Genome Aggregation Database Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title><source>Nature</source><volume>581</volume><fpage>434</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiriya</surname><given-names>IS</given-names></name><name><surname>Rao</surname><given-names>KS</given-names></name><name><surname>Iacono</surname><given-names>G</given-names></name><name><surname>Devine</surname><given-names>WP</given-names></name><name><surname>Blair</surname><given-names>AP</given-names></name><name><surname>Hota</surname><given-names>SK</given-names></name><name><surname>Lai</surname><given-names>MH</given-names></name><name><surname>Garay</surname><given-names>BI</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Gong</surname><given-names>HZ</given-names></name><name><surname>Wasson</surname><given-names>LK</given-names></name><name><surname>Goyal</surname><given-names>P</given-names></name><name><surname>Sukonnik</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>KM</given-names></name><name><surname>Akgun</surname><given-names>GA</given-names></name><name><surname>Bernard</surname><given-names>LD</given-names></name><name><surname>Akerberg</surname><given-names>BN</given-names></name><name><surname>Gu</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Speir</surname><given-names>ML</given-names></name><name><surname>Haeussler</surname><given-names>M</given-names></name><name><surname>Pu</surname><given-names>WT</given-names></name><name><surname>Stuart</surname><given-names>JM</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Heyn</surname><given-names>H</given-names></name><name><surname>Bruneau</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Modeling human TBX5 haploinsufficiency predicts regulatory networks for congenital heart disease</article-title><source>Developmental Cell</source><volume>56</volume><fpage>292</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.11.020</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konno</surname><given-names>Y</given-names></name><name><surname>Toki</surname><given-names>T</given-names></name><name><surname>Tandai</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Terui</surname><given-names>K</given-names></name><name><surname>Ohga</surname><given-names>S</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name><name><surname>Hama</surname><given-names>A</given-names></name><name><surname>Kojima</surname><given-names>S</given-names></name><name><surname>Hasegawa</surname><given-names>D</given-names></name><name><surname>Kosaka</surname><given-names>Y</given-names></name><name><surname>Yanagisawa</surname><given-names>R</given-names></name><name><surname>Koike</surname><given-names>K</given-names></name><name><surname>Kanai</surname><given-names>R</given-names></name><name><surname>Imai</surname><given-names>T</given-names></name><name><surname>Hongo</surname><given-names>T</given-names></name><name><surname>Park</surname><given-names>MJ</given-names></name><name><surname>Sugita</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mutations in the ribosomal protein genes in Japanese patients with Diamond-Blackfan anemia</article-title><source>Haematologica</source><volume>95</volume><fpage>1293</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.3324/haematol.2009.020826</pub-id><pub-id pub-id-type="pmid">20378560</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Breitbart</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A new tinman-related gene, nkx2.7, anticipates the expression of nkx2.5 and nkx2.3 in zebrafish heart and pharyngeal endoderm</article-title><source>Developmental Biology</source><volume>180</volume><fpage>722</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1006/dbio.1996.0341</pub-id><pub-id pub-id-type="pmid">8954740</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Stainier</surname><given-names>DYR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Zebrafish in the study of early cardiac development</article-title><source>Circulation Research</source><volume>110</volume><fpage>870</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.246504</pub-id><pub-id pub-id-type="pmid">22427324</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Deisenroth</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>RP-MDM2-p53 pathway: linking ribosomal biogenesis and tumor surveillance</article-title><source>Trends in Cancer</source><volume>2</volume><fpage>191</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2016.03.002</pub-id><pub-id pub-id-type="pmid">28741571</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Saeed</surname><given-names>S</given-names></name><name><surname>Bais</surname><given-names>AS</given-names></name><name><surname>Gabriel</surname><given-names>GC</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Peterson</surname><given-names>KA</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Schwartz</surname><given-names>MC</given-names></name><name><surname>Reynolds</surname><given-names>WT</given-names></name><name><surname>Saydmohammed</surname><given-names>M</given-names></name><name><surname>Gibbs</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Devine</surname><given-names>W</given-names></name><name><surname>Chatterjee</surname><given-names>B</given-names></name><name><surname>Klena</surname><given-names>NT</given-names></name><name><surname>Kostka</surname><given-names>D</given-names></name><name><surname>de Mesy Bentley</surname><given-names>KL</given-names></name><name><surname>Ganapathiraju</surname><given-names>MK</given-names></name><name><surname>Dexheimer</surname><given-names>P</given-names></name><name><surname>Leatherbury</surname><given-names>L</given-names></name><name><surname>Khalifa</surname><given-names>O</given-names></name><name><surname>Bhagat</surname><given-names>A</given-names></name><name><surname>Zahid</surname><given-names>M</given-names></name><name><surname>Pu</surname><given-names>W</given-names></name><name><surname>Watkins</surname><given-names>S</given-names></name><name><surname>Grossfeld</surname><given-names>P</given-names></name><name><surname>Murray</surname><given-names>SA</given-names></name><name><surname>Porter</surname><given-names>GA</given-names><suffix>Jr</suffix></name><name><surname>Tsang</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>LJ</given-names></name><name><surname>Benson</surname><given-names>DW</given-names></name><name><surname>Aronow</surname><given-names>BJ</given-names></name><name><surname>Lo</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The complex genetics of hypoplastic left heart syndrome</article-title><source>Nature Genetics</source><volume>49</volume><fpage>1152</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1038/ng.3870</pub-id><pub-id pub-id-type="pmid">28530678</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname><given-names>TW</given-names></name><name><surname>Hauck</surname><given-names>L</given-names></name><name><surname>Grothe</surname><given-names>D</given-names></name><name><surname>Billia</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>p53 regulates the cardiac transcriptome</article-title><source>PNAS</source><volume>114</volume><fpage>2331</fpage><lpage>2336</lpage><pub-id pub-id-type="doi">10.1073/pnas.1621436114</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>LJ</given-names></name><name><surname>Pilipenko</surname><given-names>V</given-names></name><name><surname>Benson</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of segregation for variant discovery in multiplex families ascertained by probands with left sided cardiovascular malformations</article-title><source>Frontiers in Genetics</source><volume>9</volume><elocation-id>729</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2018.00729</pub-id><pub-id pub-id-type="pmid">30687393</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGowan</surname><given-names>KA</given-names></name><name><surname>Pang</surname><given-names>WW</given-names></name><name><surname>Bhardwaj</surname><given-names>R</given-names></name><name><surname>Perez</surname><given-names>MG</given-names></name><name><surname>Pluvinage</surname><given-names>JV</given-names></name><name><surname>Glader</surname><given-names>BE</given-names></name><name><surname>Malek</surname><given-names>R</given-names></name><name><surname>Mendrysa</surname><given-names>SM</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name><name><surname>Park</surname><given-names>CY</given-names></name><name><surname>Barsh</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome</article-title><source>Blood</source><volume>118</volume><fpage>3622</fpage><lpage>3633</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-11-318584</pub-id><pub-id pub-id-type="pmid">21788341</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Men</surname><given-names>H</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The regulatory roles of p53 in cardiovascular health and disease</article-title><source>Cellular and Molecular Life Sciences</source><volume>78</volume><fpage>2001</fpage><lpage>2018</lpage><pub-id pub-id-type="doi">10.1007/s00018-020-03694-6</pub-id><pub-id pub-id-type="pmid">33179140</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>H</given-names></name><name><surname>Muruganujan</surname><given-names>A</given-names></name><name><surname>Ebert</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Thomas</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D419</fpage><lpage>D426</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1038</pub-id><pub-id pub-id-type="pmid">30407594</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Martin</surname><given-names>M</given-names></name><name><surname>Paige</surname><given-names>SL</given-names></name><name><surname>Galdos</surname><given-names>FX</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Klein</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>N</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Stewart</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Moonen</surname><given-names>JR</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Grossfeld</surname><given-names>P</given-names></name><name><surname>Mital</surname><given-names>S</given-names></name><name><surname>Chitayat</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>JC</given-names></name><name><surname>Rabinovitch</surname><given-names>M</given-names></name><name><surname>Nelson</surname><given-names>TJ</given-names></name><name><surname>Nie</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>SM</given-names></name><name><surname>Gu</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Intrinsic endocardial defects contribute to hypoplastic left heart syndrome</article-title><source>Cell Stem Cell</source><volume>27</volume><fpage>574</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.07.015</pub-id><pub-id pub-id-type="pmid">32810435</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>GI</given-names></name><name><surname>Yelon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A guide to analysis of cardiac phenotypes in the zebrafish embryo</article-title><source>Methods in Cell Biology</source><volume>101</volume><fpage>161</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-387036-0.00007-4</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monroe</surname><given-names>TO</given-names></name><name><surname>Hill</surname><given-names>MC</given-names></name><name><surname>Morikawa</surname><given-names>Y</given-names></name><name><surname>Leach</surname><given-names>JP</given-names></name><name><surname>Heallen</surname><given-names>T</given-names></name><name><surname>Cao</surname><given-names>S</given-names></name><name><surname>Krijger</surname><given-names>PHL</given-names></name><name><surname>de Laat</surname><given-names>W</given-names></name><name><surname>Wehrens</surname><given-names>XHT</given-names></name><name><surname>Rodney</surname><given-names>GG</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>YAP partially reprograms chromatin accessibility to directly induce adult cardiogenesis in vivo</article-title><source>Developmental Cell</source><volume>48</volume><fpage>765</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.01.017</pub-id><pub-id pub-id-type="pmid">30773489</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>SA</given-names></name><name><surname>Miyamoto</surname><given-names>M</given-names></name><name><surname>Kervadec</surname><given-names>A</given-names></name><name><surname>Kannan</surname><given-names>S</given-names></name><name><surname>Tampakakis</surname><given-names>E</given-names></name><name><surname>Kambhampati</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>BL</given-names></name><name><surname>Paek</surname><given-names>S</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>D-I</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>An</surname><given-names>SS</given-names></name><name><surname>Kass</surname><given-names>DA</given-names></name><name><surname>Uosaki</surname><given-names>H</given-names></name><name><surname>Colas</surname><given-names>AR</given-names></name><name><surname>Kwon</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>PGC1/PPAR drive cardiomyocyte maturation at single cell level via YAP1 and SF3B2</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>1648</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-21957-z</pub-id><pub-id pub-id-type="pmid">33712605</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ocorr</surname><given-names>K</given-names></name><name><surname>Fink</surname><given-names>M</given-names></name><name><surname>Cammarato</surname><given-names>A</given-names></name><name><surname>Bernstein</surname><given-names>SI</given-names></name><name><surname>Bodmer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Semi-automated optical heartbeat analysis of small hearts</article-title><source>Journal of Visualized Experiments</source><volume>31</volume><elocation-id>1435</elocation-id><pub-id pub-id-type="doi">10.3791/1435</pub-id><pub-id pub-id-type="pmid">19759521</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ocorr</surname><given-names>K</given-names></name><name><surname>Vogler</surname><given-names>G</given-names></name><name><surname>Bodmer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Methods to assess <italic>Drosophila</italic> heart development, function and aging</article-title><source>Methods</source><volume>68</volume><fpage>265</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2014.03.031</pub-id><pub-id pub-id-type="pmid">24727147</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ollmann</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>LM</given-names></name><name><surname>Di Como</surname><given-names>CJ</given-names></name><name><surname>Karim</surname><given-names>F</given-names></name><name><surname>Belvin</surname><given-names>M</given-names></name><name><surname>Robertson</surname><given-names>S</given-names></name><name><surname>Whittaker</surname><given-names>K</given-names></name><name><surname>Demsky</surname><given-names>M</given-names></name><name><surname>Fisher</surname><given-names>WW</given-names></name><name><surname>Buchman</surname><given-names>A</given-names></name><name><surname>Duyk</surname><given-names>G</given-names></name><name><surname>Friedman</surname><given-names>L</given-names></name><name><surname>Prives</surname><given-names>C</given-names></name><name><surname>Kopczynski</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title><italic>Drosophila</italic> p53 is a structural and functional homolog of the tumor suppressor p53</article-title><source>Cell</source><volume>101</volume><fpage>91</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80626-1</pub-id><pub-id pub-id-type="pmid">10778859</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paige</surname><given-names>SL</given-names></name><name><surname>Galdos</surname><given-names>FX</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Chin</surname><given-names>ET</given-names></name><name><surname>Ranjbarvaziri</surname><given-names>S</given-names></name><name><surname>Feyen</surname><given-names>DAM</given-names></name><name><surname>Darsha</surname><given-names>AK</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Ryan</surname><given-names>JA</given-names></name><name><surname>Beck</surname><given-names>AL</given-names></name><name><surname>Qureshi</surname><given-names>MY</given-names></name><name><surname>Miao</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>M</given-names></name><name><surname>Bernstein</surname><given-names>D</given-names></name><name><surname>Nelson</surname><given-names>TJ</given-names></name><name><surname>Mercola</surname><given-names>M</given-names></name><name><surname>Rabinovitch</surname><given-names>M</given-names></name><name><surname>Ashley</surname><given-names>EA</given-names></name><name><surname>Parikh</surname><given-names>VN</given-names></name><name><surname>Wu</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Patient-specific induced pluripotent stem cells implicate intrinsic impaired contractility in hypoplastic left heart syndrome</article-title><source>Circulation</source><volume>142</volume><fpage>1605</fpage><lpage>1608</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.119.045317</pub-id><pub-id pub-id-type="pmid">33074758</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>F</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Bai</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells</article-title><source>Stem Cell Research</source><volume>19</volume><fpage>94</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.scr.2017.01.006</pub-id><pub-id pub-id-type="pmid">28110125</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pradhan</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>XXI</given-names></name><name><surname>Sidhwani</surname><given-names>P</given-names></name><name><surname>Marques</surname><given-names>SR</given-names></name><name><surname>George</surname><given-names>V</given-names></name><name><surname>Targoff</surname><given-names>KL</given-names></name><name><surname>Chi</surname><given-names>NC</given-names></name><name><surname>Yelon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>FGF signaling enforces cardiac chamber identity in the developing ventricle</article-title><source>Development</source><volume>144</volume><fpage>1328</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1242/dev.143719</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>L</given-names></name><name><surname>Wythe</surname><given-names>JD</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Cartry</surname><given-names>J</given-names></name><name><surname>Vogler</surname><given-names>G</given-names></name><name><surname>Mohapatra</surname><given-names>B</given-names></name><name><surname>Otway</surname><given-names>RT</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>King</surname><given-names>IN</given-names></name><name><surname>Maillet</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Crawley</surname><given-names>T</given-names></name><name><surname>Taghli-Lamallem</surname><given-names>O</given-names></name><name><surname>Semsarian</surname><given-names>C</given-names></name><name><surname>Dunwoodie</surname><given-names>S</given-names></name><name><surname>Winlaw</surname><given-names>D</given-names></name><name><surname>Harvey</surname><given-names>RP</given-names></name><name><surname>Fatkin</surname><given-names>D</given-names></name><name><surname>Towbin</surname><given-names>JA</given-names></name><name><surname>Molkentin</surname><given-names>JD</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name><name><surname>Ocorr</surname><given-names>K</given-names></name><name><surname>Bruneau</surname><given-names>BG</given-names></name><name><surname>Bodmer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tinman/Nkx2-5 acts via miR-1 and upstream of Cdc42 to regulate heart function across species</article-title><source>The Journal of Cell Biology</source><volume>193</volume><fpage>1181</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1083/jcb.201006114</pub-id><pub-id pub-id-type="pmid">21690310</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ragni</surname><given-names>CV</given-names></name><name><surname>Diguet</surname><given-names>N</given-names></name><name><surname>Le Garrec</surname><given-names>JF</given-names></name><name><surname>Novotova</surname><given-names>M</given-names></name><name><surname>Resende</surname><given-names>TP</given-names></name><name><surname>Pop</surname><given-names>S</given-names></name><name><surname>Charon</surname><given-names>N</given-names></name><name><surname>Guillemot</surname><given-names>L</given-names></name><name><surname>Kitasato</surname><given-names>L</given-names></name><name><surname>Badouel</surname><given-names>C</given-names></name><name><surname>Dufour</surname><given-names>A</given-names></name><name><surname>Olivo-Marin</surname><given-names>JC</given-names></name><name><surname>Trouvé</surname><given-names>A</given-names></name><name><surname>McNeill</surname><given-names>H</given-names></name><name><surname>Meilhac</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14582</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14582</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raj</surname><given-names>N</given-names></name><name><surname>Bam</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Reciprocal crosstalk between YAP1/Hippo pathway and the p53 family proteins: mechanisms and outcomes in cancer</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>7</volume><elocation-id>159</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2019.00159</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raudvere</surname><given-names>U</given-names></name><name><surname>Kolberg</surname><given-names>L</given-names></name><name><surname>Kuzmin</surname><given-names>I</given-names></name><name><surname>Arak</surname><given-names>T</given-names></name><name><surname>Adler</surname><given-names>P</given-names></name><name><surname>Peterson</surname><given-names>H</given-names></name><name><surname>Vilo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>W191</fpage><lpage>W198</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz369</pub-id><pub-id pub-id-type="pmid">31066453</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reller</surname><given-names>MD</given-names></name><name><surname>Strickland</surname><given-names>MJ</given-names></name><name><surname>Riehle-Colarusso</surname><given-names>T</given-names></name><name><surname>Mahle</surname><given-names>WT</given-names></name><name><surname>Correa</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005</article-title><source>The Journal of Pediatrics</source><volume>153</volume><fpage>807</fpage><lpage>813</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2008.05.059</pub-id><pub-id pub-id-type="pmid">18657826</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robu</surname><given-names>ME</given-names></name><name><surname>Larson</surname><given-names>JD</given-names></name><name><surname>Nasevicius</surname><given-names>A</given-names></name><name><surname>Beiraghi</surname><given-names>S</given-names></name><name><surname>Brenner</surname><given-names>C</given-names></name><name><surname>Farber</surname><given-names>SA</given-names></name><name><surname>Ekker</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>p53 activation by knockdown technologies</article-title><source>PLOS Genetics</source><volume>3</volume><elocation-id>e78</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.0030078</pub-id><pub-id pub-id-type="pmid">17530925</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname><given-names>AM</given-names></name><name><surname>Allahyari</surname><given-names>M</given-names></name><name><surname>Vogler</surname><given-names>G</given-names></name><name><surname>Missinato</surname><given-names>MA</given-names></name><name><surname>Nielsen</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>MS</given-names></name><name><surname>Theis</surname><given-names>JL</given-names></name><name><surname>Larsen</surname><given-names>LA</given-names></name><name><surname>Goyal</surname><given-names>P</given-names></name><name><surname>Rosenfeld</surname><given-names>JA</given-names></name><name><surname>Nelson</surname><given-names>TJ</given-names></name><name><surname>Olson</surname><given-names>TM</given-names></name><name><surname>Colas</surname><given-names>AR</given-names></name><name><surname>Grossfeld</surname><given-names>P</given-names></name><name><surname>Bodmer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Model system identification of novel congenital heart disease gene candidates: focus on RPL13</article-title><source>Human Molecular Genetics</source><volume>28</volume><fpage>3954</fpage><lpage>3969</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddz213</pub-id><pub-id pub-id-type="pmid">31625562</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>JA</given-names></name><name><surname>Bloomekatz</surname><given-names>J</given-names></name><name><surname>Garavito-Aguilar</surname><given-names>ZV</given-names></name><name><surname>Yelon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>tal1 Regulates the formation of intercellular junctions and the maintenance of identity in the endocardium</article-title><source>Developmental Biology</source><volume>383</volume><fpage>214</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2013.09.019</pub-id><pub-id pub-id-type="pmid">24075907</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Gable</surname><given-names>AL</given-names></name><name><surname>Lyon</surname><given-names>D</given-names></name><name><surname>Junge</surname><given-names>A</given-names></name><name><surname>Wyder</surname><given-names>S</given-names></name><name><surname>Huerta-Cepas</surname><given-names>J</given-names></name><name><surname>Simonovic</surname><given-names>M</given-names></name><name><surname>Doncheva</surname><given-names>NT</given-names></name><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>LJ</given-names></name><name><surname>von Mering</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D607</fpage><lpage>D613</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id><pub-id pub-id-type="pmid">30476243</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talbot</surname><given-names>JC</given-names></name><name><surname>Amacher</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A streamlined CRISPR pipeline to reliably generate zebrafish frameshifting alleles</article-title><source>Zebrafish</source><volume>11</volume><fpage>583</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1089/zeb.2014.1047</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>S</given-names></name><name><surname>Yamazaki</surname><given-names>Y</given-names></name><name><surname>Kinoshita</surname><given-names>H</given-names></name><name><surname>Kuwahara</surname><given-names>K</given-names></name><name><surname>Nakao</surname><given-names>K</given-names></name><name><surname>Jay</surname><given-names>PY</given-names></name><name><surname>Noda</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Somatic chromosomal translocation between Ewsr1 and Fli1 loci leads to dilated cardiomyopathy in a mouse model</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>7826</elocation-id><pub-id pub-id-type="doi">10.1038/srep07826</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Targoff</surname><given-names>KL</given-names></name><name><surname>Schell</surname><given-names>T</given-names></name><name><surname>Yelon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Nkx genes regulate heart tube extension and exert differential effects on ventricular and atrial cell number</article-title><source>Developmental Biology</source><volume>322</volume><fpage>314</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.07.037</pub-id><pub-id pub-id-type="pmid">18718462</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theis</surname><given-names>JL</given-names></name><name><surname>Hrstka</surname><given-names>SCL</given-names></name><name><surname>Evans</surname><given-names>JM</given-names></name><name><surname>O’Byrne</surname><given-names>MM</given-names></name><name><surname>de Andrade</surname><given-names>M</given-names></name><name><surname>O’Leary</surname><given-names>PW</given-names></name><name><surname>Nelson</surname><given-names>TJ</given-names></name><name><surname>Olson</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Compound heterozygous NOTCH1 mutations underlie impaired cardiogenesis in a patient with hypoplastic left heart syndrome</article-title><source>Human Genetics</source><volume>134</volume><fpage>1003</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1007/s00439-015-1582-1</pub-id><pub-id pub-id-type="pmid">26164125</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theis</surname><given-names>JL</given-names></name><name><surname>Zimmermann</surname><given-names>MT</given-names></name><name><surname>Evans</surname><given-names>JM</given-names></name><name><surname>Eckloff</surname><given-names>BW</given-names></name><name><surname>Wieben</surname><given-names>ED</given-names></name><name><surname>Qureshi</surname><given-names>MY</given-names></name><name><surname>O’Leary</surname><given-names>PW</given-names></name><name><surname>Olson</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Recessive MYH6 mutations in hypoplastic left heart with reduced ejection fraction</article-title><source>Circulation. Cardiovascular Genetics</source><volume>8</volume><fpage>564</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1161/CIRCGENETICS.115.001070</pub-id><pub-id pub-id-type="pmid">26085007</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theis</surname><given-names>JL</given-names></name><name><surname>Vogler</surname><given-names>G</given-names></name><name><surname>Missinato</surname><given-names>MA</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Nielsen</surname><given-names>T</given-names></name><name><surname>Zeng</surname><given-names>X-XI</given-names></name><name><surname>Martinez-Fernandez</surname><given-names>A</given-names></name><name><surname>Walls</surname><given-names>SM</given-names></name><name><surname>Kervadec</surname><given-names>A</given-names></name><name><surname>Kezos</surname><given-names>JN</given-names></name><name><surname>Birker</surname><given-names>K</given-names></name><name><surname>Evans</surname><given-names>JM</given-names></name><name><surname>O’Byrne</surname><given-names>MM</given-names></name><name><surname>Fogarty</surname><given-names>ZC</given-names></name><name><surname>Terzic</surname><given-names>A</given-names></name><name><surname>Grossfeld</surname><given-names>P</given-names></name><name><surname>Ocorr</surname><given-names>K</given-names></name><name><surname>Nelson</surname><given-names>TJ</given-names></name><name><surname>Olson</surname><given-names>TM</given-names></name><name><surname>Colas</surname><given-names>AR</given-names></name><name><surname>Bodmer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Patient-specific genomics and cross-species functional analysis implicate LRP2 in hypoplastic left heart syndrome</article-title><source>eLife</source><volume>9</volume><elocation-id>e59554</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.59554</pub-id><pub-id pub-id-type="pmid">33006316</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiu</surname><given-names>GC</given-names></name><name><surname>Kerr</surname><given-names>CH</given-names></name><name><surname>Forester</surname><given-names>CM</given-names></name><name><surname>Krishnarao</surname><given-names>PS</given-names></name><name><surname>Rosenblatt</surname><given-names>HD</given-names></name><name><surname>Raj</surname><given-names>N</given-names></name><name><surname>Lantz</surname><given-names>TC</given-names></name><name><surname>Zhulyn</surname><given-names>O</given-names></name><name><surname>Bowen</surname><given-names>ME</given-names></name><name><surname>Shokat</surname><given-names>L</given-names></name><name><surname>Attardi</surname><given-names>LD</given-names></name><name><surname>Ruggero</surname><given-names>D</given-names></name><name><surname>Barna</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A p53-dependent translational program directs tissue-selective phenotypes in a model of ribosomopathies</article-title><source>Developmental Cell</source><volume>56</volume><fpage>2089</fpage><lpage>2102</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.06.013</pub-id><pub-id pub-id-type="pmid">34242585</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tögel</surname><given-names>M</given-names></name><name><surname>Meyer</surname><given-names>H</given-names></name><name><surname>Lehmacher</surname><given-names>C</given-names></name><name><surname>Heinisch</surname><given-names>JJ</given-names></name><name><surname>Pass</surname><given-names>G</given-names></name><name><surname>Paululat</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The bHLH transcription factor hand is required for proper wing heart formation in Drosophila</article-title><source>Developmental Biology</source><volume>381</volume><fpage>446</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2013.05.027</pub-id><pub-id pub-id-type="pmid">23747982</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uechi</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>Y</given-names></name><name><surname>Nakao</surname><given-names>A</given-names></name><name><surname>Torihara</surname><given-names>H</given-names></name><name><surname>Chakraborty</surname><given-names>A</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Kenmochi</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ribosomal protein gene knockdown causes developmental defects in zebrafish</article-title><source>PLOS ONE</source><volume>1</volume><elocation-id>e37</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0000037</pub-id><pub-id pub-id-type="pmid">17183665</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachos</surname><given-names>A</given-names></name><name><surname>Osorio</surname><given-names>DS</given-names></name><name><surname>Atsidaftos</surname><given-names>E</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Lababidi</surname><given-names>ML</given-names></name><name><surname>Seiden</surname><given-names>HS</given-names></name><name><surname>Gruber</surname><given-names>D</given-names></name><name><surname>Glader</surname><given-names>BE</given-names></name><name><surname>Onel</surname><given-names>K</given-names></name><name><surname>Farrar</surname><given-names>JE</given-names></name><name><surname>Bodine</surname><given-names>DM</given-names></name><name><surname>Aspesi</surname><given-names>A</given-names></name><name><surname>Dianzani</surname><given-names>I</given-names></name><name><surname>Ramenghi</surname><given-names>U</given-names></name><name><surname>Ellis</surname><given-names>SR</given-names></name><name><surname>Lipton</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Increased prevalence of congenital heart disease in children with Diamond Blackfan anemia suggests unrecognized Diamond Blackfan anemia as a cause of congenital heart disease in the general population: A report of the Diamond Blackfan Anemia Registry</article-title><source>Circulation. Genomic and Precision Medicine</source><volume>11</volume><elocation-id>e002044</elocation-id><pub-id pub-id-type="doi">10.1161/CIRCGENETICS.117.002044</pub-id><pub-id pub-id-type="pmid">29748317</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Vogler</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Gvogler/flyhearts-tdtk-rscripts: first release of the r tdtk script</data-title><source>Zenodo</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.org/records/4749935">https://doi.org/10.5281/zenodo.org/records/4749935</ext-link></element-citation></ref><ref id="bib95"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Vogler</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>Elife-2025-nielsen-et-al</data-title><version designator="swh:1:rev:8916aacfc707805a66184b5b49bf5d4a5f6b5b3b">swh:1:rev:8916aacfc707805a66184b5b49bf5d4a5f6b5b3b</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:76c0a296812b506ec274bb61839fa3b10523b2df;origin=https://github.com/gvogler/elife-2025-nielsen-et-al;visit=swh:1:snp:25953771737aeedfa190f6e4224412ffee353022;anchor=swh:1:rev:8916aacfc707805a66184b5b49bf5d4a5f6b5b3b">https://archive.softwareheritage.org/swh:1:dir:76c0a296812b506ec274bb61839fa3b10523b2df;origin=https://github.com/gvogler/elife-2025-nielsen-et-al;visit=swh:1:snp:25953771737aeedfa190f6e4224412ffee353022;anchor=swh:1:rev:8916aacfc707805a66184b5b49bf5d4a5f6b5b3b</ext-link></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Gise</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Schlegelmilch</surname><given-names>K</given-names></name><name><surname>Honor</surname><given-names>LB</given-names></name><name><surname>Pan</surname><given-names>GM</given-names></name><name><surname>Buck</surname><given-names>JN</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Ishiwata</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Camargo</surname><given-names>FD</given-names></name><name><surname>Pu</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy</article-title><source>PNAS</source><volume>109</volume><fpage>2394</fpage><lpage>2399</lpage><pub-id pub-id-type="doi">10.1073/pnas.1116136109</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Heallen</surname><given-names>T</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration</article-title><source>Nature Reviews Cardiology</source><volume>15</volume><fpage>672</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1038/s41569-018-0063-3</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Leach</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hippo/Yap signaling in cardiac development and regeneration</article-title><source>Current Treatment Options in Cardiovascular Medicine</source><volume>18</volume><elocation-id>38</elocation-id><pub-id pub-id-type="doi">10.1007/s11936-016-0461-y</pub-id><pub-id pub-id-type="pmid">27040401</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>K</given-names></name><name><surname>Bais</surname><given-names>AS</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Feinstein</surname><given-names>TN</given-names></name><name><surname>Nguyen</surname><given-names>PK</given-names></name><name><surname>Criscione</surname><given-names>JD</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Beutner</surname><given-names>G</given-names></name><name><surname>Karunakaran</surname><given-names>KB</given-names></name><name><surname>Rao</surname><given-names>KS</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Adams</surname><given-names>P</given-names></name><name><surname>Kuo</surname><given-names>CK</given-names></name><name><surname>Kostka</surname><given-names>D</given-names></name><name><surname>Pryhuber</surname><given-names>GS</given-names></name><name><surname>Shiva</surname><given-names>S</given-names></name><name><surname>Ganapathiraju</surname><given-names>MK</given-names></name><name><surname>Porter</surname><given-names>GA</given-names></name><name><surname>Lin</surname><given-names>JHI</given-names></name><name><surname>Aronow</surname><given-names>B</given-names></name><name><surname>Lo</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Uncompensated mitochondrial oxidative stress underlies heart failure in an iPSC-derived model of congenital heart disease</article-title><source>Cell Stem Cell</source><volume>29</volume><fpage>840</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2022.03.003</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Gabriel</surname><given-names>GC</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Peterson</surname><given-names>K</given-names></name><name><surname>Murray</surname><given-names>SA</given-names></name><name><surname>Aronow</surname><given-names>BJ</given-names></name><name><surname>Martin</surname><given-names>LJ</given-names></name><name><surname>Benson</surname><given-names>DW</given-names></name><name><surname>Lo</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The genetic landscape of hypoplastic left heart syndrome</article-title><source>Pediatric Cardiology</source><volume>39</volume><fpage>1069</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1007/s00246-018-1861-4</pub-id><pub-id pub-id-type="pmid">29569026</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaich</surname><given-names>L</given-names></name><name><surname>Ooi</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>M</given-names></name><name><surname>Borg</surname><given-names>JP</given-names></name><name><surname>Landry</surname><given-names>C</given-names></name><name><surname>Bodmer</surname><given-names>R</given-names></name><name><surname>Margolis</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Functional analysis of the Numb phosphotyrosine-binding domain using site-directed mutagenesis</article-title><source>The Journal of Biological Chemistry</source><volume>273</volume><fpage>10381</fpage><lpage>10388</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.17.10381</pub-id><pub-id pub-id-type="pmid">9553095</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yi</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nucleolar Stress: hallmarks, sensing mechanism and diseases</article-title><source>Cell Stress</source><volume>2</volume><fpage>125</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.15698/cst2018.06.139</pub-id><pub-id pub-id-type="pmid">31225478</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>M</given-names></name><name><surname>Coldren</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Mattina</surname><given-names>T</given-names></name><name><surname>Goldmuntz</surname><given-names>E</given-names></name><name><surname>Benson</surname><given-names>DW</given-names></name><name><surname>Ivy</surname><given-names>D</given-names></name><name><surname>Perryman</surname><given-names>MB</given-names></name><name><surname>Garrett-Sinha</surname><given-names>LA</given-names></name><name><surname>Grossfeld</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice</article-title><source>Human Molecular Genetics</source><volume>19</volume><fpage>648</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp532</pub-id><pub-id pub-id-type="pmid">19942620</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Daniels</surname><given-names>JP</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Wolf</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cardiac hypertrophy induced by active Raf depends on Yorkie-mediated transcription</article-title><source>Science Signaling</source><volume>8</volume><elocation-id>2005719</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2005719</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>MS</given-names></name><name><surname>Spiering</surname><given-names>S</given-names></name><name><surname>Colas</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Generation of first heart field-like cardiac progenitors and ventricular-like cardiomyocytes from human pluripotent stem cells</article-title><source>Journal of Visualized Experiments</source><volume>136</volume><elocation-id>e57688</elocation-id><pub-id pub-id-type="doi">10.3791/57688</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>LL</given-names></name><name><surname>Green</surname><given-names>A</given-names></name><name><surname>David</surname><given-names>L</given-names></name><name><surname>Dozier</surname><given-names>C</given-names></name><name><surname>Récher</surname><given-names>C</given-names></name><name><surname>Didier</surname><given-names>C</given-names></name><name><surname>Tamburini</surname><given-names>J</given-names></name><name><surname>Manenti</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Targeting CHK1 inhibits cell proliferation in FLT3-ITD positive acute myeloid leukemia</article-title><source>Leukemia Research</source><volume>38</volume><fpage>1342</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1016/j.leukres.2014.08.020</pub-id><pub-id pub-id-type="pmid">25281057</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanon</surname><given-names>A</given-names></name><name><surname>Kalvakuri</surname><given-names>S</given-names></name><name><surname>Rakovic</surname><given-names>A</given-names></name><name><surname>Foco</surname><given-names>L</given-names></name><name><surname>Guida</surname><given-names>M</given-names></name><name><surname>Schwienbacher</surname><given-names>C</given-names></name><name><surname>Serafin</surname><given-names>A</given-names></name><name><surname>Rudolph</surname><given-names>F</given-names></name><name><surname>Trilck</surname><given-names>M</given-names></name><name><surname>Grünewald</surname><given-names>A</given-names></name><name><surname>Stanslowsky</surname><given-names>N</given-names></name><name><surname>Wegner</surname><given-names>F</given-names></name><name><surname>Giorgio</surname><given-names>V</given-names></name><name><surname>Lavdas</surname><given-names>AA</given-names></name><name><surname>Bodmer</surname><given-names>R</given-names></name><name><surname>Pramstaller</surname><given-names>PP</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Hicks</surname><given-names>AA</given-names></name><name><surname>Pichler</surname><given-names>I</given-names></name><name><surname>Seibler</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and <italic>Drosophila</italic></article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>2412</fpage><lpage>2425</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx132</pub-id><pub-id pub-id-type="pmid">28379402</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>XXI</given-names></name><name><surname>Yelon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cadm4 restricts the production of cardiac outflow tract progenitor cells</article-title><source>Cell Reports</source><volume>7</volume><fpage>951</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.04.013</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy</article-title><source>PNAS</source><volume>100</volume><fpage>11636</fpage><lpage>11641</lpage><pub-id pub-id-type="doi">10.1073/pnas.1934692100</pub-id><pub-id pub-id-type="pmid">13130078</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Signaling to p53: ribosomal proteins find their way</article-title><source>Cancer Cell</source><volume>16</volume><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2009.09.024</pub-id><pub-id pub-id-type="pmid">19878869</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Liao</surname><given-names>WJ</given-names></name><name><surname>Liao</surname><given-names>JM</given-names></name><name><surname>Liao</surname><given-names>P</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ribosomal proteins: functions beyond the ribosome</article-title><source>Journal of Molecular Cell Biology</source><volume>7</volume><fpage>92</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1093/jmcb/mjv014</pub-id><pub-id pub-id-type="pmid">25735597</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.106231.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jagla</surname><given-names>Krzysztof</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052d1cv78</institution-id><institution>GReD Laboratory/Clermont-Auvergne University</institution></institution-wrap><addr-line><named-content content-type="city">Aubière</named-content></addr-line><country>France</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study applies an innovative multi-model strategy to implicate the ribosomal protein (RP) encoding genes as candidates causing Hypoplastic Left Heart Syndrome. The evidence from the screen in stem cell-derived cardiomyocytes and whole genome sequencing of human patients, followed by functional analyses of RP genes in fly and fish models, is <bold>convincing</bold> and supports the authors' claims. This work and methodology applied would be of broad interest to medical biologists working on congenital heart diseases.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.106231.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Nielsen et al have identified a new disease mechanism underlying hypoplastic left heart syndrome due to variants in ribosomal protein genes that lead to impaired cardiomyocyte proliferation. This detailed study starts with an elegant screen in stem cell derived cardiomyocytes and whole genome sequencing of human patients and extends to careful functional analysis of RP gene variants in fly and fish models. Striking phenotypic rescue is seen by modulating known regulators of proliferation including the p53 and Hippo pathways. Additional experiments suggest that cell type specificity of the variants in these ubiquitously expressed genes may result from genetic interactions with cardiac transcription factors. This work positions RPs as important regulators of cardiomyocyte proliferation and differentiation involved in the etiology of HLHS, and point to potential downstream mechanisms.</p><p>The revised manuscript has been extended, facilitating interpretation and reinforcing the authors' conclusions.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.106231.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Tanja Nielsen et al. presents a novel strategy for identification of candidate genes in Congenital Heart Disease (CHD). Their methodology, which is based on comprehensive experiments across cell models, drosophila and zebrafish models, represents an innovative, refreshing and very useful set of tools for identification of disease genes, in a field which are struggling with exactly this problem.</p><p>The authors have applied their methodology to investigate the pathomechanisms of Hypoplastic Left Heart Syndrome (HLHS) - a severe and rare subphenotype in the large spectrum of CHD malformations. Their data convincingly implicates ribosomal proteins (RPs) in growth and proliferation defects of cardiomyocytes, a mechanism which is suspected to be associated with HLHS.</p><p>By whole genome sequencing analysis of a small cohort of trios (25 HLHS patients and their parents) the authors investigated a possible association between RP encoding genes and HLHS.</p><p>Although the possible association between defective RPs and HLHS needs to be verified, the results suggest a novel disease mechanism in HLHS, which is a potentially substantial advance in our understanding of HLHS and CHD. The conclusions of the paper are based on solid experimental evidence from appropriate high- to medium-throughput models, while additional genetic results from an independent patient cohort is needed to verify an association between RP encoding genes and HLHS in patients.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.106231.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nielsen</surname><given-names>Tanja</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Kervadec</surname><given-names>Anaïs</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Theis</surname><given-names>Jeanne L</given-names></name><role specific-use="author">Author</role><aff><institution>Mayo Clinic</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Missinato</surname><given-names>Maria A</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Marchant</surname><given-names>James</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Romero</surname><given-names>Michaela</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Marchetti</surname><given-names>Katya</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Lamba</surname><given-names>Aashna</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Xin-Xin I</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Berenguer</surname><given-names>Marie</given-names></name><role specific-use="author">Author</role><aff><institution>Univ. Bordeaux,</institution><addr-line><named-content content-type="city">Bordeaux</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Walls</surname><given-names>Stanley M</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Schroeder</surname><given-names>Analyne</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys' Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Birker</surname><given-names>Katja</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Duester</surname><given-names>Greg</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford-Burnham-Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Grossfeld</surname><given-names>Paul</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, San Diego</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Nelson</surname><given-names>Timothy J</given-names></name><role specific-use="author">Author</role><aff><institution>Mayo Clinic</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Olson</surname><given-names>Timothy M</given-names></name><role specific-use="author">Author</role><aff><institution>Mayo Clinic</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Ocorr</surname><given-names>Karen</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Bodmer</surname><given-names>Rolf</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Vogler</surname><given-names>Georg</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Colas</surname><given-names>Alexandre R</given-names></name><role specific-use="author">Author</role><aff><institution>Sanford Burnham Prebys Medical Discovery Institute</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public review):</bold></p><p>Nielsen et al have identified a new disease mechanism underlying hypoplastic left heart syndrome due to variants in ribosomal protein genes that lead to impaired cardiomyocyte proliferation. This detailed study starts with an elegant screen in stemcell-derived cardiomyocytes and whole genome sequencing of human patients and extends to careful functional analysis of RP gene variants in fly and fish models. Striking phenotypic rescue is seen by modulating known regulators of proliferation, including the p53 and Hippo pathways. Additional experiments suggest that the cell type specificity of the variants in these ubiquitously expressed genes may result from genetic interactions with cardiac transcription factors. This work positions RPs as important regulators of cardiomyocyte proliferation and differentiation involved in the etiology of HLHS, although the downstream mechanisms are unclear.</p></disp-quote><p>We thank Reviewer 1 for the thoughtful assessment of our manuscript. Our point-bypoint responses to the recommendations are provided (Reviewer 1, “Recommendations for the authors”).</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Tanja Nielsen et al. present a novel strategy for the identification of candidate genes in Congenital Heart Disease (CHD). Their methodology, which is based on comprehensive experiments across cell models, Drosophila and zebrafish models, represents an innovative, refreshing and very useful set of tools for the identification of disease genes, in a field which are struggling with exactly this problem. The authors have applied their methodology to investigate the pathomechanisms of Hypoplastic Left Heart Syndrome (HLHS) - a severe and rare subphenotype in the large spectrum of CHD malformations. Their data convincingly implicates ribosomal proteins (RPs) in growth and proliferation defects of cardiomyocytes, a mechanism which is suspected to be associated with HLHS.</p><p>By whole genome sequencing analysis of a small cohort of trios (25 HLHS patients and their parents), the authors investigated a possible association between RP encoding genes and HLHS. Although the possible association between defective RPs and HLHS needs to be verified, the results suggest a novel disease mechanism in HLHS, which is a potentially substantial advance in our understanding of HLHS and CHD. The conclusions of the paper are based on solid experimental evidence from appropriate high- to medium-throughput models, while additional genetic results from an independent patient cohort are needed to verify an association between RP encoding genes and HLHS in patients.</p></disp-quote><p>We thank Reviewer 2 for the thoughtful assessment of our manuscript. Our point-by-point responses to the recommendations are provided (Reviewer 2, “Recommendations for the authors”).</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>(1) Despite an interesting surveillance model, the disease-causing mechanisms directly downstream of the RP variants remain unclear. Can the authors provide any evidence for abnormal ribosomes or defects in translation in cells harboring such variants? The possibility that reduced translation of cardiac transcription factors such as TBX5 and NKX2-5 may contribute to the functional interactions observed should be considered. How do the authors consider that the RP variants are affecting transcript levels as observed in the study?</p></disp-quote><p>Our model implies that cell cycle arrest does not require abnormal ribosomes or translational defects but instead relies on the sensing of RP levels or mutations as a fitness-sensing mechanism that activates TP53/CDKN1A-dependent arrest. Supporting this framework, we observed no significant changes in TBX5 or NKX2-5 expression (data not shown), but rather an upregulation of CDKN1A levels upon RP KD.</p><disp-quote content-type="editor-comment"><p>(2) The authors suggest that a nucleolar stress program is activated in cells harboring RP gene variants. Can they provide additional evidence for this beyond p53 activation?</p></disp-quote><p>We added additional data to support nucleolar stress (Suppl. Fig. 6) and text (lines 52635):</p><p>To determine whether cardiac KD of <italic>RpS15Aa</italic> causes nucleolar stress in the <italic>Drosophila</italic> heart, we stained larval hearts for Fibrillarin, a marker for nucleoli and nucleolar integrity. We found that <italic>RpS15Aa</italic> KD causes expansion of nucleolar Fibrillarin staining in cardiomyocyte, which is a hallmark of nucleolar stress (Suppl. Fig. 6A-C). As a control, we also performed cardiac KD of <italic>Nopp140</italic>, which is known to cause nucleolar stress upon loss-of-function. We found a similar expansion of Fibrillarin staining in larval cardiomyocyte nuclei (Suppl. Fig. 6C,D). This suggests that <italic>RpS15Aa</italic> KD indeed causes nucleolar stress in the <italic>Drosophila</italic> heart, that likely contributes to the dramatic heart loss in adults.</p><disp-quote content-type="editor-comment"><p>Other recommendations:</p><p><italic>(3) Concerning the cell type specificity, in the proliferation screen, were similar effects seen on the actinin negative as actinin positive EdU+ cells? It would be helpful to refer to the fibroblast result shown in Supplementary Figure 1C in the results section.</italic></p></disp-quote><p>As suggested by reviewer #1, we have added a reference to Supplementary Fig. 1C, D and noted that RP knockdown exerts a non–CM-specific effect on proliferation.</p><disp-quote content-type="editor-comment"><p>(4) The authors refer to HLHS patients with atrial septal defects and reduced right ventricular ejection fraction. Please clarify the specificity of the new findings to HLHS versus other forms of CHD, as implied in several places in the manuscript, including the abstract.</p></disp-quote><p>This study focused on a cohort of 25 HLHS proband-parent trios selected for poor clinical outcome, including restrictive atrial septal defect and reduced right ventricular ejection fraction. We have revised the following sentence in response to the Reviewer’s comment (lines 567-571): “While our study highlights the potential of this approach for gene prioritization, additional research is needed to directly demonstrate the functional consequence of the identified genetic variants, verify an association between RP encoding genes and HLHS in other patient cohorts with and without poor outcome, and determine if RP variants have a broader role in CHD susceptibility.</p><disp-quote content-type="editor-comment"><p>(5) The multi-model approach taken by the authors is clearly a good system for characterizing disease-causing variants. Did the authors score for cardiomyocyte proliferation or the time of phenotypic onset in the zebrafish model?</p></disp-quote><p>We used an antibody against phosphohistone 3 to identify proliferating cells and DAPI to identify all cardiac cells in control injected, rps15a morphants, and rps15a crispants. We found that cell numbers and proliferating cells were significantly reduced at 24 and 48 hpf. By 72 hpf cardiac cell proliferation is greatly diminished even in controls, where proliferation typically declines.</p><disp-quote content-type="editor-comment"><p>Reduced ventricular cardiomyocyte numbers could potentially result from impaired addition of LTPB3-expressing progenitors. In experiments where altered cardiac rhythm is observed, please comment on the possible links to proliferation.</p></disp-quote><p>Heart function data showed that heart period (R-R interval) was unaffected in morphants and crispants at 72 hpf where we also observed significant reductions in cell numbers. This suggests that the bradycardia observed in the rps15a + nkx2.5 or tbx5a double KD (Sup. Fig. 5D &amp; E) was not due to the reduction in cell numbers alone.</p><fig id="sa3fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-sa3-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>Finally, the use of the mouse to model HLHS in potential follow-up studies should be discussed.</p></disp-quote><p>We have added a mouse model comment to the discussion (lines 571-74): “In conclusion, we propose that the approach outlined in this study provides a novel framework for rapidly prioritizing candidate genes and systematically testing them, individually or in combination, using a CRISPR/Cas9 genome-editing strategy in mouse embryos (PMID: 28794185)”.</p><disp-quote content-type="editor-comment"><p>(6) When the authors scored proliferation in cells from the proband in family 75H, did they validate that RPS15A expression is reduced, consistent with a regulatory region defect?</p></disp-quote><p>Good point. We examined RPS15A expression in these cells and found no significant reduction in gene expression in day 25 cardiomyocytes (data not shown). One possible explanation is that this variant may regulate RPS15A expression in a stage-specific manner during differentiation or under additional stress conditions.</p><disp-quote content-type="editor-comment"><p>(7) Minor point. Typo on line 494: comma should be placed after KD, not before.</p></disp-quote><p>Thank you, this has now been corrected (new line 490)</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>(1) The authors are invited to revise the part of the manuscript that describes the genetic analysis and provide a more balanced discussion of the WGS data, with a conclusion that aligns with the strength of the human genetic data.</p></disp-quote><p>We disagree with reviewer #2’s assessment. The goal of our study is not to apply a classical genetic approach to establish variant pathogenicity, but rather to employ a multidisciplinary framework to prioritize candidate genes and variants and to examine their roles in heart development using model systems. In this context, genetic analysis serves primarily as a filtering tool rather than as a means of definitively establishing causality.</p><disp-quote content-type="editor-comment"><p>(2) The genetic analysis of patients does not appear to provide strong evidence for an association between RP gene variants and HLHS. More information regarding methodology and the identified variants is needed.</p></disp-quote><p>HLHS is widely recognized as an oligogenic and heterogeneous genetic disease in which traditional genetic analyses have consistently failed to prioritize any specific gene class as reviewer#2 is pointing out. Therefore, relying solely on genetic analysis is unlikely to yield strong evidence for association with a given gene class. This limitation provides the rationale for our multidisciplinary gene prioritization strategy, which leverages model systems to interrogate candidate gene function. Ultimately, definitive validation of this approach will require studies in relevant in vivo models to establish causality within the context of a four-chambered heart (see also Discussion).</p><disp-quote content-type="editor-comment"><p>In Table S2, it would be appropriate to provide information on sequence, MAF, and CADD. Please note the source of MAF% (GnomAD version?, which population?).</p></disp-quote><p>As summarized in Figure 2A, the 292 genes from the families with the 25 proband with poor outcome displayed in Supplemental Table 2 fulfilled a comprehensive candidate gene prioritization algorithm based on the variant, gene, inheritance, and enrichment, which required all of the following: (1) variants identified by whole genome sequencing with minor allele frequency &lt;1%; (2) missense, loss-of-function, canonical splice, or promoter variants; (3) upper quartile fetal heart expression; and (4) De novo or recessive inheritance. Unbiased network analysis of these 292 genes, which are displayed in Supplemental Table 2 for completeness, identified statistically significant enrichment of ribosomal proteins. The details about MAF, CADD score, and sequence highlighted by the Reviewer are provided for the RP genes in Table 1, which are central to the focus and findings of the manuscript.</p><disp-quote content-type="editor-comment"><p>It would also be helpful for the reader if genome coordinates (e.g., 16-11851493-G-A for RSL1D1 p.A7V) were provided for each variant in both Table 1 and S2.</p></disp-quote><p>Genome coordinates have been added to Table 1.</p><disp-quote content-type="editor-comment"><p>(3) The dataset from the hPSC-CM screen could be of high value for the community. It would be appropriate if the complete dataset were made available in a usable format.</p></disp-quote><p>The dataset from the hPSC-CM screen has been added to the manuscript as Supp Table 1</p><disp-quote content-type="editor-comment"><p>(4) The &quot;rare predicted-damaging promoter variant in RPS15A&quot; (c.-95G&gt;A) does not appear so rare. Considering the MAF of 0,00662, the frequency of heterozygous carriers of this variant is 1 out of 76 individuals in the general population. Thus, considering the frequency of HLHS in the population (2-3 out of 10,000) and the small size of family 75H, the data do not appear to indicate any association between this particular variant and HLHS. The variants in Table 1 also appear to have relatively mild effects on the gene product, judging from the MAF and CADD scores. The authors are invited to discuss why they find these variants disease-causing in HLHS.</p></disp-quote><p>Our study design is based on the widely held premise that HLHS is an oligogenic disorder. Our multi-model systems platform centered on comprehensive filtering of coding and regulatory variants identified by whole genome sequencing of HLHS probands to identify candidate genes associated with susceptibility to this rare developmental phenotype. 75H proved to be a high-value family for generating a relatively short list of candidate genes for left-sided CHD. Given the rarity of both left-sided CHD and the <italic>RPS15A</italic> variant identified in the HLHS proband and his 5th degree relative, with a frequency consistent with a risk allele for an oligogenic disorder, we made the reasonable assumption that this was a <italic>bona fide</italic> genotype-phenotype association rather than a chance occurrence. Moreover, incomplete penetrance and variable expression is consistent with a genetically complex basis of disease whereby the shared variant is risk-conferring and acts in conjunction with additional genetic, epigenetic, and/or environmental factors that lead to a left-sided CHD phenotype. In sum, we do not claim these variants are definitively disease causing, but rather potentially contributing risk factors.</p><disp-quote content-type="editor-comment"><p>(5) Information is lacking on how clustering of RP genes was demonstrated using STRING (with P-values that support the conclusions). What is meant by &quot;when the highest stringency filter was applied&quot;? Does this refer to the STRING interaction score or something else? The authors could also explain which genes were used to search STRING (e.g., all 292 candidate genes) and provide information on the STRING interaction score used in the analysis, the number of nodes and edges in the network.</p></disp-quote><p>To determine whether certain gene networks were over-represented, two online bioinformatics tools were used. First, genes were inputted into STRING (Author response image 2) to investigate experimental and predicted protein-protein and genetic interactions. Clustering of ribosomal protein genes was demonstrated when applying the highest stringency filter. Next, genes were analyzed for potential enrichment of genes by ontology classification using PANTHER .Applying Fisher’s exact test and false discovery rate corrections, ribosomal proteins were the most enriched class when compared to the reference proteome, including data annotated by molecular function (4.84-fold, p=0.02), protein class (6.45-fold, p=0.00001), and cellular component (9.50fold, p=0.001). A majority of the identified RP candidate genes harbored variants that fit a recessive inheritance disease model.</p><fig id="sa3fig2" position="float"><label>Author response image 2.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106231-sa3-fig2-v1.tif"/></fig></body></sub-article></article>